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ABSTRACT OF THE DISSERTATION 
THE ROLE OF THE TRANSCRIPTION FACTOR ETS1 IN MELANOCYTE 
DEVELOPMENT 
by 
Amy Saldana Tavares 
Florida International University, 2014 
Miami, Florida 
Professor Lidia Kos, Major Professor 
Melanocytes, pigment-producing cells, derive from the neural crest (NC), a 
population of pluripotent cells that arise from the dorsal aspect of the neural tube during 
embryogenesis. Many genes required for melanocyte development were identified using 
mouse pigmentation mutants. The deletion of the transcription factor Ets1 in mice results in 
hypopigmentation; nevertheless, the function of Ets1 in melanocyte development is 
unknown. The goal of the present study was to establish the temporal requirement and role 
of Ets1 in murine melanocyte development. In the mouse, Ets1 is widely expressed in 
developing organs and tissues, including the NC. In the chick cranial NC, Ets1 is required 
for the expression of Sox10, a transcription factor critical for the development of 
melanocytes, enteric ganglia, and other NC derivatives.  
Using a combination of immunofluorescence and cell survival assays Ets1 was 
found to be required between embryonic days 10 and 11, when it regulates NC cell and 
melanocyte precursor (melanoblast) survival. Given the requirement of Ets1 for Sox10 
expression in the chick cranial NC, a potential interaction between these genes was 
investigated. Using genetic crosses, a synergistic genetic interaction between Ets1 and 
	  viii 
	  
Sox10 in melanocyte development was found. Since Sox10 is essential for enteric ganglia 
formation, the importance of Ets1 on gut innervation was also examined. In mice, Ets1 
deletion led to decreased gut innervation, which was exacerbated by Sox10 heterozygosity.  
At the molecular level, Ets1 was found to activate a Sox10 enhancer critical for 
Sox10 expression in melanoblasts.  Furthermore, mutating Ets1 at a site I characterized in 
the spontaneous variable spotting mouse pigmentation mutant, led to a 2-fold decrease in 
enhancer activation. Overexpression and knockdown of Ets1 did not affect Sox10 
expression; nonetheless, Ets1 knockdown led to a 6-fold upregulation of the transcription 
factor Sox9, a gene required for melanocyte and chondrocyte development, but which 
impairs melanocyte development when its expression is prolonged. Together, these results 
suggest that Ets1 is required early during melanocyte development for NC cell and 
melanoblast survival, possibly acting upstream of Sox10. The transcription factor Ets1 may 
also act indirectly in melanocyte fate specification by repressing Sox9 expression, and 
consequently cartilage fate.  
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I. INTRODUCTION 
Melanocytes, the pigment producing cells, are derived from neural crest (NC) 
cells, a population of pluripotent cells that arise from the dorsal aspect of the neural tube 
during vertebrate embryogenesis (Le Douarin and Kalcheim, 1999). Neural crest cells 
undergo an epithelial to mesenchymal transition (EMT) and migrate out of the neural 
tube along distinct pathways to contribute to different tissues and organs (Le Douarin et 
al., 2004). In addition to melanocytes, other NC-derived lineages include endocrine cells, 
glial cells, neurons, craniofacial bone and cartilage, and cardiac cells (Le Douarin and 
Kalcheim, 1999). Defects in NC cell development result in a range of human disorders 
known as Neurocristopathies (Bolande, 1997). These include craniofacial malformations, 
cardio- and neurocutaneous syndromes, Waardenburg Syndrome (WS), Hirschsprung’s 
disease, Tietz Syndrome, and piebaldism, among others (reviewed in Hou and Pavan, 
2008; Pingault et al., 2010). 
Neurocristopathies are caused by mutations in genes required for proper NC cell 
development. Mutations in the transcription factors sex determining region Y (SRY)-box 
10 (SOX10), paired box 3 (PAX3), Microphthalmia-associated transcription factor 
(MITF) and snail homolog 2 (SNAI2) and in the signaling molecules Endothelin 3 
(EDN3) and Endothelin receptor b (EDNRB) are responsible for the four different known 
types of WS. Waardenburg Syndrome is characterized by pigmentation defects, 
congenital deafness, and heterochromia irides; however, other anomalies, such as 
craniofacial and limb abnormalities, aganglionosis of the distal colon (Hirschsprung’s 
disease), and neurological defects are found in a group of WS patients and serve for the 
classification of the different types of WS.  The study of mouse pigmentation mutants 
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was instrumental in the identification of the genes involved in WS (reviewed in 
Tachibana et al., 2003) (Figure 1.1). The first indication that PAX3 mutations were 
responsible for WS type I was the identification of loss of function mutations in the 
murine ortholog Pax3 gene in the Splotch mouse, an embryonic lethal pigmentation 
mutant that exhibits neural tube and NC defects (Tassabehji et al., 1992). In the same 
manner, the piebald lethal and lethal spotting mouse mutants, which harbor spontaneous 
mutations in Ednrb and Edn3 respectively, were instrumental for the identification of 
mutations in these genes in WS type IV and in Hirschsprung’s disease (Hosoda et al., 
1994; Puffenberger et al., 1994). The study of mouse pigmentation mutants has also been 
important for the elucidation of signaling pathways required for proper melanocyte and 
NC cell development and for understanding other pathological conditions of NC-derived 
cell lineages (Barsh, 1996; Baxter et al., 2004) 
1.1 The neural crest 
1.1.1 Neural crest induction 
The neural crest (NC) is a transient population of cells that originates during 
embryonic development, between the neural ectoderm and the non-neural ectoderm, 
which give rise to the central nervous system and the epidermis, respectively (Le Douarin 
and Kalcheim, 1999). Neural crest cells delaminate from the dorsal aspect of the neural 
tube and travel through the embryo giving rise to various cell lineages, which include 
neurons and glia of the sympathetic, parasympathetic, and sensory nervous systems, 
smooth muscle cells, facial cartilage and bone cells, medullary secretory cells, and 
pigment cells or melanocytes (reviewed in Dupin et al., 2006). Much of what is known 
about the NC has been elucidated using avian and amphibian embryos, since these 
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develop externally, and are easier to manipulate than mouse embryos. Additionally, NC 
cells arise very early in development, at a time when mouse embryos are difficult to 
experiment on as a result of their small size (Gammill and Bronner-Fraser, 2003). 
Transplantation and in vitro culture experiments using quail and chick neural 
plate and prospective epidermis have demonstrated that both the neural and the non-
neural ectoderm contribute to the formation of the NC. Nonetheless, older neural plates, 
in the absence of prospective epidermis, are able to give rise to certain NC derivatives, 
particularly melanocytes, under permissive culture conditions (Selleck and Broner-Fraser, 
1995). The paraxial mesoderm, which gives rise to paired somites from which the axial 
skeleton and skeletal muscles are derived, was also found to contribute to NC cell 
formation (Selleck and Broner-Fraser, 1995; Bonstein et al., 1999).  
Several secreted signaling molecules are required for the induction of the NC 
(Figure 1.2). Intermediate levels of Bone Morphogenetic Proteins (BMPs) at the neural 
plate border were initially thought to be required for NC induction (Marchant et al., 1998; 
Tribulo et al., 2003). Bone Morphogenetic Protein levels are controlled by the BMP 
antagonists, Noggin, Chordin and Follistatin, all of which are expressed in the paraxial 
mesoderm and are important for embryonic patterning (reviewed in Sauka-Spengler and 
Bronner-Fraser, 2008). Experiments in the avian system using the BMP inhibitor Noggin 
later showed that BMPs are not required for NC induction, but rather appear to be 
required after neural tube closure for the maintenance of the induced NC cell population 
(Selleck et al., 1998). Similar experiments in Xenopus, using the BMP inhibitor Chordin, 
showed that intermediate levels of BMP signaling are not essential for NC induction 
(LaBonne and Broner-Fraser, 1998). In frogs and birds, BMP appears to be regulated via 
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Notch-Delta signaling. In the avian system, Notch activation via Delta1 was found to be 
required for BMP4 expression in the epidermis and for inhibiting NC formation in this 
region (Endo et al., 2002). The requirement of Notch for both BMP4 expression and 
inhibition of NC cell formation in the epidermis suggests that Notch signaling is not only 
important for NC formation or maintenance via BMP4, but also for restricting the NC to 
the neural plate border (Sauka-Spengler and Bronner-Fraser, 2008). In addition to BMPs 
and Notch, in Xenopus, fibroblast growth factor (FGF) signaling proteins from the 
paraxial mesoderm, particularly FGF2 and FGF8, have been found to be important for 
NC induction (reviewed in Gammill and Bronner-Fraser, 2003; Sauka-Spengler and 
Bronner-Fraser, 2008).  
Experiments in Xenopus, zebrafish, and the chick have placed the canonical Wnt 
signaling pathway at the center of NC induction. In Xenopus, β-catenin overexpression 
can cell autonomously induce the expression of the NC marker Slug in cells that normally 
give rise to the epidermis (LaBonne and Broner-Fraser, 1998). Furthermore, 
overexpression of Wnt3a in the neuroectoderm can expand the number of cells expressing 
the NC markers Slug and Krox20, even in the presence of proliferation inhibitors. 
Conversely, overexpression of the β-catenin inhibitor, glycogen synthase kinase 3 beta 
(GSK3β), was found to inhibit NC cell formation (Saint-Jeannet et al., 1997). Similarly, 
in zebrafish, early blockage of Wnt signaling results in a significant loss of expression of 
NC cell markers. Moreover, transplantation experiments confirmed that Wnt acts cell-
autonomously to direct the formation of NC cells (Lewis et al., 2004). In the chick, 
blocking Wnt signaling inhibits the expression of the NC cell marker Slug. On the other 
hand, incubating naïve neural plate cells in medium containing the Drosophila Wnt 
	  6 
	  
homolog wingless, can induce NC cell formation, in the absence of other factors. These 
experiments showed that Wnt signaling is both required and sufficient for NC induction 
in the chick embryo (Garcia-Castro et al., 2002).  
In the mouse, the role of the canonical Wnt signaling pathway in NC induction 
has not been well established (Sauka-Spengler and Bronner-Fraser, 2008). Double 
knockout mouse embryos of Wnt1 and Wnt3a have severely reduced numbers of cells 
expressing NC markers and decreased numbers of NC derivatives. Similarly, conditional 
β-catenin knockout mice have severe abnormalities in cranial NC cell derivatives, but the 
expression of NC cell markers is unaffected in these embryos. Given the normal levels of 
NC cell marker expression in β-catenin knockout mice, it is unclear whether the decrease 
in NC cells seen in these mutant embryos is the result of improper NC formation or of 
decreased survival or proliferation (reviewed in Wu et al., 2003). 
1.1.2 Specification of the neural plate border and neural crest specifier genes. 
The induction signals at the border between the neural and non-neural ectoderm, 
lead to the expression of transcription factors that serve to specify the neural plate border, 
which is the region from which NC cells will be derived (Figure 1.2). The transcription 
factors expressed in this region are known as neural plate border specifiers (Sauka-
Spengler and Bronner-Fraser, 2008). The neural plate border is not a well demarcated 
area (Sargent, 2006). Fate mapping experiments in the chick embryo have shown that NC 
cells are interspersed with otic placode precursor cells, epidermal, and neural progenitor 
cells in this region (Streit, 2002). The neural plate border specifier genes include the zinc-
finger transcription factor Zic1, the activating enhancer binding protein 2 alpha (TFAP2 
or AP2) transcription factor, members of the paired box family of transcription factors 
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Pax3 and Pax7, the homeobox transcriptional repressors Msx1 and Msx2, and the 
homeodomain transcription factors Dlx3 and Dlx5 (Figure 1.2) (reviewed in Gammill and 
Bronner-Fraser, 2003; Sargent, 2006; Sauka-Spengler and Bronner-Fraser, 2008). The 
expression of these genes at the neural plate border is required for the subsequent 
specification of NC cells. In addition to being expressed in prospective NC cells, some of 
the neural plate border specifiers are expressed in the neural plate while others are 
expressed in the non-neural ectoderm (reviewed in Gammill and Bronner-Fraser, 2003).  
In the mouse, most neural plate border specifiers begin to be expressed at embryonic day 
(E) 7.5, around the time the neural folds form (reviewed in Stuhlmiller and Garcia-
Castro, 2012).  
Following neural plate border specification, a group of transcription factors 
required for the specification of NC cells is upregulated. Neural crest specifier 
transcription factors include Snail2, Sex determining region Y (SRY)-box 9 (Sox9), 
Sox10 and Forkhead box D3 (FoxD3) (Figure 1.2). In the mouse, Sox9, Sox10 and FoxD3 
are expressed in the neural folds soon after the neural plate border is specified and right 
before the initiation of cranial NC cell migration around E8 (reviewed in Stuhlmiller and 
Garcia-Castro, 2012). The expression of NC specifiers is essential for the maintenance of 
the NC population and for the epithelial-to-mesenchymal transition (EMT), delamination 
and migration that these cells must undergo in order to reach their final destinations 
(Sauka-Spengler and Bronner-Fraser, 2008). Members of the Snail family of transcription 
factors seem to play an essential role in NC specification and EMT in chick (Nieto et al., 
1994; Del Barrio and Nieto, 2002; Taneyhill et al., 2007), and frog (Carl et al., 1999; 
LaBonne and Bronner-Fraser, 2000) embryos, however; in the mouse embryo, migrating 
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NC cells can be detected in double knockouts of the Snail and Slug mouse homologs 
Snai1 and Snai2, respectively, which suggests that other transcription factors are able to 
compensate for the deficiency of these two (Murray and Gridley, 2006). The transcription 
factor FoxD3 is also involved in NC specification. It is expressed in almost all pre-
migratory and migratory NC cells, except for cells fated to become melanocyte 
precursors (melanoblasts) (Kos et al., 2001). In NC cells, FoxD3 cooperates with Snail2, 
Sox9 and Sox10 to promote the changes required for EMT (reviewed in Theveneau and 
Mayor, 2012). 
The transcription factors Sox9 and Sox10 are expressed in the pre-migratory NC 
in the frog and zebrafish. In the frog, Sox9 expression is maintained in migrating NC cells 
(Spokony et al., 2002). In the mouse, Sox9 is expressed in pre-migratory and migratory 
NC cells, while Sox10 expression is initiated at the onset of NC cell migration. The 
transcription factor Sox9 is required for the formation of NC precursor cells by driving 
the expression of other NC cell markers, including Sox10 (Cheung and Briscoe, 2003; 
Cheung et al., 2005; Betancur et al., 2010). In addition to its importance for NC cell 
formation, Sox9 is also required for NC cell survival (Yan et al., 2005; Cheung et al., 
2005) and delamination (Cheung et al., 2003). Like Sox9, Sox10 is also essential for NC 
cell survival; however, it does not appear to be required for the initial specification of the 
NC cells (Southard-Smith et al., 1998; Kapur, 1999). Sox10 also appears to be required 
for maintaining the pluripotency of NC cells (Kim et al., 2003; McKeown et al., 2005), 
and in cooperation with Sox9, FoxD3 and Snail, it is also involved in NC cell 
delamination (McKeown et al., 2005; reviewed in Theveneau and Mayor, 2012). 
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1.1.3 Neural crest delamination and neural crest derivatives 
 Neural crest delamination refers to the segregation of the NC into separate 
populations. The process of NC delamination varies according to the region along the 
anterior-posterior axis from which the cells delaminate. Cranial NC cell delamination 
occurs all at once, while trunk NC cells delaminate gradually in a cranial to caudal order. 
In the mouse, cranial NC cells delaminate prior to the closure of the neural tube, while 
trunk NC cells migrate after neural tube closure (reviewed in Theveneau and Mayor, 
2012). Nevertheless, neural tube closure and NC cell delamination do not appear to be 
related, as NC cell delamination and NC derivatives are unaffected in Pax3 null mouse 
embryos, in which failure of neural tube closure results in severe spina bifida (Estiberio 
et al., 1993; Franz, 1993).  
 Neural crest cell delamination has been mostly studied in the chick embryo; 
however, the general events and signaling cascades at work are common to other 
vertebrate species (Sauka-Spengler and Bronner-Fraser, 2008). As a result of somite 
maturation, BMP and Wnt signaling promote EMT via activation of the transcription 
factors FoxD3, Snail2, Sox8 and Sox9. The combined effect of these transcription factors 
is a shift in the expression of calcium-dependent adhesion proteins, or Cadherins, from 
type I Cadherins, like E-Cadherin and N-Cadherin, which are associated with stable 
epithelial and neuronal cell assemblies, respectively, to type II cadherins, like Cadherin 
6B, Cadherins 7 and 11, which are expressed in mesenchymal cells (Figure 1.2) 
(reviewed in Sauka-Spengler and Bronner-Fraser, 2008; Theveneau and Mayor, 2012). 
The transcription factors FoxD3, Snail2, Sox8 and Sox9 also activate the expression of 
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extracellular signaling molecules and cytoskeletal proteins and promote laminin synthesis 
and the degradation of the basal lamina (Theveneau and Mayor, 2012). 
 Neural crest cells are divided into four overlapping domains, along the anterior-
posterior axis, which give rise to different cell lineages. Nonetheless, NC cells from 
different levels or domains contribute to both distinct and overlapping derivatives 
(Bronner and Le Douarin, 2012). The four NC domains are the cranial and cephalic, the 
vagal and sacral, the trunk, and the cardiac NC (Le Douarin, 1982). The cranial and 
cephalic NC includes the cells derived from the prosencephalic, mesencephalic and 
anterior rhomencephalic regions (Bronner and Le Douarin, 2012). Cranial NC cells 
migrate dorsolaterally and give rise to mesenchymal cells that contribute to cartilage, 
bone, cranial neurons, glia and Schwann cells, ciliary and cranial sensory ganglia, and 
melanocytes of the skin and inner ear (Gilbert, 2003; Dupin and Sommer, 2012; Bronner 
and Le Douarin, 2012). The vagal crest is composed of the posterior rhombencephalic 
crest at the level of somites 1 through 7, while the sacral crest refers to the NC cells 
caudal to somite 28. Vagal NC cells give rise to the sympathetic ganglia of the gut. Some 
cells from the vagal and sacral levels also give rise to melanocytes (Bronner and Le 
Dourain, 2012). Cardiac NC cells overlap with the anterior portion of the vagal NC. They 
are located in the region from the first to the third somite between the cranial and trunk 
NC (Gilbert, 2003). Cardiac NC cells contribute to the septum and outflow tract of the 
heart (Bronner and Le Douarin, 2012). They can also give rise to melanocytes, neurons, 
connective tissue and cartilage (Gilbert, 2003). 
 Trunk NC cells comprise the cells at the cervical and thoracic levels adjacent to 
somites 8-28 (Bronner and Le Douarin, 2012). In the mouse, trunk NC cells migrate via 
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two mayor pathways, the ventral and dorsolateral pathways. Cells of the ventral pathway 
migrate through the rostral side of the somite between the neural tube and the 
dermamyotome. Trunk NC cells of the ventromedial pathway migrate in two overlapping 
phases. The first wave of cells migrate ventrolaterally from E9 through E9.5 (Serbedzija 
et al., 1990); these cells migrate more ventrally than those from the second wave, and 
give rise to the sympathetic ganglia, the adrenal medulla, and nerves around the aorta 
(Gilbert, 2003). The second wave of cells migrates ventromedially, along the lateral 
surface of the neural tube, in the ventromedial portion of the sclerotome, from E9.5 
through E10.5. The second wave of ventrally migrating trunk NC cells gives rise to the 
dorsal root ganglia (DRG), Schwann cells (Serbedzija et al., 1990), and a portion of the 
skin melanocytes that derive from Schwann cell precursor cells (Adameyko et al., 2009). 
Trunk NC cells of the dorsolateral pathway migrate between the dermamyotome and the 
epidermis (Serbedzija et al., 1990). Dorsolaterally migrating NC cells move through the 
epidermis to the ventral midline and give rise to skin melanocytes (Gilbert, 2003). 
 The NC has been referred to as the fourth germ layer because it makes 
contributions to almost every tissue of the body (Hall, 2000). The large diversity of cells 
that are derived from the neural crest contributes to numerous features that are specific to 
vertebrates, including craniofacial bone and sensory glia (Bronner and Le Douarin, 
2012). The multipotent nature of NC cells also makes them a useful model for the field of 
stem cell biology (Dupin and Sommer, 2012). 
1.2 Melanocyte Development 
The pigment producing cells, or melanocytes, are derived from all NC domains, 
but most are derived from the cranial and trunk NC. In mice, the cells fated to become 
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melanocyte precursors (melanoblasts) develop around E8.5, when they express Wnt1, 
Pax3 and Sox10. Around E10-10.5, these cells begin to express the melanoblast markers 
microphthalmia-associated transcription factor (Mitf) and Kit, which codes for a tyrosine 
kinase receptor. After a few hours, melanoblasts localize to the migration staging area 
(MSA), which is located in the dorsal aspect of the neural tube. At this point 
melanoblasts begin to express Dopachrome tautomerase (Dct), which codes for one of the 
key enzymes in the melanin synthesis pathway. Between E10 and E12.5, signaling via the 
Endothelin receptor b (Ednrb) and the tyrosine kinase receptor Kit are required for 
melanoblast survival, proliferation, and migration. At this point, melanoblasts continue to 
divide as they migrate through the dermis. A large portion of melanoblasts enter the 
epidermis between E13.5 and E14.5 and by E15.5, a subset of them populate the still 
developing hair follicles. At E15.5, melanoblasts begin to express other melanogenic 
enzymes, including Tyrosinase (Tyr) and Tyrosinase-related protein 1 (Tyrp1 or Trp1), 
and sometime between E15.5 and birth, these cells differentiate into mature melanocytes 
once they begin to produce pigment (reviewed in Silver et al., 2006) (Figure 1.3). The 
final steps of differentiation also require the transcription factors Mitf and Sox10 as well 
as Kit and Endothelin signaling for the expression of melanogenic enzymes and 
subsequent pigment production (Hou et al., 2004; Hou et al., 2006; Levy et al., 2006).  
For many years, all trunk melanoblasts where thought to derive solely from cells 
traveling via the dorsolateral pathway. Recently, a second population of melanocytes was 
found to derive from NC cells traveling along the ventral pathway, specifically from 
Schwann cell precursors (SCPs) (Adameyko et al., 2009). Schwann cell precursors 
express Sox10, and associate with neuronal projections that allow them to travel long 
	  13 
	  
distances along the nerves (Jessen and Mirsky, 2005). In the chick and mouse embryos, a 
population of Mitf-positive cells was found within nerves of the peripheral nervous 
system, particularly in the distal ventral ramus of the spinal nerve, which innervates the 
skin. These cells were associated but not in direct contact with nerve bundles, and were 
found, via lineage tracing experiments, to be derived from SCPs (Adameyko et al., 2009). 
In the mouse, a subset of cranially derived melanocytes has also been shown to arise from 
SCPs around cranial nerves IX-X. Similar to trunk melanoblasts of the dorsolateral 
pathway, cranial SCP-derived melanoblast appear to depend on Ednrb signaling for their 
expansion and dispersal (Adameyko et al., 2012).  
1.3. Genetic network of melanocyte development: Lessons from pigmentation 
mutants 
 The development of melanocytes from the NC is dependent upon the activation of 
several transcription factors, including Sox10, Pax3, and Mitf, which are involved in the 
specification, survival and final differentiation of melanocyte precursors. In addition to 
these factors, environmental cues also guide the development of melanocytes. Signaling 
molecules such as Wnt, Kitl and Edn3 are essential for the survival, proliferation, 
migration and differentiation of melanocytes. Studies in various model organisms, 
including the chick, zebrafish, Xenopus, and the mouse, have been essential for 
understanding the various functions and interactions of these transcription factors and 
signaling molecules in melanocyte development (Silver et al., 2006). 
1.3.1 Cell intrinsic factors 
 The basic-helix-loop-helix-leucine-zipper Microphthalmia-associated 
transcription factor (Mitf) has been described as the master regulator of melanocyte 
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development (McGill et al., 2002). The expression of this transcription factor is 
considered the key event in the specification of melanoblasts from the neural crest. In 
humans, MITF is mutated in Waardenburg syndrome type 2a (WS2a), which is 
characterized by a decrease in the number of melanocytes of the eye, inner ear and 
forelock (Levy et al., 2006). In mice, at least 25 spontaneous Mitf allelic mutants have 
been identified. The effect of these mutations range from minor pigmentation defects in 
some, to complete absence of mature melanocytes in others (reviewed in Hou and Pavan, 
2008). In mice homozygous for a severe Mitf mutation in which Mitf function is 
completely abrogated, NC-derived cells fail to express Dct. In addition, a small number 
of Mitf-expressing cells arise in NC cell cultures derived from wild type and Mitf 
mutants; however, Mitf mutant cells fail to express Dct and are quickly lost (Opdecamp et 
al., 1997). These results suggest that Mitf is necessary for either the survival, 
proliferation, or to prevent the trans-differentiation of melanocytes into other cell 
lineages. Of these functions, support for the role of Mitf in survival has come from the 
hypomorphic Mitfvit mouse mutants, which initially exhibit normal coat pigmentation, but 
gradually lose it as a result of the depletion of melanocyte stem cells caused by reduced 
Mitf levels within the bulge of the hair follicles (Lerner et al., 1986; Nishimura et al., 
2005). 
Additional evidence supporting a role for Mitf in melanocyte survival stems from 
its role as a transcriptional regulator of the Bcl2 anti-apoptotic protein (McGill et al., 
2002).  This protein has also been shown to be required for melanocyte viability, 
specifically for the maintenance of melanocyte stem cells (Nishimura et al., 2005) and 
melanoblasts (Mak et al., 2006). Mitf also interacts with cyclin-dependent kinase 2 
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(Cdk2), a cell cycle regulator essential for the maintenance of melanoma cell viability 
and cell cycle. Phenotypes associated with deletion Bcl2 and Cdk2 are less severe than 
those that result from Mitf null mutations, suggesting that Mitf may be important for 
melanocyte survival during development through additional pathways as of yet 
characterized (Lin and Fisher, 2007). Another transcriptional target of Mitf, is the 
hepatocyte growth factor (HGF) receptor, c-Met which has been shown to be involved in 
melanocyte survival in vitro, where HGF treatment of NC cells results in increased 
melanoblast numbers, and in vivo, where restricted HGF expression in the epidermis 
leads to an increase in the number of melanoblasts and mature dermal melanocytes 
(McGill et al., 2006).  
 A role for Mitf in melanocyte proliferation has been suggested because many of 
its transcriptional targets are important regulators of cell cycle progression and 
proliferation. One such target is the T-Box transcription factor 2 (TBX2), which indirectly 
regulates cell cycle progression and apoptosis by repressing the p19 Alternate Reading 
Frame (p19Arf) promoter and thus inducing the degradation of the pro-apoptotic p53 
protein. Mitf regulation of Cdk2 may also be important for melanocyte proliferation, as 
Cdk2 promotes cell cycle progression (reviewed in Hou and Pavan, 2008). Interestingly, 
Mitf targets also include the cell cycle inhibitors p21 and Ink4a (Inhibitor of CKD4). The 
inhibition of cell cycle progression is essential for differentiation, an additional role of 
Mitf in melanocyte development. Mitf promotes early melanocyte fate specification and 
melanocyte differentiation through direct transcriptional regulation of Tyrosinase (Tyr), 
Tyrosinase related protein-1 (Trp1) and Tyrosinase-related protein-2 (Trp2 or Dct), all of 
which code for pigment enzymes. Other genes that have been implicated in melanocyte 
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differentiation and are transcriptionally regulated by Mitf include absent in melanoma-1 
(AIM-1), melanoma antigen recognized by T-cells 1 (MART1), and silver homolog (SILV 
or PMEL17). The latter two genes encode melanosomal structural proteins (reviewed in 
Levy et al., 2006). 
 Other transcription factors interact with Mitf to promote melanocyte development. 
The transcription factors Pax3 and Sox10 have been shown to activate the Mitf promoter 
both individually (Watanabe et al., 1998; Bondurand et al., 2000; Lee et al., 2000; Potterf 
et al., 2000; Verastegui et al., 2000) and synergistically (Bondurand et al., 2000; Potterf 
et al., 2000). The specific roles of Pax3 in melanocyte development are not fully 
understood. In humans, PAX3 mutations are associated with Waardenburg Syndrome 
(WS) types 1 and 3, which are characterized, by hipopigmentation, heterochromia irides, 
deafness, and in type 3, skeletal abnormalities. Spontaneous Pax3 mutations have also 
been described in the mouse. The spontaneous Splotch mouse mutant harbors a loss of 
function mutation in Pax3. Homozygous Splotch mutants exhibit spina bifida and are 
embryonic lethal as a result. Splotch heterozygotes present a belly spot, suggesting a role 
for this transcription factor in melanocyte development (reviewed in Hou and Pavan, 
2008). In homozygous Splotch mutants, Dct-positive melanoblasts can be observed 
traveling along the dorsolateral pathway. In these mutants melanoblast numbers are 
reduced but not completely absent, which suggests that Pax3 may not be essential for the 
initial specification of melanoblasts, but appears to be required for their expansion 
(Hornyak et al., 2001).  
 The transcription factor Pax3 has been suggested to both promote and inhibit 
melanocyte fate specification (Kubic et al., 2008). By activating Mitf, Pax3 may influence 
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melanoblasts towards the melanocytic fate. At the same time Pax3 has also been shown 
to inhibit Dct activation, which is dependent on Sox10 and Mitf, by forming a repressor 
complex with the transcription factor Lymphoid enhancer binding factor 1 (Lef1) and the 
Groucho co-repressor Grg4, and by competing with Mitf for binding to Dct regulatory 
elements (Lang et al., 2005). The dual role of Pax3 in promoting Mitf expression while 
inhibiting Dct expression, suggests that Pax3 may be involved in the initial fate decision 
of melanoblasts as well as in preventing the terminal differentiation of precursors. 
Maintenance of melanoblasts in an undifferentiated state may be necessary to allow the 
sufficient expansion of melanocyte precursors before they become terminally 
differentiated (Lang et al., 2005). Interestingly, Pax3 may also act to promote melanocyte 
differentiation as it has been shown to transactivate the Trp1 promoter (Galibert et al., 
1999). 
 The transcription factor Sox10 appears to be important in the specification of 
melanoblasts from the NC. Sox10 is a member of the SoxE family of transcription 
factors, which contain a high mobility group (HMG) box DNA-dependent dimerization 
domain (reviewed in Harris et al., 2010). Zebrafish harboring a mutant allele of the 
zebrafish Sox10 homologue display an almost complete absence of NC cells on migratory 
pathways associated with pigment cells. In these mutants, the differentiation of certain 
tissues arising from NC derivatives, including craniofacial skeleton and fin mesenchyme, 
is unaffected, while differentiation of other NC derivatives, including melanocytes, is 
severely impaired and is accompanied by the lack of Mitf or Kit expression. The 
pigmentation phenotype of these mutants can be rescued by Mitf overexpression, pointing 
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to a role for Sox10 in the specification of melanocytes from the NC that appears to be 
mediated via transcriptional activation of Mitf (Dutton et al., 2001).  
 In the mouse, the role of Sox10 in melanocyte development appears to be slightly 
different than in zebrafish. The spontaneous Dominant megacolon (Dom) mouse mutant 
harbors a mutation in Sox10 which results in premature truncation of the Sox10 protein. 
Heterozygous Dom (Sox10Dom/+) mutants exhibit white spotting and aganglionosis of the 
distal colon. Similar developmental abnormalities are observed in human cases of WS2 
and WS4, a subset of which are associated with SOX10 mutations (Bondurand et al., 
2007). Homozygous Dom (Sox10Dom/Dom) mutants die by E13.5 for reasons that are not 
fully understood. Homozygous Dom mutant embryos have defects in dorsal root ganglia, 
sympathetic ganglia, and terminal oligodendrocyte differentiation, reduced dorsal 
trigeminal and facial ganglia, and absence of melanoblasts and enteric neurons (Herbarth 
et al., 1998; Southard-Smith et al., 1998). Similar developmental defects are also 
observed in Sox10LacZ mice, in which the Sox10 open reading frame is replaced by the 
LacZ gene (Britsch et al., 2001). The pigmentation phenotype observed in both Sox10 
mutants results from decreased melanoblast numbers. In Sox10Dom/Dom embryos, complete 
lack of Dct expression (Southard-Smith et al., 1998), and increased apoptosis in NC 
migratory pathways (Southard-Smith et al., 1998; Kapur, 1999) are observed and suggest 
a role for Sox10 in NC cell survival. Overexpression of Mitf in NC cultures from 
Sox10LacZ/LacZ mice can partially rescue cell survival, which implies that the regulation of 
melanoblast survival by Sox10 may be linked to its role in driving Mitf expression (Hou 
et al., 2006). 
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 The role of Sox10 in melanoblast specification appears to be both Mitf-dependent 
and Mitf-independent. In Sox10Dom/+ mice, melanoblasts lack Dct expression between 
E10.5 and E12.5; nevertheless, this transient lack of Dct expression does not appear to 
affect melanocyte differentiation because adult mice are almost completely pigmented, 
and Dct-expressing melanoblasts, although in reduced numbers, can be detected after 
E13.5. Neural tube cultures from Sox10Dom/Dom mice completely lack Mitf and Kit 
positive cells, while those from Sox10Dom/+ mice have Mitf and Kit positive cells, but lack 
Dct expression. The lack of Dct expression in Mitf positive cells from Sox10Dom/+ mice 
suggests that Sox10 is required for Dct expression and that endogenous Mitf may not be 
sufficient to drive Dct expression when Sox10 levels are reduced. Furthermore, Sox10 
was found to transactivate the Dct promoter in melanocyte cell lines as well as in non-
melanocyte cell lines, which do not express Mitf (Potterf et al., 2001). The requirement of 
Sox10 for Mitf and Dct expression suggests a role for Sox10 in the initial specification of 
melanoblasts. Sox10 also appears to be required for the final differentiation of 
melanocytes via Mitf-independent transcriptional regulation of Tyr, the rate-limiting 
enzyme in melanin-synthesis (Hou et al., 2006). 
 Another member of the SoxE family of transcription factors that has recently been 
implicated in melanocyte development is Sox9. Although Sox9 appears to be involved in 
early melanocyte development its specific role in this process is not well characterized. In 
the mouse, Sox9 is first expressed in pre-migratory NC cells around E8.5, prior to the 
expression of migratory NC markers, in the hindbrain region at the dorsal tip of the 
closing neural tube and in the dorsal folds of the neural tube in the trunk. Sox9 remains 
expressed in migrating cranial NC cells (reviewed in Lee and Saint-Jeannet, 2011) but it 
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is downregulated in trunk NC cells soon after they become migratory (Cheung et al., 
2005). The expression of Sox9 appears to be required for the initial specification and 
survival of NC cells, but it is unclear whether it acts to promote melanocyte development. 
Loss of function experiments in the frog and zebrafish suggest that Sox9 does not appear 
to be important for melanocyte development. In Xenopus embryos, morpholino-induced 
Sox9 depletion results in decreased expression of the NC marker Slug (Snail homolog) 
and loss of cranial NC cell progenitors; however, melanoblasts in the trunk appear to 
develop normally (Spokony et al., 2002). Likewise zebrafish mutants of the Sox9 
ortholog, Sox9b, which is expressed in cranial and trunk NC cells, have severe 
craniofacial defects but only mild defects in pigment cells. These defects, which include a 
reduction in the number of iridophores, one of the types of pigment cells present in 
zebrafish, and dispersed melanosomes within melanocytes, do not seem to be associated 
with impaired melanocyte development because Dct expression is normal in Sox9b 
mutants (Yan et al., 2006).  
  Although loss of function experiments do not implicate Sox9 in melanocyte 
development, gain of function experiments support a role for Sox9 in the development of 
melanocytes from the NC. In the chick embryo, forced expression of Sox9 in the neural 
tube induces neural crest-like properties at the expense of neuronal progenitors. 
Furthermore, Sox9 overexpression in migrating NC cells in the trunk region seems to bias 
these cells to melanocyte and glial fates, at the expense of neuronal NC-derivatives 
(Cheung and Briscoe, 2003). In zebrafish, both Sox9 and Sox10 overexpression were 
shown to strongly favor melanocytic fate specification, as confirmed by the presence of 
ectopic melanoblasts, labeled via Mitf, Sox10 and Dct, in embryos, and the presence of 
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greater than normal melanocyte numbers in the tadpole stage (Taylor and LaBonne, 
2005). The inconsistencies observed in Sox9 loss of function and gain of function studies 
suggests that other factors may be able to compensate for the absence of Sox9 expression 
in melanoblast; consequently, the effects of Sox9 in melanocyte development may be 
more apparent when Sox9 is overexpressed rather than when it is knocked down. 
In the mouse, Sox9 appears to be important for the survival of trunk NC cells and 
for the formation of trunk NC cell derivatives. Homozygous embryos carrying a 
conditional Sox9 null allele, exhibit reduced numbers of neurons and glia in the trunk 
region as a result of increased apoptosis of pre-migratory and early migrating NC cells at 
E9.5 and E10.5. In these embryos, Sox10 expression is maintained in pre-migratory NC 
cells but is reduced along the NC cell migration route. In pre-migratory NC cells, Sox9 
was also found to be required for the expression of Snail (Cheung et al., 2005), a 
transcription factor that has been implicated in early pigment cell development and 
differentiation (Silver et al., 2006). Although Sox9 seems to be required for melanocyte 
development early on, its prolonged expression in cells fated to become melanoblast has 
been shown to negatively affect melanocyte development (Qin et al., 2004). The adverse 
effect of prolonged Sox9 expression on melanocyte development may be an indirect 
result of the role of Sox9 in the development of chondrocyte precursor cells, in which 
Sox9 is required for the regulation of alpha-1 type-II Collagen (Col2A1) expression (Bell 
et al., 1997). Studies in the mouse, chick and Xenopus suggest that Sox9 acts upstream of 
Sox10 (reviewed in Silver et al., 2006). In the chick, Sox9 was recently shown to directly 
bind to and activate Sox10 regulatory regions, and to be required, for Sox10 expression in 
cranial NC cells (Betancur et al., 2010). The decrease in Sox10 expression observed in 
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migratory trunk NC cells in Sox9 null mutant mouse embryos also implicates Sox9 in the 
regulation of Sox10 expression in the mouse. It has been suggested that the importance of 
Sox9 in melanocyte development may be related to its role in regulating embryonic 
Sox10 expression (Harris et al., 2010). 
Although in the mouse embryo, members of the Snail family of zinc-finger 
transcription factors do not seem to be required for NC formation or delamination 
(Murray and Gridley, 2006), the mouse Slug homolog gene Snai2 appears to be involved 
in melanocyte development. Early in development, the expression domains of the mouse 
homologs of the Snail and Slug genes are reversed relative to the expression domains of 
these genes in the chick. Later in development the expression domains of these two 
transcription factors are conserved in the chicken and the mouse. In the chick, Snail is not 
expressed in pre-migratory or migratory NC cells; however, the mouse Snail homolog 
Snai1 is expressed in both pre-migratory and migratory NC cells. In contrast, Slug is 
expressed in pre-migratory and migratory NC cells, while in the mouse the Slug homolog 
Snai2 is expressed in migratory NC cells but not in pre-migratory NC cells (Sefton et al., 
1998). Snai2 null mutant mice exhibit pigmentation defects and display similar 
developmental defects as those observed in Kit and Kit ligand (Kitl) null mutant mice.  
The phenotypic similarities observed in Snai2 and Kit/Kitl mutants suggests that Snai2 
may be involved in melanocyte development and that its function in this process may be 
associated to Kit expression. Kit-positive cells from wild type mice express Snai2, while 
Kit-positive cells derived from the Kit and Kitl null mutants W/Wv and Sl/Sld respectively, 
do not express Snai2. Furthermore, Kitl is unable to drive melanoblast migration in Kit-
positive cells purified from Snai2 null mutant mice. These results suggest that Snai2 may 
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be a transcriptional target of Kit signaling, thus it is possible that at least some of the 
roles of Kit signaling in melanocyte development are mediated by Snai2 (Perez-Losada et 
al., 2002). Mutations in the human SNAI2 gene have been described in WS2, which is 
characterized by pigmentation defects and sensorineural deafness (Tachibana et al., 
2003), further implicating this transcription factor in melanocyte development.  
While Mitf, Pax3, Sox10, Sox9 and Slug seem to promote melanocyte 
development, the transcription factor FoxD3 has been found to inhibit melanocyte 
development. Although FoxD3 has been shown to be required for the maintenance and 
specification of NC cells in the chick (Kos et al., 2001), the frog (Sasai et al., 2001) and 
the mouse (Teng et al., 2008), it appears to negatively regulate melanoblast specification. 
In the chick embryo, FoxD3 is expressed in all NC cell lineages, except for late-
emigrating melanoblasts. In vitro and in vivo knockdown of FoxD3 results in an 
expansion of the melanoblast lineage at the expense of neurons and glia. On the other 
hand, ectopic FoxD3 expression in late-migrating NC cells prevents the entrance of these 
cells into the dorsolateral migration pathway. The inability of FoxD3-expressing NC cells 
to enter the dorsolateral migration pathway is assumed to be the result of FoxD3-
mediated inhibition of melanoblast specification (Kos et al., 2001), because melanoblast 
specification has been shown to be required for dorsolateral migration (Erickson and 
Goins, 1995; Erickson et al., 1998; Reedy et al., 1998). In quail NC cell cultures, FoxD3 
overexpression inhibits Mitf expression and melanoblast specification, driving instead the 
expression of glial cell markers (reviewed in Thomas and Erickson, 2008). In zebrafish, 
FoxD3 prevents NC precursors from being specified as melanophores by inhibiting Mitfa 
expression (Curran et al., 2009). At the same time, FoxD3 works to promote the 
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specification of another type of pigment cell, the iridophore, by inhibiting Mitfa 
expression in a bi-potent precursor of iridophores and melanophores (Curran et al., 2010). 
1.3.2. Signaling molecules and receptors 
 Melanocyte development begins with the induction of NC cells by cues received 
from the surrounding environment. In addition to its importance in NC induction, the 
canonical Wnt signaling pathway, which acts via the Frizzled receptor and activates the 
signaling molecule and transcription factor β-catenin as well as the transcription factor 
Lef1, is also essential for melanoblast specification. In mice, individual knockouts of 
Wnt1 and Wnt3a do not present with defects in NC derivatives; however Wnt1 and Wnt3a 
double knockouts have decreased numbers of melanoblasts, which appear to be result of 
defective melanoblast specification, rather than decreased survival or proliferation (Ikeya 
et al., 1997). In mice, NC-specific deletion of β-catenin prevents the proper formation of 
melanoblasts and sensory neurons (Hari et al., 2002). On the other hand, overexpression 
of β-catenin in migratory NC cells promotes the formation of pigment cells at the 
expense of neurons and glia in zebrafish (Dorsky et al., 1998). The transcription factor 
Lef1, which functions downstream of the canonical Wnt/β-catenin pathway, is also 
important in melanocyte development. Loss of function of Lef1 in Xenopus results in the 
depletion of NC-derived cell lineages, including melanocytes (Roel et al., 2009). 
Molecular targets of the canonical Wnt signaling pathway, as it pertains to melanocyte 
development, include Mitf, Dct, and Sox10, which further supports a role for this 
signaling pathway in the early stages of melanoblast specification (reviewed in Larue and 
Delmas, 2006).  
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 Signaling via the Endothelin receptor b is also essential for melanoblast 
development. In humans, mutations in EDNRB and its ligand Endothelin 3 (EDN3) are 
associated with WS4, which is characterized by sensorineural deafness, 
hypopigmentation, and aganglionosis of the distal colon (Puffenberg et al., 1994; Attie et 
al., 1995). Mutations or deletions of the mouse Ednrb and Edn3 result in the piebald 
lethal and lethal spotting phenotypes, respectively, which display similar characteristics 
to those seen in humans. Ednrb and Edn3 null homozygotes have a mostly white coat 
except for the head and rump, while heterozygotes usually have a belly spot. Piebald 
lethal mice also display megacolon as a result of the absence of enteric ganglia in the 
distal colon (Baynash et al., 1994; Hosoda et al., 1994).  
Endothelin signaling plays multiple roles in melanocyte development, regulating 
the survival, proliferation, migration, and final differentiation of melanoblasts (reviewed 
in Saldana-Caboverde and Kos, 2010). In the mouse, signaling via Ednrb is required 
between E10 and E12.5, which corresponds to the time point when melanoblasts reach 
the migration stage area (MSA). Through the use of inducible mouse models, Ednrb was 
shown to rescue hypopigmentation in Ednrb mutants as late as E10 (Shin et al., 1999). 
Additionally, the hypopigmentation phenotype of piebald lethal mice was shown to be 
rescued by driving Ednrb expression via the Dct promoter, which does not become active 
until E10 (Ittah, 2005). The results of these studies suggest that Ednrb is not required for 
the initial specification of melanocytic fate. The presence of small numbers of 
melanoblasts at E10-11.5 in Ednrb null mutants is consistent with Ednrb not being 
required for melanoblast specification. Given that Ednrb is required during the time 
melanoblasts reach the MSA, it has been suggested that Endothelin signaling may be 
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required for melanoblast migration. In transgenic Ednrb null mice, Dct-positive cells are 
present and can be found at the right locations from E10.5-E11.5; however, these 
melanoblasts are gradually lost without apparent defects in survival, and the few 
melanoblasts that remain appear to accumulate in the MSA. The apparent defect in 
melanoblast migration observed in Ednrb null mice implies that Endothelin signaling 
may be required for these cells to enter the dorsolateral migration pathway (Lee et al., 
2003). 
 Several in vitro studies have implicated the Ednrb signaling pathway in the 
survival and proliferation of melanoblasts. Endothelin 3 has been shown to promote the 
survival and proliferation of glia and melanocyte precursors in NC cultures (Reid et al., 
1996; Lahav et al., 1998; Opdecamp et al., 1998; Dupin et al., 2000). Endothelin 
signaling was also shown to promote the maintenance of an undifferentiated state in vitro. 
Treatment of pigmented melanocytes with Edn3 can induce the expression of the NC 
markers Slug, Sox10, FoxD3, and Pax3 in these cells and can lead to the trans-
differentiation of pigmented melanocytes into cells expressing glial markers (reviewed in 
Saldana-Caboverde and Kos, 2010) 
 Although Ednrb does not appear to be required for the initial specification of 
melanoblasts and appears to favor the maintenance of undifferentiated state, in vitro and 
in vivo studies have implicated Endothelin signaling in melanocyte differentiation. Even 
though Edn3 treatment of avian NC cultures initially promotes the maintenance of 
undifferentiated precursors, prolonged treatment leads to the development of pigment-
producing melanocytes (Lahav et al., 1996; Lahav et al., 1998). In mouse NC cultures, 
Dct-positive cells are found in the absence of Edn3; however, Edn3 treatment, or 
	  27 
	  
activation of protein kinase C (PKC), a downstream target of Endothelin signaling, is 
necessary for the generation of pigmented melanocytes (Ono et al., 1998; Opdecamp et 
al., 1998). Similarly, Dct-positive cells from Ednrb null mutant embryos can express 
Sox10, Mitf and Kit but fail to express Tyr and do not differentiate into mature pigment-
producing melanocytes (Hou et al., 2004). Together these results suggest that although 
Endothelin signaling does not appear to be required for the initial specification of 
melanoblasts, it is essential for the final differentiation of melanocytes (reviewed in 
Saldana-Caboverde and Kos, 2010). 
 Signaling via the tyrosine kinase receptor Kit has also been shown to be involved 
in normal melanocyte development. In the mouse, mutations in Kit and Kit ligand (Kitl) 
(formerly known as Stem Cell Factor) result in a phenotype characterized by a belly spot 
in heterozygous animals, and by anemia, lack of coat pigmentaion, and sterility in 
homozygotes that survive to adulthood. In humans, KIT and KITL mutations are 
responsible for piebaldism, which is characterized by hair and skin hypopigmentation 
(reviewed in Hou and Pavan, 2008). Similar to Endothelin signaling, Kit signaling does 
not appear to be required for the initial specification of melanoblasts, as Dct and Mitf 
positive cells are present in Kit null mutants and in mice carrying a dominant negative 
form of the Kit receptor (reviewed in Sommer, 2011).  
Kit ligand is produced in soluble and membrane bound forms, which are 
differentially required in melanocyte development, with the former being required for 
melanoblast migration on the lateral pathway and/or their survival in the MSA, and the 
latter being required for melanoblast survival in the dermis (Wherler-Haller and Weston, 
1995). During development, melanocyte precursors are sensitive to Kit signaling at 
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particular stages, specifically during migration in the dermis and after entering the 
epidermal layer before entering the hair follicle. Inhibition of Kit signaling with the 
ACK2 anti-Kit antibody during these stages results in the loss of melanocytes hinting at 
the importance of Kit signaling for melanocyte survival and proliferation (Yoshida et al., 
1996). Additional evidence for these roles comes from the K14-SCF transgenic mouse, in 
which transgenic Kitl (formerly known as SCF) expression in the epidermis promotes the 
survival of melanocytes in the epidermis, where they are not normally found in the adult 
mouse, and leads to a large increase in melanocyte numbers (Kunisada et al., 1998).  
 Endothelin and Kit signaling have been found to interact in melanocyte 
development. In mouse NC cultures, treatment with Edn3 and Kitl significantly increases 
melanoblasts numbers, compared to treatment with either factor on its own. Nevertheless, 
Edn3 treatment of Kitl null NC cells cannot induce Kit expression or the generation of 
fully pigmented melanocytes in vitro. Similarly, Kitl treatment in the absence of Edn3 
cannot induce the differentiation of pigment-producing melanocytes, which can only be 
found in culture in the presence of both factors (Ono et al., 1998). The apparent 
interaction between Endothelin and Kit signaling may underlie the non-cell autonomous 
and cell-autonomous roles of Ednrb signaling in melanocyte differentiation.  Neural crest 
cells from Ednrb null mice can give rise to melanoblasts; however, these melanoblasts 
fail to express Tyr.  Treatment of Ednrb null melanoblasts with Kitl can induce Tyr 
expression; nevertheless, pigmented melanocytes do not develop in the absence of 
functional Ednrb signaling. These results suggest that Ednrb functions non-cell 
autonomously to induce Tyr expression in the presence of Kitl, and cell-autonomously in 
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the final differentiation of melanocytes (Hou et al., 2004). These results also help explain 
why both factors are needed for the generation of fully pigmented melanocytes  
1.4 Research Questions 
Melanocytes provide pigmentation to skin and hair via the production of melanin, 
and confer protection against the damaging effects of ultraviolet radiation. Mutations or 
deletions in genes required for the development of melanocytes from the NC can result in 
hypopigmentation owing to the reduction or complete loss of melanocyte precursors 
(melanoblasts) or to the impaired migration of these precursors (reviewed in Lin and 
Fisher, 2007). For this reason, the study of mouse pigmentation mutants has been 
instrumental for the elucidation of genes and signaling pathways involved in NC and 
melanocyte development (Baxter et al., 2004). Nevertheless, fundamental questions 
regarding the transcriptional regulation of these genes as well as their interactions in NC 
and melanocyte development remain to be answered. In recent studies, mice having a 
targeted disruption of the transcription factor Ets1 were shown to develop cardiac 
malformations, as a result of NC defects, and to exhibit ventral hypopigmentation (Gao et 
al., 2010). A specific role for Ets1 in melanocyte development has not been established; 
however, the hypopigmentation phenotype observed in Ets1 mutants suggests that this 
transcription factor is involved in this process. Recent studies in the chick embryo have 
established a requirement for Ets1 in the endogenous expression of the transcription 
factor Sox10 in cranial NC cells (Betancur et al., 2010); therefore, it is possible that the 
role of Ets1 in melanocyte development could be mediated via transcriptional activation 
of Sox10. Establishing the function(s) of this transcription factor in melanocyte 
development has important implications for understanding pathological NC and 
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melanocytic conditions. It can also serve to provide a more complete picture of the 
transcriptional network that controls melanocyte development. My central hypothesis is 
that Ets1 plays a role in early melanocyte development and regulates the activity of other 
critical melanoblast-specific genes. To test this hypothesis I addressed the following 
questions: 
Question 1: What is the temporal requirement of Ets1 in murine melanocyte 
development? 
I hypothesized that Ets1 is required early in melanocyte development. I used Dct-
LacZ transgenic mice in which LacZ expression is driven to melanoblasts under the 
control of the Dopachrome tautomerase (Dct) promoter (Zhao and Overbeek, 1999), to 
label melanoblasts via β-galactosidase activity in Ets1 null, heterozygous, and wild type 
embryos in order to determine the earliest time at which differences in melanoblast 
numbers and/or position can be observed. 
Question 2: Is Ets1 required for melanoblast survival or proliferation in the mouse 
embryo? 
Given the hypopigmentation phenotype observed in Ets1 mutant mice, I 
hypothesized that Ets1 regulates melanocyte survival or proliferation during embryonic 
development. Using a combination of in vivo and in vitro proliferation and cell survival 
assays I compared the extent of melanoblast survival and proliferation in Ets1 null, 
heterozygous, and wild type mouse embryos. 
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Question 3: Does Ets1 genetically interact with the transcription factor Sox10 in 
melanocyte development? 
Findings in the avian system, which implicate Ets1 in the regulation of the 
transcription factor Sox10 (Betancur et al., 2010), pointed to a potential interaction 
between Ets1 and Sox10 in melanocyte development. To establish whether Ets1 
genetically interacts with Sox10, Ets1 heteroxygous (Ets1+/-) mice were crossed to Sox10 
heterozygous (Sox10LacZ/+) mice, in which LacZ is inserted into the Sox10 locus (Britsch 
et al., 2001). The hypopigmentation phenotypes of the double heterozygous progeny were 
compared to that of single heterozygotes in 3 generations of mice, to establish whether an 
additive, epistatic, suppressed, or synergistic genetic interaction exists between Ets1 and 
Sox10 in melanocyte development. 
Question 4: Does Ets1 affect the development of enteric ganglia and does it interact 
with the transcription factor Sox10 in enteric innervation? 
In addition to being required for melanocyte development, Sox10 is also required 
for the development of NC-derived enteric ganglia (Kapur, 1999) and mutations in this 
transcription factor have been described in both syndromic and non-syndromic 
aganglionosis of the distal colon or Hirschsprung’s disease (Sanchez-Mejias et al., 2010). 
Given the importance of Sox10 for proper gut innervation, I also analyzed the guts of 
Ets1 heterozygous and null mutant mice that were either wild type or heterozygous for 
Sox10, to establish whether Ets1 plays a role in the development of enteric ganglia, and if 
so, whether it genetically interacts with Sox10 to promote proper gut innervation. 
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Question 5: Can Ets1 transcriptionally regulate Sox10? 
In light of the importance of Ets1 for Sox10 expression in cranial NC cells in the 
chick embryo, I hypothesized that Ets1 can activate the expression of Sox10 by binding to 
cis-binding sites on Sox10 enhancers. To address this question I tested the ability of wild 
type and mutated Ets1 protein to activate the Sox10-MCS4 enhancer, which is known to 
drive Sox10 expression to melanocytes and melanoblasts in the mouse (Antonellis et al., 
2008). 
Question 6: Does Ets1 regulate the expression of genes required for melanoblast 
development?  
In order to characterize the molecular basis for the hypopigmentation phenotype 
observed in Ets1 mutant mice, I analyzed the effect of Ets1 overexpression and 
knockdown on the expression of various genes required for melanocyte development. 
Using semi-quantitative real-time Polymerase Chain Reaction (PCR), I compared the 
expression levels of the transcription factors Pax3, Mitf, Sox9, and Sox10, and of the 
Ednrb and Kit receptors, in mouse melanocyte and melanoma cell lines transfected with 
Ets1 and control siRNAs or with Ets1 overexpression and control vectors.  
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Figure 1.1. Mouse pigmentation mutants. Mutations in Endothelin 3 (Edn3) (A) and the 
Endothelin receptor b (Ednrb) (C) are responsible for the hypopigmentation phenotypes 
of the lethal spotting (Edn3ls/ls) and piebald lethal (Ednrbsl/sl) spontaneous mouse 
mutants. Mutations or deletions in the transcription factors Mitf (B), Sox10 (D) and Pax3 
(E) also result in hypopigmentation in mice. 
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Figure 1.2. Neural crest development. Neural crest induction is mediated by Wnt, BMP, 
Delta and FGF signaling molecules which are released from the surrounding 
neuroectoderm, paraxial mesoderm and non-neural ectoderm. The induction signals at the 
border between the neural and non-neural ectoderm, lead to the expression of 
transcription factors that serve to specify the neural plate border, which is the region from 
which NC cells will be derived. The neural plate border specifiers include the 
transcription factors Pax3, Pax7, Zic, Msx1, Msx2, Dlx3, and Dlx5. Following neural 
plate border specification, a group of transcription factors required for the specification of 
NC cells is upregulated. These transcription factors include Snail2, Sox9, Sox10 and 
FoxD3. In the mouse, Sox9, Sox10 and FoxD3 are expressed in the neural folds soon after 
the neural plate border is specified. The expression of NC specifiers is essential for the 
maintenance of the NC population and for the epithelial-to-mesenchymal transition 
(EMT), delamination and migration that these cells must undergo in order to reach their 
final destinations. Neural crest EMT, delamination and migration are mediated by the 
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transcription factors, FoxD3, Snail2, Sox8 and Sox9. These transcription factors work 
together to induce a switch in the expression of calcium-dependent adhesion proteins 
(Cadherins), from type I Cadherins to type II Cadherins. They also activate the 
expression of extracellular signaling molecules and cytoskeletal proteins and promote 
laminin synthesis and the degradation of the basal lamina. 
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Figure 1.3. Melanocyte development from the neural crest. Cells fated to give rise to 
melanocyte precursors are specified by Wnt signaling and the transcription factors Pax3 
and Sox10, among others. Around E10-10.5, these cells begin to express the melanoblast 
markers Kit and Mitf and localize to the migration staging area (MSA), which is located 
in the dorsal aspect of the neural tube. At this point melanoblasts begin to express Dct, 
which codes for one of the key enzymes in the melanin synthesis pathway. Between E10 
and E12.5, signaling via the Endothelin receptor b (Ednrb) and the tyrosine kinase 
receptor Kit are required for melanoblast survival, proliferation, and migration, and 
differentiation. Melanoblasts continue to divide as they migrate through the dermis. A 
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large portion of melanoblasts enter the epidermis between E13.5 and E14.5 and by E15.5, 
a subset of them populate the still developing hair follicles. At E15.5, melanoblasts begin 
to express other melanogenic enzymes, including Tyrosinase (Tyr) and Tyrosinase-
related protein 1 (Tyrp1 or Trp1), which are transcriptionally regulated by Mitf and 
Sox10. Sometime between E15.5 and birth, these cells differentiate into mature 
melanocytes once they begin to produce pigment. 
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II. TEMPORAL REQUIREMENT OF THE TRANSCRIPTION FACTOR Ets1 IN 
MURINE MELANOCYTE DEVELOPMENT 
2.1 Abstract 
Melanocytes are derived from neural crest (NC) cells, which arise from the dorsal 
aspect of the neural tube. Several genes required for the specification of melanocytes 
were identified via the study of mouse pigmentation mutants. Recently, the deletion of 
the transcription factor Ets1 was shown to cause hypopigmentation in mice; however, the 
role of Ets1 in melanocyte development is unknown. The Ets1 gene codes for a helix-
turn-helix transcription factor that is expressed in various developing organs and tissues, 
including the NC, in the mouse embryo. It is required for the expression of the 
melanocyte-specific transcription factor Sox10 in the chick cranial NC. The goal of the 
present study is to determine the temporal requirement and mechanism of action of Ets1 
in melanocyte development. Embryos from crosses between Ets1 heterozygous (Ets1+/-) 
and Dct-LacZ transgenic mice, in which LacZ expression is driven to melanocyte 
precursors (melanoblasts) under the control of the Dopachrome tautomerase (Dct) 
promoter, were harvested between embryonic days (E) 10.75-15.5 and LacZ staining was 
performed. Ets1-/- embryos have fewer melanoblasts compared to Ets1+/- and wild type 
littermates. Cell survival assays showed increased melanoblast cell death in E10.75 Ets1-/- 
embryos. Similarly, double-label immunofluorescence staining against Sox10 and 
cleaved Caspase-3 showed increased NC cell death in E10.25 Ets1-/- embryos. The 
increased numbers of dying NC cells and melanoblasts in Ets1 null mutants suggest that 
Ets1 acts early during melanocyte development and regulates melanoblasts and NC cell 
survival. 
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2.2 Introduction 
The transcription factor Ets1 is a member of a large family of helix-turn-helix 
transcription factors that are characterized by the presence of the E26 transforming 
specific sequence (Ets) domain, which was first identified in the avian erythroblastosis 
virus, E26. The Ets domain recognizes the core nucleotide sequence GGAA/T (Dittmer, 
2003). Human homologs of the viral Ets were later discovered on chromosomes 11 and 
21, and designated Ets1 and Ets2 respectively (Watson et al., 1985). Homologs of Ets1 
from a wide variety of species, which include birds, amphibians, fish and mammals, 
share high sequence similarity. In fact, the mouse and human Ets1 protein sequences are 
highly homologous, sharing 97% amino acid identity (Garrett-Sinha, 2013).  
The transcription factor Ets1 is widely expressed during embryonic development. 
In the chick embryo, Ets1 is expressed in the mesoderm, the blood-forming system 
endothelial cells (Vandenbunder et al., 1989), in mesenchymal cells, lymphocytes, 
erithrocytes (Queva et al., 1993), and NC cells (Fafeur et al., 1997; Theveneau et al., 
2007). In the mouse embryo, Ets1 is expressed early in the developing hindbrain, the 
neural tube, the second and third brachial arches (Maroulakou et al., 1994), and the NC 
(Kola et al., 1993; Maroulakou et al., 1994; Dittmer et al., 2003; Gao et al., 2010; Ye et 
al., 2010). It is later expressed in the blood-forming system, lymphoid organs, lung, gut, 
and skin (Maroulakou et al., 1994) and becomes expressed in all organs by embryonic day 
(E) 15 (Kola et al., 1993). In later stages of fetal development and after birth, Ets1 
expression becomes primarily restricted to lymphoid organs and the brain (Kola et al., 
1993). Expression of Ets1 has also been correlated with pathological invasive processes. 
It has been found to be upregulated in various tumor types, including melanoma (Keehn 
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et al., 2003; Rothhammer et al., 2004; Rothhammer et al., 2005; reviewed in Garrett-
Sinha, 2013), and its expression in certain tumors has been correlated with the expression 
of matrix metalloproteases (MMPs), particularly MMP1, MMP2 and MMP9 (reviewed in 
Dittmer, 2003; Rothhammer et al., 2004; Okuducu et al., 2006). The Ets1-induced 
upregulation of MMPs has also been reported in several in vitro and in vivo Ets1 
overexpression studies (Oda et al., 1999; Park et al., 2008; Nagarajan et al., 2009). 
Several studies implicate Ets1 in the proper development of NC cell derivatives. In 
the mouse, Ets1 is expressed by cardiac NC cells and Ets1 deletion was found to produce 
cardiac malformations (Gao et al., 2010; Ye et al., 2010). Some of these cardiac 
malformations were found to arise as a result of the lack of NC-derived cells in the proximal 
aspects of the outflow tract endocardial cushions and the presence of an abnormal nodule of 
NC-derived cartilage within the heart. The cardiac defects seen in Ets1 null mice have been 
attributed to a role of Ets1 in proper NC cell migration and differentiation (Gao et al., 2010). 
During chick embryonic development, Ets1 expression is correlated with epithelial-to-
mesenchymal transition (EMT). It is expressed in migrating NC cells and in dispersing 
somites but is not detected in tissues where EMT does not occur (Fafeur et al., 1997). 
Additionally, Ets1 is required for the initiation of cranial NC cell delamination by promoting 
cell mobilization, and can induce cranial-like delamination when misexpressed in trunk NC 
cells. Although Ets1 is not required for cranial NC cell EMT per se, it cooperates with the 
transcription factor Snail homolog 2 (Snail2) to promote EMT in NC cells (Theveneau et al., 
2007).   
In addition to being involved in NC cell migration, Ets1 is also required for the 
survival of various cell lineages. Murine thymocytes and T cells derived from Ets1 null 
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mutant mice display higher apoptotic rates compared to those derived from wild type mice 
(Muthusamy et al., 1995). In cooperation with Ets2, Ets1 is also required for the survival of 
endothelial cells in the developing mouse embryo. Although, Ets1-/- mice and mice carrying a 
mutation in an important threonine target of ERK (extracellular signal regulated kinase) 
phosphorylation in Ets2 (Ets2A72/A72) are viable, Ets1-/-;Ets2A72/A72 double homozygous 
mutants are embryonic lethal. The embryonic lethality observed in these double mutant mice 
is caused by impaired angiogenesis as a result of decreased endothelial cell survival (Wei et 
al., 2009). 
Recently, the deletion of the transcription factor Ets1 in particular murine genetic 
backgrounds (i.e., C57BL/6J), was shown to produce ventral hypopigmentation (Gao et 
al., 2010) (Figure 2.1), hinting to the involvement of this transcription factor in 
melanocyte development from the NC. The exact mechanism by which Ets1 deficiency 
during embryonic development results in hypopigmentation is currently unknown. In the 
chick embryo, Ets1 is required for the activation of the transcription factor sex determining 
region Y (SRY)-box 10 (Sox10) (Betancur et al., 2010), a gene required for the 
development of various NC cell derivatives, including melanocytes (Herbarth et al., 1998; 
Southard-Smith et al., 1998; Kapur, 1999; Potterf et al., 2001). The importance of Sox10 for 
melanocyte survival is evidenced by the hypopigmentation phenotype that results when it 
is mutated or deleted. The targeted deletion of Sox10 in the mouse results in almost a 
complete absence of trunk melanoblasts (Hou et al., 2006). Although Ets1 has not been 
linked to Sox10 expression in the mouse embryo, its requirement for proper Sox10 expression 
in the chick embryo and the hypopigmentation phenotype of Ets1 null mutants, suggests that 
Ets1 could also play an important role in the regulation of this and other melanocyte-specific 
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genes in the mouse. Furthermore, the involvement of Ets1 in normal and pathological 
invasive processes (Fafeur et al., 1997; Theveneau et al., 2007; Garrett-Sinha, 2013), and its 
requirement for the survival of certain cell lineages (Muthusamy et al., 1995; Wei et al., 
2009) suggest that this transcription factor may be an important regulator of NC cell and/or 
melanoblast survival, proliferation, migration, and/or differentiation.  
2.3 Materials and methods 
2.3.1 Animals  
Mice heterozygous for Ets1 were obtained from Dr. Eric Svensson (Universtiy of 
Chicago, Chicago, IL) and generated as previously described to harbor a targeted deletion 
of exons 3 and 4 of the Ets1 gene (Barton et., al. 1998). Mice heterozygous for Ets1 were 
re-derived by outcrossing to C57BL/6J mice for eight generations (Gao et., al. 2010). 
They have been maintained on C57BL/6J genetic background by intercrossing and by 
outcrossing to C57BL/6J mice (Jackson Laboratories). Mice carrying the Dct-LacZ 
transgene were obtained from Dr. Paul Overbeek (Baylor College of Medicine, Houston, 
TX). The Dct-LacZ transgenic mice were generated on an FVB/N genetic background as 
previously described (Zhao and Overbeek, 1999) by embryonic microinjection of a 
transgene composed of the mouse Dopachrome tautomerase (Dct) promoter upstream of 
the LacZ gene. Sox10tmlWegLacZ mice (hereafter referred to as Sox10LacZ/+) were obtained 
from Dr. Michael Wegner (Institut für Biochemie, Universität Erlangen-Nürnberg, 
Germany). Sox10LacZ/+ mice were generated as previously described (Britsch et al., 2001) 
via insertion of the LacZ gene into the Sox10 coding sequence. Sox10LacZ/+ mice have 
been maintained on their original C3H mixed background by backcrossing. 
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Timed matings were set for the generation of embryos. Animals were mated 
overnight, and females were examined for vaginal plugs after approximately 16 hours. 
Noon of the day a vaginal plug was observed, was considered embryonic day (E) 0.5. 
Pregnant females were euthanized by exposure to Isoflurane (Vedco, Inc.) followed by 
cervical dislocation, and an abdominal incision was made to expose the uterus. As soon 
as embryos were recovered from the euthanized mother, they were dissected out of the 
uterine sacs and placed in Phosphate Buffered Saline (PBS) (pH7.2 or 7.4, depending on 
the procedure for which the embryos were used). For all embryos, yolk sacs were isolated 
for genotyping. Embryos that were used for Lysotracker Red staining were stained 
immediately after dissection and fixed in 2% paraformaldehyde prior to β-galactosidase 
staining. Embryos that were used for immunofluorescence staining of tissue sections 
were fixed with 4% paraformaldehyde immediately after dissection. Embryos that were 
used for in situ hybridization were dehydrated via incubation in methanol solutions of 
increasing concentrations (25%, 50%, 75% methanol in PBT (PBS containing 0.1% 
Tween 20 (Fisher Scientific)), and 100% methanol, 5 minutes each at room temperature) 
and stored at -??????????????????????????????????????????????????????????????????????????
established by the National Institutes of Health (NIH) (Guide for the Care and Use of 
Laboratory Animals, 2011; Institutional Animal Care and Use Committee (IACUC) 
Protocol No. 13-064). 
2.3.2 Genotyping 
Genomic DNA was isolated from tail biopsies for adult mice or yolk sacs for 
embryos, and used for PCR genotyping. Genotyping for Ets1was performed using the 
primers 5’-GTCTTCTTCTCTAGTTTCTGAGTGCTC, 5’-
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GTCCTGCTTACAACACTCTGAATCCTG and 5’-
GCCTGCTCTTTACTGAAGGCTCTTT (Gao et al., 2010), under standard PCR 
???????????????????????????????????????????????????????????????????????????Products were 
visualized in a 2% agarose gel containing 0.5µg/ml Ethidium Bromide (Fisher Scientific). 
The wild type Ets1 allele produced a 438bp product while the mutant allele produced a 
350bp product (Gao et al., 2010). Heterozygous animals were identified by the presence 
of both PCR products. For Sox10, genotyping of adult mice and embryos was performed 
using the primers 5’-CAGGTGGGCGTTGGGCTC, 5’-CAGAGCTTGCCTAGTGTCT, 
and 5’-TAAAAATGCGCTCAGGTCAA, under standard PCR conditions (35 cycles of 
????? ???? ??? ??? ????? ???? ??? ??? ???? ????? ???? ??? ???? Products were visualized in a 2% 
agarose gel containing 0.5µg/ml Ethidium Bromide (Fisher Scientific). The wild type 
Sox10 allele produced a 500bp product while the mutant allele produced a 600bp product 
(Britsch et al., 2001). Heterozygous animals were identified by the presence of both PCR 
products. 
The Dct-LacZ mice were genotype via β-galactosidase staining. Briefly, ear tip 
biopsies were fixed with 2% paraformaldehyde for 50 minutes at room temperature. 
Samples were briefly washed in PBS (pH 7.2) and incubated o???????????????????????-gal 
solution consisting of 2mM MgCl2, 0.01% Sodium Deoxycholate, 5mM Potassium 
Ferricyanide, 5mM Postassium Ferrocyanide (Fisher Scientific), 0.02% Nonidet P40 
(Roche Diagnostics), and 1mg/ml X-gal (Life Technologies) (Nagy, 2003). The staining 
was visualized under a dissecting scope (Leica Model MZ6). Mice carrying the Dct-LacZ 
transgene were identified by positive X-gal staining.  
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2.3.3 β-galactosidase and Lysotracker Red staining of whole mount embryos 
Embryos from intercrosses between Ets1+/-::Dct-LacZ+ mice were harvested 
between E11.5 and E15.5, while those from intercrosses between Ets1+/-::Sox10LacZ/+ 
mice were harvested at E9.5. β-galactosidase (LacZ) staining was performed using 
standard protocols (Nagy, 2003). Whole embryos were dissected in cold 0.05M PBS 
(pH7.2) and fixed with 2% paraformaldehyde for 50 minutes at room temperature. 
Embryos were briefly washed in PBS (pH 7.2) and incubated 3 to12 hours (the 
incubation time was directly proportional to the embryonic age), protected from light, at 
???????????-gal solution consisting of 2mM MgCl2, 0.01% Sodium Deoxycholate, 5mM 
Potassium Ferricyanide, 5mM Postassium Ferrocyanide (Fisher Scientific), 0.02% 
Nonidet P40 (Roche Diagnostics), and 1mg/ml X-gal (Life Technologies). Embryos were 
washed twice in PBS to stop the reaction. The staining was visualized under a dissecting 
scope (Leica, Model MZ6). Whole embryos were photographed using a Leica DC500 
camera. For each stage, at least 3 embryos of each genotype (Ets1+/+, Ets1+/-, and Ets1-/-) 
were stained and photographed.  
Embryos from crosses between Ets1+/-::Dct-LacZ+ mice were harvested at 
E10.75. Lysotracker Red (Zucker et al., 1998) and LacZ staining (Nagy, 2003) were 
performed after dissection to identify melanoblasts (LacZ positive cells), dying cells 
(Lysotracker Red positive cells), and dying melanoblasts (double-labeled cells). To 
perform Lysotracker Red staining, embryos were incubated in 5µM Lysotracker Red 
DND-99 (Life Technologies) in PBS??????????????????????????????????????????utes. Still 
protected from light, embryos were washed twice with PBS (pH7.2) and β-galactosidase 
staining was performed, visualized, and photographed as described above. Still protected 
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from light, embryos were then post-fixed in 4% paraformaldehyde, 20 minutes at room 
temperature, incubated in 10% sucrose 4-??????????????????????????????????????????????
????????? ?????????? ??? ???? ????? ?????? ????????? Embryos were embedded in Tissue-Tek 
Tissue Freezing Medium (Sakura), frozen at -?????????????????????????µm. Sections were 
then stained against phospho-Histone H3 (Millipore) via immunofluorescence (as 
described in 2.3.4). 
2.3.4 Immunofluorescence 
Cryosections of 10µm thickness from E10.75 embryos previously stained with 
???????????????????????????????????? ???????????????????????????????????????????????
PBS and blocked with 1% Bovine Serum Albumin (BSA) (Amresco), 0.1% Triton X-100 
(Sigma) in PBS 45 minutes at room temperature. Sections were incubated in rabbit anti-
phospho-Histone H3 antibody (Ser10) (06-570, Millipore), (1:100 in 1% BSA, 0.1% Triton 
X-100 in PBS), 1 hour at room temperature, to label proliferating cells. After washing, 
sections were incubated in a secondary antibody against rabbit, tagged with Alexa Fluor 
488 (A11008, Invitrogen) (1:200 in 1% BSA, 0.1% Triton X-100 in PBS), 1 hour at room 
temperature, to label proliferating cells with green fluorescence. Cell nuclei were 
counterstained using 1µg/ml Hoechst Dye (BioRad). Using a compound fluorescence 
microscope (Leica, Model DMRB), melanoblasts (LacZ positive cells), dying 
melanoblasts (LacZ and Lysotracker Red positive cells), and proliferating melanoblasts 
(LacZ and p-Histone H3 positive cells) were counted over 80 sections spanning the trunk 
region for E10.75 Ets1-/-::Dct-LacZ+ (n=3) and Ets1+/-::Dct-LacZ+ (n=3) embryos. 
In order to label dying NC cells parallel cryosections from E10.25 embryos were 
stained with antibodies against Sox10, to label NC cells, and Cleaved caspase-3, to label 
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dying cells. Specifically, embryos were harvested in PBS and fixed in 4% paraformaldehyde, 
?????????????????????????????????????????????????????????????????????????????????????10% 
sucrose 4-6 hours ???????????? ?????????????????????????????????????????????????????????
light rocking. Embryos were embedded in Tissue-Tek Tissue Freezing Medium (Sakura) 
and frozen at -????????????????????????µm thickness were prepared and dried, 2 hours at 
????????????????ly described. Sections were incubated with goat polyclonal anti-Sox10 
(N20) (sc-17342, Santa Cruz Biotechnology) (1:100) antibody and rabbit anti Cleaved 
Caspase-3 (9664S, Cell Signaling) (1:100) antibody. After washing extensively with PBS, 
sections were incubated in donkey anti-goat Alexa Fluor 594 (A11058, Invitrogen) (1:200). 
Sections were once again washed extensively with PBS and subsequently incubated in goat 
anti-rabbit Alexa Fluor 488 (A11008, Invitrogen), followed by extensive PBS washes. All 
antibodies were diluted in 1% BSA, 0.1% Triton X-100 in PBS. All antibody incubations 
were carried out for 1 hour at room temperature. Cell nuclei were counterstained using 
1µg/ml Hoechst Dye (BioRad). Neural crest cells (Sox10 positive cells) and dying neural 
crest cells (double-labeled cells) were counted over 35 sections spanning the anterior half 
of the trunk region for E10.25 Ets1-/- (n=3) and Ets1+/- (n=3) embryos. 
2.3.5 Probe preparation for in situ hybridization 
In situ hybridization probes were prepared from plasmids containing the full 
length Pmel17 cDNA (Baxter and Pavan, 2003) or a 1.5kb cDNA fragment of the Sox10 
cDNA (Southard-Smith et al., 1998). The plasmids used for cloning the Pmel17 and 
Sox10 constructs contained the promoters for T3 and T7 RNA Polymerase, respectively. 
In these plasmids, the cDNAs are oriented such that an antisense probe can be generated 
from in vitro transcription. In order to have a sufficient amount of plasmid for probe 
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synthesis, plasmids were transformed into Escherichia coli Dh5α competent cells (Life 
Technologies) and glycerol stocks were prepared (Appendix I). Plasmids were purified 
from overnight cultures using the Promega Wizard Plus SV Minipreps DNA Purification 
System (Promega). Plasmids were linearized via restriction enzyme digestion, using KpnI 
(Promega) for Pmel17 and PvuII (New England Biolabs) for Sox10. Digestions were 
???????? ???? ????????????????????????? ?????????????? ?? ?????? ??? ???????????????? ?????????
were visualized in a 1% agarose gel containing 0.5µg/ml Ethidium Bromide (Fisher 
Scientific). Linearized templates were purified via phenol-chloroform extraction, 
followed by ethanol precipitation. Template DNA was resuspended in Diethyl 
Pyrocarbonate (DEPC) (Sigma-Aldrich) treated water at an approximate concentration of 
1µg/ml. 
Riboprobe synthesis was carried out by incubating 5µl of linearized template with 
4µl of 5x transcription buffer (Promega), 2µl of nucleotide tri-phosphate (NTP) labeling 
mix (Roche Diagnostics), 2µl of T3 or T7 RNA Polymerase (Promega), 1µl of RNasin 
RNase inhibitor (Promega) and 6µl of DEPC-???????? ??????? ?? ?????? ??? ??????
Transcription efficiency was assayed by visualizing the resulting probes in a 1% agarose 
gel containing 0.5µg/ml Ethidium Bromide (Fisher Scientific). Probes were purified via 
Ethanol precipitation with 0.02M EDTA and 0.5M LiCl, and resuspended in 20µl of 
DEPC-treated water. 
2.3.6 In situ hybridization  
In situ hybridization using Pmel17 and Sox10 probes were performed on E10.5 
and E9.5 embryos, respectively, according to standard protocols (Wilkinson and Nieto, 
1993; Wilkinson, 1998). Embryos that had been previously dehydrated with methanol, 
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were re-hydrated by incubation in methanol solutions of decreasing concentration (75%, 
50% and 25% methanol in PBT (PBS containing 0.1% Tween 20 (Fisher Scientific)), 5 
minutes each at room temperature), and washed with PBT. Embryos were then bleached 
with 6% Hydrogen Peroxide (Fisher) in PBT, 1 hour at room temperature with light 
rocking. Permeabilization of the tissue was achieved by incubation in 10µg/ml Proteinase 
K (Fisher Scientific) in PBT (8 minutes for E9.5 and 12 minutes for E10.5). 
Permeabilization was stopped by incubation in 2mg/ml Glycine (Fisher Scientific) in 
PBT, 10 minutes at room temperature. Embryos were post-fixed in 4% 
paraformaldehyde, 20 minutes at room temperature and pre-hybridized by incubation in 
Hybridization Solution (50% Formamide (Fisher Scientific), 5XSSC, pH4.5 (0.75M 
NaCl, 0.075M Sodium Citrate), 50µg/ml yeast tRNA (Sigma Aldrich), 1% SDS (Fisher 
Scientific), 50µg/ml Heparin (Sigma-Aldrich???? ?? ????? ??? ?????? ???????? ????? ?????
incubated in fresh, pre-??????? ?????????????????????????????? ??????????? ??????????????
probe (2µl per ml of Hybridization Solution), ove???????????????? 
 The second day of in situ hybridization consisted of washes and antibody 
incubation. Embryos were first washed with Solution 1 (50% Formamide, 5XSSC, 1% 
?????? ?? ?????? ??? ?????? ???? ??? ???????? ????? ?????? ???????? ????? ????? ??????? ?????
Soluti??? ?? ????? ??????????? ??????? ?? ?????? ??? ?????? ???? ??? ???????? ????? ??????
Embryos were washed in TBST (Tris Buffered Saline (TBS): 137mM NaCl, 2.7mM KCl, 
25mM Tris-Base (Fisher Scientific), pH8.0 + 0.1% Tween 20 (Fisher Scientific)) 3 times, 
5 minutes each time at room temperature. Blocking was achieved by incubating the 
embryos in 10% goat serum (Gibco) in TBST, 2 hours at room temperature with rocking. 
During this time, the anti-Digoxigenin antibody (Roche Diagnostics) was pre-absorbed as 
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follows. For each embryo, a pinch of embryo powder (Appendix II) was added to 0.5ml 
of TBST in a 1.5ml sterile microcentrifuge tube. The embryo powder in TBST was 
??????? ??? ?????? ???? ???????????? ???????? ????????? ???? ?????????? ??? ???? ???? ????????????
Subsequently, 5µl of heat inactivated 100% goat serum and 1µl of anti-Digoxigenin 
??????????????????????????????????????????????????????????????????????????????????????
??????? ??????????????????????????????????supernatant was then collected and placed in a 
sterile 2ml microcentrifuge tube containing 1.5ml of 1% goat serum in TBST.  Embryos 
were incubated in pre-absorbed anti-?????????????????????????????????????????????????????
light rocking. 
On the third day of in situ hybridization, embryos were washed with TBST, 3 
times, 5 minutes each time at room temperature, followed by 5 washes of at least 1 hour 
each, at room temperature. Embryos were incubated overnight in 2mM Levamisole 
(Sigma-Aldrich) in TBST. The purpose of the prolonged washes was the removal of 
excess antibody to prevent background staining. On the fourth and final day, embryos 
were washed with NTMT (100mM NaCl, 100mM Tris pH9.5, 50mM MgCl2, 0.1% 
Tween 20 (Fisher Scientific) 2mM Levamisole (Sigma-Aldrich)), 3 times, 10 minutes 
each time at room temperature. Each embryo was then protected from light and incubated 
in a color substrate solution consisting of 4.5µl of 4-Nitro blue tetrazolium chloride 
(NBT) (Roche Diagnostics) and 3.5µl of 5-Bromo-4-chloro-3-indolyl-phosphate (BCIP) 
(Roche Diagnostics) in 1ml of NTMT for a period of 45 minutes to 2 hours, depending 
on the amount of time it took for the staining to develop. Embryos were monitored 
periodically (approximately every 20 minutes) under a dissecting scope, for color 
development. The staining was stopped by washing the embryos 2 times with PBT, 5 
	  63 
	  
minutes each time at room temperature. Embryos were photographed in 50% Glycerol in 
PBT under a dissecting scope (Leica, Model MZ6) using a Leica DC500 camera. Pictures 
were taken at a total magnification of 40X. For each stage, at least 3 embryos of each 
genotype (Ets1+/- and Ets1-/-) were stained and photographed.  
2.3.7 Statistical analysis 
The Student’s t-test was used to compare the mean number of melanoblasts, as well 
as the mean numbers of dying and proliferating melanoblasts in E10.75 Ets1-/- and Ets1+/- 
embryos. The same statistical test was used to compare the mean number of NC cells and the 
mean number of dying NC cells in E10.25 Ets1-/- and Ets1+/- embryos. Data were considered 
statistically significant at p<0.05. All analyses were carried out using PASW Statistics 18 
(IBM). Graphical representations of the data were generated using GraphPad Prism 6 
(GraphPad Software, Inc). 
2.4 Results 
2.4.1 Ets1 null embryos show reduced numbers of melanoblasts 
In order to establish the earliest time point at which Ets1 deficiency results in 
impaired melanocyte development, embryos from intercrosses between Ets1+/-::Dct-
LacZ+ mice were harvested between embryonic days (E) 10.75 and E15.5 and subjected 
to LacZ staining. A gross decrease in the number of trunk melanoblasts is visibly 
apparent in E11.5-E15.5 Ets1-/- embryos compared to Ets1+/- littermates (Figure 2.2). 
Melanoblasts were counted in 80 sections spanning the trunk region in E10.75 embryos 
(Figure 2.3). These counts revealed a significant decrease in the number of trunk 
melanoblasts in Ets1-/- embryos compared to Ets1+/- littermates (p=0.018, Figure 2.3 E).  
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2.4.2 Ets1 deletion results in decreased melanoblast survival  
To establish the mechanism of action of Ets1 in murine melanocyte development, 
the total numbers of trunk melanoblasts, as well as the numbers of dying and proliferating 
melanoblasts, were quantified at E10.75. The earliest time point at which Dct is 
expressed in melanoblasts is E10.5; however, at this stage most melanoblasts are 
restricted to the head and cervical region and the number of trunk melanoblasts is very 
small (Baxter et al., 2004). For this reason, trunk melanoblasts, labeled via LacZ staining, 
were quantified at E10.75. Embryos from crosses between Ets1+/-::Dct-LacZ+ mice were 
harvested at E10.75 and subjected to Lysotracker Red staining, LacZ staining, and 
phospho-Histone H3 immunofluorescence staining.  LacZ positive cells, as well as 
double-labeled cells (LacZ and Lysotracker Red positive, and LacZ and phospho-Histone 
H3 positive) were counted in 80 sections spanning the trunk region of each embryo. As 
previously stated, a significant decrease in the number of trunk melanoblasts was 
observed in Ets1-/- embryos compared to Ets1+/- littermates (p=0.018, Figure 2.3 E). At 
this stage, the percent of proliferating melanoblasts, which are identified by LacZ and 
phospho-Histone H3 double-labeling, did not differ significantly between Ets1+/- and 
Ets1-/- littermates (p=0.852, Figure 2.3 G). These results indicate that Ets1 deficiency 
does not result in impaired melanoblast proliferation at E10.75. A significant increase in 
the percent of dying melanoblasts, labeled by Lysotracker Red and LacZ staining, was 
observed in Ets1-/- embryos compared to Ets1+/- littermates (p=0.023, Figure 2.3 F). The 
increase in melanoblast cell death observed in E10.75 Ets1-/- embryos indicates that Ets1 
is required for melanoblast survival at this stage.  
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 Melanoblasts were also labeled via Pmel17 in situ hybridization in E10.5 embryos 
(Figure 2.4). The Pmel17 gene encodes a melanocyte-specific transmembrane protein, 
which has been shown to label melanoblast and cells of the retinal pigmented epithelium 
(RPE) beginning at E9.5. At E9.5, Pmel17 expression is restricted to the otic vesicle and 
presumptive RPE. At E10.5, Pmel17 has been shown to be expressed in the RPE as well 
as in melanoblasts mostly in the head and neck, although a few melanoblasts are also 
labeled along the trunk (Baxter and Pavan, 2003). Although no gross differences in the 
number of melanoblasts between Ets1-/- and Ets1+/- littermates were observed at E10.5, 
only a few melanoblasts located in the cervical region were labeled by Pmel17 in situ 
hybridization at this stage (Figure 2.4). The absence of Pmel17-positive cells along the 
trunk region did not allow for the quantification of trunk melanoblasts at this stage. 
2.4.3 Ets1 deletion results in decreased neural crest cell survival 
Given the increase in cell death observed in Ets1-/- mutant embryos at E10.75, a 
potential role for Ets1 prior to melanocyte cell specification was investigated. Embryos 
from intercrosses between Ets1+/- mice were harvested at E10.25. Embryos were fixed, 
embedded in tissue freezing media and sectioned at 10µm. Neural crest cells were labeled 
via Sox10 antibody staining, while dying cells were labeled via cleaved Caspase-3 
antibody staining (Figure 2.5). The transcription factor Sox10 was chosen as a NC cell 
marker because it is expressed in various migrating NC cell derivatives, including the 
dorsal root, cranial, enteric and sympathetic ganglia (Southard-Smith et al., 1998). Sox10 
is initially expressed in NC cells as they begin to delaminate from the neural tube and 
persists in cells that will give rise to peripheral nervous system components (Kuhlbrodt et 
al., 1997) and melanocytes (Southard-Smith et al., 1998). Neural crest cells as well as 
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dying NC cells were counted in 35 sections spanning the anterior portion of the trunk 
region for 3 embryos of each genotype (Ets1-/- and Ets1+/-). The total number of NC cells 
(Sox10 positive cells) did not differ significantly between Ets1-/- and Ets1+/- embryos 
(p=0.848, Figure 2.5 C). Nonetheless, the percent of dying NC cells (Sox10 and cleaved 
Caspase-3 positive cells) was significantly higher in Ets1-/- embryos compared to Ets1+/- 
littermates (p=0.033, Figure 2.5 D).  
Embryos at E9.5 were also assessed for Sox10 expression via in situ hybridization 
(Figure 2.6) and LacZ staining (Figure 2.7) of whole embryos from crosses between 
Ets1+/-::Sox10LacZ/+ mice. At this stage, the pattern and levels of Sox10 expression as well 
as the numbers of Sox10 positive cells do not appear to differ much between Ets1 null 
embryos and Ets1 wild type or heterozygous littermates. Nevertheless, Sox10 in situ 
hybridization revealed ectopic Sox10 expression in the frontal aspect of the head in Ets1 
null embryos. 
2.5 Discussion 
While coat color variations in mice are the result of changes in melanin 
production and distribution, white spotting is caused by impaired melanoblast 
development, or from defects in melanocyte stem cell survival. Specifically, defects in 
melanoblast survival, proliferation, migration, hair follicle and integument invasion, and 
stem cell renewal in the hair follicles will result in various spotting phenotypes, which 
include head and belly spots, white belts that extend to the caudal trunk region, piebald 
spotting and peppering (Baxter et al., 2004). The hypopigmentation phenotype observed 
in Ets1 mutant mice pointed to a potential role for Ets1 in melanocyte development, 
particularly in survival, proliferation or migration. 
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In vivo analysis of Ets1 mutant embryos via labeling of melanoblasts using Dct-
LacZ transgenic mice, revealed an apparent gross decrease in melanoblast numbers in 
embryos ranging from E15.5 through E10.75 (Figure 2.2). Quantification of trunk 
melanoblasts at E10.75 revealed a large and significant reduction in melanoblast 
numbers, as a result of increased apoptosis, in Ets1 null mutants compared to 
heterozygous littermates (Figure 2.3). The increased melanoblast cell death observed in 
Ets1 null mutants indicates that Ets1 acts early during melanocyte development and 
appears to be required for the survival of melanocyte precursors. The presence of viable 
melanocytes in Ets1 null mutant mice implies that Ets1 may not be required for 
melanocyte differentiation. We also failed to detect significant differences in the numbers 
of proliferating melanoblasts between Ets1 null and heterozygous embryos at this stage.  
The early defect observed in the melanoblast population in Ets1 null mutant mice 
suggests that Ets1 may be involved in the regulation of one or more early melanocyte-
specific genes. Although the presence of viable melanocytes in Ets1 null mutants 
suggests that Ets1 is not required for proper melanocyte differentiation, it is possible that 
the large decrease in melanoblast cell numbers observed in these mice could in part arise 
as a consequence of altered NC cell fate decisions. The presence of ectopic NC cell-
derived cartilage nodules in the hearts of Ets1 null mutant mice suggests that Ets1 may 
act as a negative regulator of cartilage fate in NC cells (Gao et al., 2010). Consequently, 
in spite of the melanoblast survival defect observed in Ets1 null mutants, we cannot 
discard the possibility that, in addition to being required for melanoblast survival, Ets1 
may also be involved in NC cell lineage specification.  
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Given the increase in melanoblast cell death observed in Ets1 null mutant mice at 
E10.75, it was plausible that Ets1 may regulate the survival of NC cells prior to their 
specification into the melanocyte lineage. Labeling of NC cells via Sox10 antibody 
staining revealed similar numbers of trunk NC cells in Ets1-/- and Ets1+/- littermates. In 
spite of this, double-labeling with cleaved Caspase-3 antibody revealed a significant 
increase in the percent of dying NC cells from 4.2% in Ets1 heterozygotes to 6.5% in 
Ets1 null littermates (Figure 2.5). These results point to a role for Ets1 as a survival factor 
for NC cells prior to their differentiation into the melanocytic lineage. The lack of a 
significant difference in the numbers of Sox10-positive NC cells at this stage, implies that 
Ets1 appears to act precisely at this time point so that the effects of Ets1 deficiency would 
become apparent soon after. The sharp and significant decrease observed in melanoblast 
numbers at E10.75 supports this possibility. Furthermore, Sox10 expression did not 
appear to be affected in Ets1 null mutant mice at E9.5, suggesting that the critical time 
point at which Ets1 regulates NC cell and melanoblast survival is somewhere between 
E10 and E11.  
Other pigmentation mutants in which melanoblast survival defects are observed as 
early as E10.5-E11.5 include mutants of the transcription factors  Sox10, paired box 3 
(Pax3), and Microphthalmia-associated transcription factor (Mitf) as well as mutants of 
the G-coupled Endothelin receptor b (Ednrb) and  the tyrosine kinase receptor Kit. 
Mutations in these genes not only affect melanoblast survival, but also proliferation, 
migration and final differentiation (Baxter et al., 2004; Silver et al., 2006). The 
transcription factors Pax3 and Sox10 are initially expressed in NC cells at E8.5 prior to 
their commitment into the melanocytic fate. Mitf, Kit, and Ednrb, on the other hand are 
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first expressed at E10-E10.5, around the time of melanoblast specification from the NC 
(reviewed in Silver et al., 2006). All of these genes are required for melanoblast survival 
and it is possible that the Ets1-induced effect on melanoblast survival is mediated via one 
or more of these essential melanocytic genes. In the chick embryo, Ets1 drives Sox10 
expression in cranial NC cells via the Sox10E2 enhancer, which is critical for the 
initiation of Sox10 expression in cranial NC cells. Ets1 was found to directly bind to and 
activate this enhancer (Betancur et al., 2010). Although the hypopigmentation phenotype 
observed in Ets1 null mutant mice is the result of improper development of NC cells 
emerging from the trunk region, it is possible that in the mouse, Ets1 may be an important 
regulator of Sox10 in the trunk NC. The early defects in melanoblast and NC cell survival 
observed in Ets1 null mutants point to Sox10 as a probable target of Ets1, particularly in 
light of the essential role of Sox10 in NC cell, melanocyte and glial cell survival (Britsch 
et al., 2001). In an attempt to examine whether Ets1 acts upstream of Sox10, phenotypic 
analysis of Ets1 and Sox10 double heterozygous mutants will be carried in order to 
determine whether a synergistic genetic interaction exists between these genes in 
melanocyte development. 
 
 
 
 
 
 
 
	  70 
	  
 
 
Figure 2.1. Ventral hypopigmentation in Ets1 mutant mice. Ets1 null (Ets1-/-) and 
heterozygous (Ets1+/-) mice (A and B, respectively) exhibit ventral hypopigmentation 
compared to Ets1 wild type (Ets1+/+) (C) littermates.  
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Figure 2.2. Ets1 null mutant embryos have decreased melanoblast numbers. Dct-LacZ 
transgenic mice, in which LacZ expression is driven by the Dopachrome tautomerase 
(Dct) promoter that drives expression to melanoblasts, were crossed to Ets1+/- mice to 
produce Ets1+/-::Dct-LacZ+ mice. Embryos from intercrosses between Ets1+/-::Dct-LacZ+ 
mice were harvested at embryonic days (E)10.75-15.5, subjected to LacZ staining and 
analyzed for the amount and position of melanoblasts (blue dots) in the trunk region. At 
all these ages, Ets1-/- embryos have reduced numbers of melanoblasts (D, H, L, P, T, X) 
compared to Ets1+/- (B, F, J, N, R, V) and wild type (not shown) littermates (HL: 
Hindlimb, FL: Forelimb). 
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Figure 2.3. Decreased melanoblast survival in E10.75 Ets1 null mutants. LacZ staining, 
Lysotracker Red staining, and phospho-Histone H3 (p-Histone H3) immunofluorescence 
of E10.75 mouse embryos. (A & C) Melanoblasts traveling along the surface of the 
embryo are marked via LacZ staining (black arrows). (B) Lysotracker Red marks 
lysosomes in dying cells (red fluorescence). (D) Proliferating cells are positive for the p-
Histone H3 antibody (green fluorescence). (A & B) Dying melanoblasts (DM, arrows) 
are LacZ and Lysotracker Red positive. (C & D) Proliferating melanoblasts (PM, arrows) 
are LacZ and p-Histone H3 positive. (E) Melanoblasts (LacZ positive cells), (F) dying 
melanoblasts (LacZ and Lysotracker Red positive cells) and (G) proliferating 
melanoblasts (LacZ and p-Histone H3 positive cells) were counted in 80 sections for 
E10.75 Ets1+/- (n=3) and Ets1-/- (n=3) embryos. (E) Ets1-/- embryos have significantly 
reduced numbers of melanoblasts compared to Ets1+/- littermates (*p<0.05). (F) The 
percent of dying melanoblasts was significantly higher (*p<0.05) in Ets1-/- embryos 
compared to Ets1+/- littermates, (G) while the percent of proliferating melanoblasts did 
not differ significantly between these. 
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Figure 2.4. Melanoblasts in E10.5 Ets1 null vs. Ets1 heterozygous mouse embryos. In 
situ hybridization using a Pmel17 probe was carried out to label developing melanoblasts 
at E10.5. No gross differences in the position and numbers of melanoblasts are apparent 
between Ets1+/- and Ets1-/- littermates (black arrows) (Magnification = 40x). 
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Figure 2.5. Decreased neural crest cell survival in E10.25 Ets1 null mutants. Sox10 and 
cleaved Caspase-3 double-label immunofluorescence of E10.25 mouse embryos. (A & B) 
Neural crest (NC) cells traveling along the surface of the embryo were labeled with 
Sox10 antibody (red fluorescence). Dying cells were labeled using a cleaved Caspase-3 
antibody (green fluorescence). Dying NC cells are positive for Sox10 and cleaved 
Caspase-3 (white arrows). (C) NC cells and (D) dying NC cells were counted in 35 
sections spanning the anterior half of the trunk region for E10.25 Ets1+/- (n=3) and Ets1-/- 
(n=3) embryos. (C) The number of NC cells in Ets1-/- embryos is not significantly 
different from that of Ets1+/- littermates (p=0.848). (D) The percent of dying NC cells is 
significantly higher (*p<0.05) in Ets1-/- embryos compared to Ets1+/- littermates. 
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Figure 2.6. Sox10 expression in E9.5 Ets1 mutant embryos examined via in situ 
hybridization. Whole mount in situ hybridization of E9.5 embryos using a Sox10 
riboprobe. Sox10 expression can be seen in the cranial ganglia (cg), otocyst (ot) and 
dorsal root ganglia (drg). Ectopic Sox10 expression was also detected on the frontal 
aspect of the head in Ets1-/- embryos (red arrowhead) (Magnification = 40x). 
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Figure 2.7. Sox10 expression in Ets1 mutant embryos visualized via LacZ staining. 
Sox10 expression was visualized via LacZ staining in E9.5 embryos from intercrosses 
between Ets1+/-::Sox10LacZ/+ mice. Sox10 expression can be seen in the cranial ganglia 
(cg), the otocyst (ot), the dorsal root ganglia (drg) and the first and second branchial 
arches (ba1 and ba2, respectively). Overall, no gross differences were observed in Sox10 
expression between Ets1-/- and Ets1+/+ or Ets1+/- (not shown) littermates (Magnification: 
40x). 
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GENETIC INTERACTION BETWEEN THE TRANSCRIPTION FACTORS Ets1 AND 
Sox10 IN THE DEVELOPMENT OF MELANOCYTES AND ENTERIC GANGLIA 
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III. GENETIC INTERACTION BETWEEN THE TRANSCRIPTION FACTORS Ets1 
AND Sox10 IN THE DEVELOPMENT OF MELANOCYTES AND ENTERIC 
GANGLIA 
3.1 Abstract 
 The study of synergistic genetic interactions through the use of double 
heterozygous pigmentation mutants has been instrumental to the elucidation of the 
transcriptional networks at play in the development of melanocytes from the neural crest 
(NC). We previously established a role for Ets1 in the survival of early melanocyte 
precursors (melanoblasts). This observation, along with findings in the avian system, 
which implicate Ets1 in the regulation of the transcription factor Sox10, a factor critical 
for melanoblast survival, pointed to a potential genetic interaction between Ets1 and 
Sox10 in melanocyte development. To establish whether Ets1 interacts with Sox10, 
Ets1+/- mice were crossed to Sox10LacZ/+ mice, in which LacZ is inserted into the Sox10 
locus, and the hypopigmentation phenotypes of the progeny were compared. The 
incidence of hypopigmentation in Ets1+/-::Sox10LacZ/+ mice was significantly higher than 
that of Ets1+/- and Sox10LacZ/+ mice. Additionally, the areas of hypopigmentation of 
Ets1+/-::Sox10LacZ/+ mice were significantly greater than the sum of the areas of 
hypopigmentation of Ets1+/- and Sox10LacZ/+ mice, suggesting that a synergistic genetic 
interaction exists between Ets1 and Sox10 in melanocyte development. The transcription 
factor Sox10 is also required for the development of NC-derived enteric ganglia, and 
mutations in this transcription factor have been described in both syndromic and non-
syndromic aganglionosis of the distal colon or Hirschsprung’s disease. Given the 
importance of Sox10 for proper gut innervation, the enteric innervation in the distal 
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portion of the colon from Ets1 heterozygous and null mutant mice, that were either wild 
type or heterozygous for Sox10, were also analyzed. Colons from Ets1-/-::Sox10+/+ mice 
had significantly larger nerve-free areas compared to Ets1+/-::Sox10+/+ and Ets1+/-
::Sox10LacZ/+ mice. Sox10 heterozygosity was found to exacerbate the decrease in gut 
innervation observed in Ets1 null mutants. Finally, analysis of Sox10 expression, via 
LacZ staining in E11.5 and E12.5 Ets1-/-::Sox10LacZ/+ and Ets1+/-::Sox10LacZ/+  littermates 
revealed an apparent decrease in Sox10 expression in approximately 50% of the embryos 
analyzed. Together, these results suggest that Ets1 interacts synergistically with Sox10 in 
melanocyte and enteric ganglia development. Furthermore, the nature of this synergistic 
interaction may underlie a functional interaction, with Ets1 acting in the regulation of 
Sox10 expression during embryonic development. 
3.2 Introduction 
The study of genetic interactions has been widely used as a means of revealing 
functional interactions among genes (Mani et al., 2008). A genetic interaction is the 
interaction of two genetic alterations in the specification of a given phenotype (Drees et 
al., 2005). Genetic interactions can be additive, epistatic, suppressed, or synergistic in 
nature. A genetic interaction is considered additive when the phenotype of the double 
mutant is a combination of the phenotypes observed in the single mutants. An epistatic 
interaction refers to interactions in which the phenotype of the double mutant is similar to 
that of one of the single mutants but not the other. Suppressed genetic interactions are 
those in which the phenotype of the double mutant more closely resembles the wild type 
phenotype than the phenotype of the single mutants. A synergistic genetic interaction, on 
the other hand, exists when the presence of both mutations results in a more extreme or 
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exacerbated phenotype than would be expected from the addition of the phenotypes of 
the single mutants (Mani et al., 2008; Perez-Perez et al., 2009). Epistatic and suppressive 
genetic interactions are considered as evidence of an underlying functional relationship, 
while additive interactions indicate the absence of a functional relationship (Perez-Perez 
et al., 2009).  
Instances of suppressed genetic interactions have been described in mouse 
pigmentation mutants. One such instance revealed a functional interaction between Nf1, 
the gene encoding the Ras-GTPase activating protein Neurofibromin, with two critical 
melanocytic genes, the tryrosine kinase receptor Kit and the Microphthalmia-associated 
transcription factor (Mitf). When mice heterozygous for Nf1 were crossed to KitW/+ or 
Mitfwh/+ mutant mice a reduction in the sizes of the belly spots normally present in these 
mutants was observed in progeny that were also heterozygous for Nf1. In triple 
heterozygotes for Kit, Mitf, and Nf1, Nf1 heterozygosity was also able to partially rescue 
the exacerbated hypopigmentation phenotype that is normally observed in mice that are 
double heterozygous for  KitW/+ and MitfWh/+ (KitW/+;MitfWh/+). These results not only 
suggested a functional interaction between Nf1 and Kit, and between Nf1 and Mitf, but 
also suggested that this interaction occurs via a pathway that links Mitf and Kit rather 
than through independent downstream and upstream regulators of Kit and Mitf, 
respectively. At the cellular level, Nf1 heterozygosity was found to induce an increase in 
the expression of melanogenic enzymes. Additionally,  higher levels of phosphorylated 
ERK (extracellular signal regulated kinase), a component of the mitogen activated protein 
kinase (MAPK) pathway, which acts downstream of Kit to activate Mitf, were observed 
in Nf1+/- melanocytes prior to and after stimulation with Kit ligand (Diwakar et al., 2008). 
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Whether synergistic genetic interactions can serve as evidence of an underlying 
functional relationship remains controversial (Perez-Perez et al., 2009). A synergistic 
interaction may result if the genes in question are involved in the same genetic pathway, 
but act at different nodes, so that the process is more severely impaired when both genes 
are mutated compared to when either gene is mutated (Hekimi et al., 2001). An apparent 
synergistic interaction can also result if a mutation increases the sensitivity of an 
organism to the effects of another mutation (Perez-Perez et al., 2009).  
Synergistic genetic interactions identified through the study of double 
heterozygous mice were the first indication of an underlying functional interaction 
between Kit and Mitf.  Mice heterozygous for a semi-dominant Mitf mutation (Mitfmi-wh/+) 
have a uniform ventral spot and a lighter coat color. Crossing Mitfmi-wh/+  mice to mice 
heterozygous for a semi-dominant mutation in Kit (KitW-36H), which only have ventral 
spots and occasionally white feet and tail, resulted in an exacerbated pigmentation 
phenotype, which was more severe than expected if the hypopigmented areas of the 
single heterozygotes were added (Beechey et al., 1994). Similar results were obtained 
when Mitfmi-wh/+ mice were crossed to heterozygous mice in which the LacZ gene was 
inserted into the Kit locus (KitW-LacZ/+). Additional experiments demonstrated that 
signaling via the Kit receptor modulates Mitf and is required for Mitf-dependent induction 
of Tyrosinase (Tyr), a rate limiting enzyme in melanin production (Hou et al., 2000). 
Evaluation of other Mitf mutant alleles, demonstrated that not all Mitf alleles produce a 
similar effect when present in a Kit-deficient background, even if the alleles have 
equivalent mutations or produce similar alterations in mRNA levels (Hou et al., 2010).  
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The study of double heterozygous pigmentation mutants also revealed a 
synergistic interaction between Mitf and the anti-apoptotic factor Bcl2. Mice homozygous 
for a recessive Bcl2 null allele or for the recessive Mitfvit allele, exhibit gradual pigment 
loss over time, whereas heterozygous mice do not show pigmentation defects. Similar to 
the homozygous mice for either allele, double heterozygotes display a gradual loss of 
pigmentation as a result of melanocyte stem cell death. The synergistic genetic 
interaction between Mitf and Bcl2 was found to be the result of a direct functional 
interaction between these genes, with Mitf directly binding to and activating the Bcl2 
promoter (McGill et al., 2002).  
A synergistic genetic interaction has likewise been described between Kit and the 
transcription factor paired box 3 (Pax3). Double heterozygous mice for semi-dominant 
mutations in Pax3 (wbs+/-) and Kit (wps+/-) exhibit significantly more severe dorsal and 
ventral hypopigmentation compared to single heterozygous littermates. At the cellular 
level, luciferase assays revealed the ability of Pax3 to transactivate the Kit promoter. 
Furthermore, a form of Pax3 carrying the same mutation present in the wps mice 
abrogated Kit promoter activation, further validating a role for Pax3 in Kit regulation. 
Nonetheless, Pax3 was not found to directly bind the Kit promoter, which suggests that 
the functional interaction between these genes is most likely indirect (Guo et al., 2010). 
Given the hypopigmentation phenotype observed in Ets1 mutant mice and the 
increased melanocyte and NC cell death observed in Ets1 null mutant embryos, it is 
likely that Ets1 plays a role in the regulation of melanocyte or NC-specific genes. In 
order to dissect potential functional interactions between Ets1 and other melanocyte-
specific genes, a genetic interactions approach was chosen because the pigmentation 
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phenotypes of single and double mutant progenies can be easily assessed and compared. 
In light of the fact that, in the chick embryo, Ets1 is required for the activation of the 
transcription factor sex determining region Y (SRY)-box 10 (Sox10) (Betancur et al., 
2010), a gene required for the development of various NC cell derivatives, including 
melanocytes and enteric ganglia (Herbarth et al., 1998; Southard-Smith et al., 1998; Kapur, 
1999; Potterf et al., 2001), Sox10 was the best candidate for this study. A potential 
synergistic genetic interaction between Ets1 and Sox10 was studied by comparing the 
areas of hypopigmentation in single and double heterozygous progenies. Additionally, 
because Sox10 is also required for the development of enteric ganglia, the innervation of 
colons from Ets1 heterozygous and null mutant mice, that were either wild type or 
heterozygous for Sox10, was also examined. 
3.3 Materials and methods 
3.3.1 Animals  
Mice heterozygous for Ets1 were obtained from Dr. Eric Svensson (Universtiy of 
Chicago, Chicago, IL) and generated as previously described to harbor a targeted deletion 
of exons 3 and 4 of the Ets1 gene (Barton et., al. 1998). Mice heterozygous for Ets1 were 
re-derived by outcrossing to C57BL/6J mice for eight generations (Gao et., al. 2010). 
They have been maintained on C57BL/6J genetic background by intercrossing and by 
outcrossing to C57BL/6J mice (Jackson Laboratories). Sox10tmlWegLacZ mice (hereafter 
referred to as Sox10LacZ/+) were obtained from Dr. Michael Wegner (Institut für 
Biochemie, Universität Erlangen-Nürnberg, Germany). Sox10LacZ/+ mice were generated 
as previously described (Britsch et al., 2001) via insertion of the LacZ gene into the 
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Sox10 coding sequence. Sox10LacZ/+ mice have been maintained on their original C3H 
mixed genetic background by backcrossing. 
Timed matings were set for the generation of embryos. Animals were mated 
overnight, and females were examined for vaginal plugs after approximately 16 hours. 
Noon of the day a vaginal plug was observed, was considered embryonic day (E) 0.5. 
Pregnant females were euthanized by exposure to Isoflurane (Vedco, Inc.) followed by 
cervical dislocation, and an abdominal incision was made to expose the uterus. As soon 
as embryos were recovered from the euthanized mother, they were placed in Phosphate 
Buffered Saline (PBS) (pH7.2) and dissected out of the uterine sacs. For all embryos, 
yolk sacs were isolated for genotyping. Embryos were fixed in 2% paraformaldehyde 
immediately after dissection, just prior to β-galactosidase staining. All animal work was 
performed according to institutional guidelines established by the National Institutes of 
Health (NIH) (Guide for the Care and Use of Laboratory Animals, 2011; Institutional 
Animal Care and Use Committee (IACUC) Protocol No. 13-064). 
3.3.2 Genotyping 
Genomic DNA was isolated from tail biopsies from adult mice, or yolk sacs from 
embryos, and used for PCR genotyping. For Ets1, genotyping of adult mice and embryos 
was performed using the primers 5’-GTCTTCTTCTCTAGTTTCTGAGTGCTC, 5’-
GTCCTGCTTACAACACTCTGAATCCTG and 5’-
GCCTGCTCTTTACTGAAGGCTCTTT (Gao et al., 2010), under standard PCR 
???????????????????????????????????????????????????????????????????????????Products were 
visualized in a 2% agarose gel containing 0.5µg/ml Ethidium Bromide (Fisher Scientific). 
The wild type Ets1 allele produced a 438bp product while the mutant allele produced a 
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350bp product (Gao et al., 2010). For Sox10, genotyping of adult mice and embryos was 
performed using the primers 5’-CAGGTGGGCGTTGGGCTC, 5’-
CAGAGCTTGCCTAGTGTCT, and 5’-TAAAAATGCGCTCAGGTCAA under 
????????????????????????????????????????????????????????????? ??????????????????????????
Products were visualized in a 2% agarose gel containing 0.5µg/ml Ethidium Bromide 
(Fisher Scientific). The wild type Sox10 allele produced a 500bp product while the 
mutant allele produced a 600bp product (Britsch et al., 2001). Heterozygous animals 
were identified by the presence of both PCR products. 
3.3.3 Crosses and phenotypic analysis 
Heterozygous Ets1 mutant (Ets1+/-) mice were crossed to Sox10 heterozygous 
mutants (Sox10LacZ/+) to generate progeny that were either heterozygous for Ets1, 
heterozygous for Sox10, or heterozygous for both genes (Ets1+/-::Sox10LacZ/+). The single 
heterozygous progeny of the first generation (F1) were intercrossed to generate the second 
generation (F2) animals of the genotypes noted above. Third generation animals (F3) were 
generated by intercrossing single heterozygous as well as double heterozygous F2 mice. 
For each generation, the ventral aspects of each mouse were photographed at 6 weeks of 
age. The areas of hypopigmentation were measured using the Image J 1.44p program 
(NIH). 
3.3.4 β-galactosidase staining of whole mount embryos 
Embryos from intercrosses between Ets1+/-::Sox10LacZ/+ mice were harvested at 
E11.5 and E12.5. β-galactosidase (LacZ) staining was performed using standard 
protocols (Nagy, 2003). Whole embryos were dissected in 0.05M PBS (pH7.2) and fixed 
with 2% paraformaldehyde for 50 minutes at room temperature. Embryos were briefly 
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washed in PBS (pH 7.2) and incubated 3-5 hours (the incubation time was directly 
????????????? ??? ???? ?????????? ?????? ?????????? ????? ??????? ??? ??????? ??? ?-gal solution 
consisting of 2mM MgCl2, 0.01% Sodium Deoxycholate, 5mM Potassium Ferricyanide, 
5mM Postassium Ferrocyanide (Fisher Scientific), 0.02% Nonidet P40 (Roche 
Diagnostics), and 1mg/ml X-gal (Life Technologies). Embryos were washed twice in 
PBS to stop the reaction. The staining was visualized under a dissecting scope (Leica, 
Model MZ6). Whole Embryos were photographed using a Leica DC500 camera. For each 
stage, at least 3 embryos of each genotype (Ets1+/+, Ets1+/- and Ets1-/-) were stained and 
photographed.  
3.3.5 Colon dissection and Acetylcholinesterase staining 
Mice heterozygous for Ets1 (Ets1+/-), Sox10 (Sox10LacZ/+) or both genes (Ets1+/-
::Sox10LacZ/+) were crossed to generate progeny of the following genotypes: Ets1+/-
::Sox10+/+, Ets1+/-::Sox10LacZ/+, Ets1-/-::Sox10+/+, and Ets1-/-::Sox10LacZ/+. Littermates of 
the genotypes listed above, ranging from 4 to 7 months of age, were euthanized and their 
colons dissected. Euthanasia was carried out by exposure to Isoflurane in a closed 
chamber, and was followed by cervical dislocation. Once euthanized, approximately 
30mm of the distal aspect of the colons of each animal were removed and pinned down to 
4% agar plates, with the serosa aspect of each colon facing up. Colons were fixed in 4% 
paraformaldehyde, containing 10mM CaCl2??????????????????????????????????????????????
washed twice with PBS (pH7.4), 5 minutes each time, and incubated overnight in 5% 
sucrose. On the third and last day, colons were washed twice with PBS (pH7.4), 5 
minutes each time, and subjected to Acetylcholinesterase staining to visualize gut 
innervation. Briefly, colons were transferred to 3ml glass vials, and incubated in a 
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solution consisting of 15mM Sodium Citrate, 3mM Copper Sulfate, 64mM Sodium 
Acetate (Fisher Scientific), 1% Triton X-100 (Sigma-Aldrich), 0.5mM Potassium 
Ferricyanide (Fisher Scientific), 0.05% Acetylcholine Iodide, and 5mM Tetraisopropyl 
Pyrophosphoramide (Sigma-?????????? ?? ?????? ??? ?????? ???????? ??? ??? ???????????? ????
minute (RPM). Colons were then washed twice with PBS (pH7.4), 5 minutes each time, 
and incubated for 5 minutes at room temperature in a color substrate solution prepared 
with the SIGMAFASTTM Diamonobenzidine Peroxidase tablet set (Sigma-Aldrich). The 
solution consisted of 0.7mg/ml 3,3’-Diaminobenzidine (DAB), 2.0mg/ml Urea Hydrogen 
Peroxide, and 60mM Tris Buffer (Sigma-Aldrich). Finally colons were rinsed with 
10mM Tris Base (pH 8.0) and pinned in 4% agar plates, with the serosa aspect of each 
colon facing up (Gariepy et al., 1998). The staining was visualized under a dissecting 
scope (Leica, Model MZ6). Colons were photographed using a Leica DC500 camera. 
Colons from at least 5 animals of each genotype were stained and photographed. The 
extent of innervation of each colon was quantified using the images captured, by 
measuring the white (nerve-free) area in 8 squares of 0.25mm2 each (for a total of 2mm2), 
within a region located 15mm anterior to the anus (Appendix IV). The ImageJ 1.44p 
program (NIH) was used for measuring the white areas in each segment of colon.  
3.3.6 Statistical analysis 
Statistical analyses were carried out using the PASW Statistics 18 Software 
(IBM). The frequency of belly spot appearance was analyzed using the Chi-square test. In 
order to compare the mean areas of hypopigmentation among the different genotypes, a 
Box-Cox transformation was applied to the belly spot area data (measured in mm2). This 
transformation was used to approximate a normal distribution and to achieve equal or 
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near equal variances, in order to enable the use of parametric tests (Appendix III). The 
lambda value used for the Box-Cox transformations was 0.35 for generations 1 and 3 (F1 
and F3) and 0.3 for generation 2 (F2). For each generation, the transformed areas of 
hypopigmentation of Ets1+/-::Sox10LacZ/+ mice were compared to the sum of the 
transformed areas of hypopigmentation of Ets1+/- and Sox10LacZ/+ mice using a One-Way 
ANOVA with a contrast, where Ets1+/- = 1, Sox10LacZ/+ = 1, and Ets1+/-::Sox10LacZ/+ = -2. 
Scatter plots of the hypopigmentation areas showing the mean and standard deviations for 
each group were created using GraphPad Prism 6 (GraphPad Software, Inc).  
To compare the nerve-free areas in colons from Ets1+/-::Sox10+/+, Ets1+/-
::Sox10LacZ/+, and Ets1-/-::Sox10+/+ mice a One-Way ANOVA with Tukey’s and 
Bonferroni’s Post-Hoc Multiple Comparisons was carried out.  An independent samples 
t-test was carried out to compare the nerve-free area of colons from Ets1-/-::Sox10+/+ and 
Ets1-/-::Sox10LacZ/+ mice. All data were confirmed to follow a normal distribution and to 
have variances that did not differ significantly within the genotypes being tested. Scatter 
plots of the nerve-free areas in 2mm2 of colon for each genotype, showing the mean and 
standard deviations were created using GraphPad Prism 6 (GraphPad Software, Inc).  
3.4. Results 
3.4.1 Ets1 and Sox10 double heterozygosity increases hypopigmentation frequency 
In order to determine whether a genetic interaction exists between Ets1 and 
Sox10, Ets1+/- mice were crossed to Sox10LacZ/+ mice and the hypopigmentation 
phenotypes of the progeny were examined for three generations. For all generations, the 
frequency of belly spot appearance in double heterozygotes (Ets1+/-::Sox10LacZ/+) was 
significantly higher than in Ets1+/- and Sox10LacZ/+ mice (Figure 3.1, p<0.001 for all 
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generations). In the three generations examined, almost all Ets1+/-::Sox10LacZ/+  mice had 
belly spots (F1: 97%, F2: 96%, F3: 100%), compared to approximately 40% for Ets1+/- 
mice and 48% of Sox10LacZ/+  mice. The increased frequency of belly spot appearance 
observed in double heterozygotes suggests that a genetic interaction exists between Ets1 
and Sox10. 
3.4.2 Ets1 and Sox10 double heterozygosity exacerbates hypopigmentation 
To further characterize the nature of the genetic interaction between Ets1 and 
Sox10 the areas of the belly spots of the Ets1 heterozygous and Sox10 heterozygous mice 
were compared to the areas of the belly spots of double heterozygous mice. Mice 
heterozygous for Ets1 mice usually display a normal coat color. Small belly spots are 
observed in approximately 40% of Ets1+/- mice. Sox10LacZ/+ mice have belly spots 
approximately 50% of the time. The belly spots in Sox10LacZ/+ mice vary in size but also 
tend to be small. If a synergistic interaction exists between Ets1 and Sox10, the areas of 
the belly spots of Ets1+/-::Sox10LacZ/+ should be greater than the sum of the areas of the 
belly spots of Ets1+/- and Sox10LacZ/+ mice. For all three generations examined, double 
heterozygotes were found to have belly spots that were significantly larger than expected 
from the addition of the areas of the belly spots in the single heterozygotes (p<0.001 for 
all generations, Figures 3.2 and 3.3, Apprendix III), indicating that a synergistic genetic 
interaction exists between Ets1 and Sox10 in melanocyte development. 
3.4.3 Ets1 null mutants show decreased gut innervation. 
 Mutations in the transcription factor Sox10 are responsible for Waardenburg 
syndrome type IV (WS4), which is characterized by pigmentation defects and 
aganglionosis of the distal colon (Hirschsprung’s disease) (Pingault et al., 1998). 
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Mutations in Sox10 have also been associated with non-syndromic Hirschsprung’s 
disease (Sanchez-Mejias et al., 2010). Given the importance of Sox10 for proper gut 
innervation, and the synergistic genetic interaction between Ets1 and Sox10 in 
melanocyte development, it was possible that Ets1 deficiency would negatively affect gut 
innervation. Megacolon was observed in two Ets1 null mice, both of which were 
heterozygous for Sox10 (Ets1-/-::Sox10LacZ/+) (Figure 3.4). In both instances, the 
megacolon manifested early (3.5 weeks of age and 12 weeks of age) and was found to be 
the result of severe hypoganglionosis of the distal colon (Figure 3.4). Nevertheless, since 
megacolon was only observed in 2 animals (of  the 7 animals that were obtained for this 
genotype), a more detailed analysis was required to determine whether or not Ets1 
deficiency results in impaired gut innervation and, if a defect was observed, whether 
Sox10 heterozygosity would exacerbate this phenotype. 
To analyze the effect of Ets1 deficiency on gut innervation, colons from animals 
from crosses between Ets1+/-, Sox10LacZ/+ and Ets1+/-::Sox10LacZ/+ mice were dissected 
and the innervation of the gut labeled via Acetylcholinesterase staining. For each colon, 
the nerve-free (white) area in 8 squares of 0.25mm2 each, within a region located 15mm 
anterior to the anus, was measured using the ImageJ program (Appendix IV). The mean 
nerve-free area in colons from Ets1+/-::Sox10+/+ mice (n=6, mean=1.260±0.048mm2) did 
not differ significantly (p=1.000) from that of colons from Ets1+/-::Sox10LacZ/+ mice (n=5, 
mean=1.291±0.075mm2) (Figures 3.5 and 3.6). The mean nerve-free area of colons from 
Ets1-/-::Sox10+/+ mice (n=8, mean=1.402±0.048mm2) was significantly larger than the 
mean nerve-free areas of colons from Ets1+/-::Sox10+/+ (p=0.001) and Ets1+/-:: 
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Sox10LacZ/+  (p=0.010) mice (Figures 3.5 and 3.6). These results suggest that Ets1 
deficiency results in impaired gut innervation.  
Since no significant difference in gut innervation was observed between Ets1+/-
::Sox10+/+ and Ets1+/-::Sox10LacZ/+  mice, in order to further explore whether a synergistic 
genetic interaction exists between Ets1 and Sox10 in gut innervation, the nerve free areas 
of Ets1-/-, Sox10LacZ/LacZ and Ets1-/-::Sox10LacZ/LacZ mice would have to be compared. 
Unfortunately, this comparison could not be carried out because Sox10LacZ/LacZ mutants 
are embryonic lethal.  Nonetheless, a comparison of the mean nerve-free areas in colons 
from Ets1-/-::Sox10LacZ/+  mice (n=5, mean=1.501±0.081mm2)  and Ets1-/-::Sox10+/+ mice 
revealed a significant difference between these two groups (p=0.017) (Figures 3.5 and 
3.6, Appendix IV), with colons from Ets1-/-::Sox10LacZ/+ having a greater nerve-free area. 
These results support a potential genetic interaction between Ets1 and Sox10 in the 
development of enteric ganglia. The colons from the two Ets1-/-::Sox10LacZ/+ animals in 
which megacolon was detected were not included in this analysis because these were 
considered extreme cases.  
3.4.4 Ets1 null mutants appear to display decreased Sox10 expression 
The synergistic genetic interaction observed between Ets1 and Sox10 in double 
heterozygous mutants pointed to a potential functional interaction between these 
transcription factors in melanocyte development. Given that Ets1 is required for Sox10 
expression in the chick cranial NC (Betancur et al., 2010), it is possible that it could also 
be an important regulator of Sox10 expression in the mouse embryo. In order to visualize 
gross changes in Sox10 expression in Ets1 null mutants, embryos from intercrosses 
between Ets1+/-::Sox10LacZ/+ mice were harvested between E11.5 and E12.5 and Sox10 
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expression was analyzed via LacZ staining. At E11.5, Sox10 expression appeared to be 
reduced in 75% of the Ets1-/- (n=4) embryos examined compared to Ets1+/- (n=3) (Figure 
3.7) and Ets1+/+ (n=3) (not shown) littermates. At E12.5, Sox10 expression appeared to 
be reduced in 50% of Ets1-/- (n=6) embryos compared to heterozygous (n=9) (Figure 3.7) 
and wild type (n=3) (not shown) littermates. The apparent decrease in Sox10 expression 
observed in Ets1 null mutant embryos suggests that Ets1 may regulate Sox10 expression 
during embryonic development. 
3.5 Discussion 
 The study of the transcriptional networks underlying the development of NC cell 
derivatives, and particularly of melanocytes, has been largely aided by the use of double 
heterozygous mouse mutants (Beechey et al., 1994, Cantrell et al., 2004, Stanchina et al., 
2006, Diawakar et al., 2008, Guo et al., 2010, Hou et al., 2010). In the case of 
melanocytes, the use of double heterozygous pigmentation mutants is well suited for the 
study of genetic interactions because of the ease with which these interactions can be 
analyzed by comparing the pigmentation phenotypes of double and single heterozygotes. 
The presence of a pigmentation defect in Ets1 mutant mice points to the requirement of 
this transcription factor for proper melanocyte development; however, the mechanism via 
which Ets1 acts to promote melanocyte development is currently unknown. We 
previously showed that the marked decrease in melanoblast numbers in Ets1 null mutant 
embryos is caused, at least in part, by an increase in apoptosis, which suggests that Ets1 
is required for early melanoblast survival. Other genes required for melanoblast survival, 
include those that code for the transcription factors Mitf, Sox10, and Pax3, and for the 
signaling molecules Edn3 and Kitl, and their receptors Ednrb and Kit (Silver et al., 2006).  
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Evidence from studies in the chick embryo pointed to a potential interaction 
between Ets1 and Sox10. In the chick embryo, Ets1, along with Sox9 and c-Myb, directly 
binds to and activates a Sox10 enhancer element that drives Sox10 expression to cranial 
but not trunk or vagal NC cells (Betancur et al., 2010). Melanocytes are mostly derived 
from trunk NC cells, and currently there are no studies linking Ets1 to Sox10 expression 
in trunk NC cells; Nonetheless, the pigmentation defect observed in Ets1 mutant mice, 
the importance of Ets1 for melanoblast survival, and its role in the regulation of Sox10 
expression in the chick embryo, hinted to a potential genetic interaction between these 
two transcription factors in murine melanocyte development. 
 The study of genetic interactions can be influenced by the presence of genetic 
background modifiers, which can affect the penetrance of the phenotype in question 
(Cantrell et al., 2004). For this reason, genetic interactions should be studied across more 
than a single generation, particularly if different genetic strains are being used. The 
potential effect that background modifiers can exert upon a given phenotype is illustrated 
by studies describing both the absence and presence of a genetic interaction between 
Sox10 and the Endothelin receptor b (Ednrb) in melanocyte development. In one study, 
mice heterozygous for both Ednrb and Sox10 (Ednrbs-l/+;Sox10Dom/+), were found to 
exhibit belly spots that were not significantly larger than the belly spots of the single 
heterozygotes. In this study, progeny from a single generation of mice were analyzed and 
a lack of a synergistic interaction between Sox10 and Ednrb was reported (Hakami et al., 
2006). In a subsequent study, progeny from crosses between Ednrbs-l/+ and Sox10LacZ/+ 
mice were analyzed for three generations. In the first generation, a genetic interaction 
was not observed between Sox10 and Ednrb; however, a synergistic genetic interaction 
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became apparent in the second and third generations, in which double heterozygous mice 
had belly spots that were significantly larger than would be expected from the sum of the 
areas of the belly spots present in the single heterozygous mice (Lowenstein, 2009). It is 
likely that in the first study, which reported a lack of a genetic interaction between Ednrb 
and Sox10, strain-specific loci decreased the penetrance of the hypopigmentation 
phenotype that results from combined Ednrb and Sox10 heterozygosity, masking the 
existence of an interaction between these genes. 
 To begin dissecting a potential interaction between Ets1 and Sox10, the 
pigmentation phenotypes of single heterozygotes were compared to those of double 
heterozygotes. Three generations of mice were examined in order to take into account the 
potential effect of background modifiers, since the Ets1+/- and Sox10LacZ/+ mice were 
generated in different genetic backgrounds. A significant increase in the frequency of 
belly spot appearance was observed in Ets1+/-::Sox10LacZ/+ mice compared to single 
heterozygotes. These results were consistent throughout the 3 generations examined, with 
almost all double heterozygous mice having belly spots, compared to 40-50% of single 
heterozygotes. Analysis of the hypopigmentation areas of Ets1+/-, Sox10LacZ/+ and Ets1+/-
::Sox10LacZ/+ mice revealed that the mean areas of hypopigmentation in double 
heterozygous mice were significantly larger than the sum of the areas of 
hypopigmentation in the single heterozygous progeny. These results were consistent and 
significant across all generations and indicate that a synergistic genetic interaction exists 
between Ets1 and Sox10. The fact that the results were consistent across all generations 
suggests that the presence of strain-specific alleles did not seem to significantly affect the 
penetrance of the phenotype in these mice. 
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 In addition for being required for proper melanocyte development, Sox10 is also 
required for the development of enteric ganglia (Southard-Smith et al., 1998). In the 
spontaneous embryonic lethal Sox10Dom/Dom mutant mouse, NC cells fail to colonize the 
gut as a result of increased apoptosis (Kapur, 1999). This may be the result, at least in 
part, of decreased activation of the tyrosine kinase receptor c-Ret, which is also required 
for the development of enteric ganglia, and has been shown to be activated by Pax3 and 
Sox10 (Lang et al., 2000). The requirement of Sox10 for the survival of enteric ganglia 
precursors prompted the examination of the guts of Ets1 null mutant mice to determine 
whether Ets1 deficiency would negatively affect gut innervation. Close examination of 
the guts of Ets1-/-::Sox10+/+ and Ets1+/-::Sox10+/+ mice revealed a significantly larger 
nerve-free area in Ets1-/-::Sox10+/+ mutant mice compared to Ets1+/-::Sox10+/+, suggesting 
that Ets1 may play a role in the development of enteric ganglia during development. 
Given the role of Ets1 in NC cell survival (Figure 2.5), it is possible that the decreased 
innervation observed in Ets1 null mutant mice may be the result of a reduction in the 
number of NC cells available to colonize the distal colon. 
 Throughout the course of the present study, two instances of hypoganglionic 
megacolon were observed in Ets1 null mutant mice, which were also heterozygous for 
Sox10 (Ets1-/-::Sox10LacZ/+). Although no significant difference in the extent of gut 
innervation was observed between Ets1+/-::Sox10+/+ and Ets1+/-::Sox10LacZ/+ mice, Ets1-/-
::Sox10LacZ/+ mice were found to have colons with greater nerve-free areas compared to 
Ets1-/- mice carrying both copies of the wild type Sox10 allele. The significant decrease in 
gut innervation observed in Ets1-/-::Sox10LacZ/+  mice compared to Ets1-/-::Sox10+/+ may 
be the result of a synergistic interaction between Ets1 and Sox10. In light of the absence 
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of a significant difference in gut innervation between Ets1+/-::Sox10+/+ and Ets1+/-
::Sox10LacZ/+  mice and the embryonic lethality of Sox10LacZ/LacZ mutants, it was not 
possible to directly test the presence of a synergistic interaction by using double null 
mutant mice. Nevertheless, the decrease in gut innervation observed in Ets1-/-
::Sox10LacZ/+ mice compared to Ets1-/-::Sox10+/+ mice and the presence of 
hypoganglionic megacolon in 2 of  7 Ets1-/-::Sox10LacZ/+  mice examined suggests that 
Ets1 and Sox10 may interact in the development of enteric ganglia. Our previous finding 
that Ets1 plays a role in promoting the survival of melanoblasts and NC cells is also 
consistent with this hypothesis (Figure 2.3 and Figure 2.5).  
A decrease in enteric progenitor cell survival has been described in Sox10 
heterozygous mice that are also homozygous for the mutant Ednrbsl/sl (piebald) or 
Edn3ls/ls (lethal spotting) alleles. Compared to single mutants, these animals show a 
dramatic decrease in the number of enteric neuronal progenitor cells in the gut, which 
results from increased apoptosis in vagal neural crest cells prior to the time when they 
begin to invade the gut at E9.5-10 (Stanchina et al., 2006). In Sox10 homozygous mutants 
increased apoptosis of enteric ganglia precursor cells, also results in the failure of these 
cells to colonize the gut (Kapur, 1999). Additional cell survival assays to compare the 
numbers of dying enteric ganglia precursor cells in Ets1-/-::Sox10+/+ and Ets1-/-
::Sox10LacZ/+embryos are needed to determine whether  Ets1 and Sox10 work together to 
promote the survival of these cells.   
Synergistic genetic interactions may or may not indicate the presence of a 
functional interaction between the genes in question. The apparent decrease in Sox10 
expression observed in about half of all E11.5 and E12.5 Ets1-/- embryos compared to 
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Ets1+/- and wild type littermates suggests that Ets1 may play a role in the regulation of 
Sox10 expression. However, this apparent decrease in expression may also be the result 
of a decrease in the number of NC cell derivatives, thus further studies are needed to 
determine whether Ets1 regulates embryonic Sox10 expression. In order to gain a better 
understanding of the underlying functional interaction that may exist between Ets1 and 
Sox10, the ability of wild type and mutated Ets1 protein to activate the Sox10-MCS4 
enhancer, an enhancer critical for Sox10 expression in mouse melanocytes (Antonellis et 
al., 2008) will be analyzed via luciferase reporter assay in the next chapter.  
 
 
 
Figure 3.1. Ets1 and Sox10 double heterozygosity increases hypopigmentation 
frequency. The incidence of hypopigmentation in Ets1+/-::Sox10LacZ/+ mice was 
significantly greater than the incidence of  hypopigmentation in Ets1+/-  and Sox10LacZ/+ 
mice (p<0.001) for all three generations analyzed. 
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Figure 3.2. Ets1 and Sox10 double heterozygotes display increased ventral 
hypopigmentation compared to single heterozygotes. Representative pictures of ventral 
hypopigmentation for each genotype show that double heterozygous mice had larger 
areas of hypopigmentation compared to Ets1 and Sox10 single heterozygotes (F1 = 1st 
generation, F2 = 2nd generation, F3 = 3rd generation). 
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Figure 3.3. Ets1 and Sox10 double heterozygosity results in an aggravated 
hypopigmentation phenotype. The areas of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice 
were significantly greater than the sum of the areas of  hypopigmentation of Ets1+/-  and 
Sox10LacZ/+ mice (p<0.001) in all three generations analyzed (Appendix III).  
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Figure 3.4. Aganglionic megacolon in Ets1-/-::Sox10LacZ/+ mice. (A) 3.5-week-old and 
(C) 3 month old Ets1-/-::Sox10LacZ/+ mice exhibiting megacolon as a result of impaired 
innervation of the distal colon (B & D, respectively) (Magnifications B=35x, D=25x).  
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Figure 3.5. Ets1 null mutants show decreased gut innervation. Representative images of 
colon innervation labeled via Acetylcholinesterase staining in colons from (A) Ets1+/-
::Sox10+/+, (B) Ets1+/-::Sox10LacZ/+, (C) Ets1-/-::Sox10+/+, and (D) Ets1-/-::Sox10LacZ/+ 
mice. (Magnifications = 16x). Colons from Ets1 null mutants (C & D) appear less 
innervated compared to colons from Ets1 heterozygotes (A & B). (D) Sox10 
heterozygosity further exacerbates the hypoganglionic phenotype observed in Ets1 null 
mutants.  
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Figure 3.6. Ets1 deficiency results in decreased gut innervation. Scatterplots showing the 
nerve-free areas (including means and standard deviations) in 2mm2 regions of colons 
from Ets1+/-::Sox10+/+, Ets1+/-::Sox10LacZ/+, Ets1-/-::Sox10+/+, and Ets1-/-::Sox10LacZ/+ 
mice. The mean nerve-free area in colons from Ets1+/-::Sox10+/+ mice did not differ 
significantly from that of Ets1+/-::Sox10LacZ/+ (p=1.000). The mean nerve-free area of 
colons from Ets1-/-::Sox10+/+ mice was significantly larger than the mean nerve-free 
areas of colons from Ets1+/-::Sox10+/+ (p=0.001) and Ets1+/-::Sox10LacZ/+ (p=0.010) mice. 
The mean nerve-free area of the colons from Ets1-/-::Sox10LacZ/+mice was significantly 
greater compared to that of Ets1-/-::Sox10+/+ mice (p=0.017). 
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Figure 3.7. Sox10 expression in Ets1 mutant embryos. Sox10 expression was visualized 
via LacZ staining in E11.5 (A-D) and E12.5 (E-H) embryos from intercrosses between 
Ets1+/-::Sox10LacZ/+ mice. At E11.5, Sox10 expression appears to be reduced in 75% of 
Ets1-/- embryos (n=4) (C & D), compared to Ets1+/- (n=3) (A & B) and Ets1+/+ (n=3) (not 
shown) littermates. At E12.5, Sox10 expression appears to be reduced in 50% of Ets1-/- 
embryos (n=6) (G & H) compared to Ets1+/- (n=9) (E & F), and Ets1+/+ (n=3) (not 
shown) littermates. (Magnifications: A & C= 16x, B & D= 25x, E & G= 12.5x, F & H= 
21x).  
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THE TRANSCRIPTION FACTOR Ets1 ACTIVATES THE MELANOCYTE 
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IV. THE TRANSCRIPTION FACTOR Ets1 ACTIVATES THE MELANOCYTE 
LINEAGE-SPECIFIC Sox10-MCS4 ENHANCER 
4.1. Abstract 
Phenotypic analysis of double heterozygous mutants for the transcription factors 
Ets1 and Sox10 revealed a synergistic genetic interaction between these genes in 
melanocyte development. The presence of this synergistic genetic interaction hinted to a 
potential functional interaction between Ets1 and Sox10. To characterize the nature of 
this interaction, the ability of Ets1 to activate the Sox10-MCS4 enhancer, which was 
previously shown to direct Sox10 expression in melanoblasts and melanocytes, was 
analyzed via luciferase reporter assay. In the mouse melanoma cell line B16, Ets1 was 
able to activate the Sox10-MCS4 enhancer, suggesting a possible role for Ets1 in the 
regulation of Sox10 expression. Consistent with Ets1 function in melanocyte 
development, whole exome sequence analysis of the spontaneous mouse mutant variable 
spotting at the NIH Sequencing Center identified a G-to-A nucleotide transition in exon 3 
of the Ets1 gene, which results in a missense Glycine to Glutamate mutation at amino 
acid 102 (G102E) of the Ets1 protein.  We determined that this results in a hypomorphic 
mutation as in vitro luciferase reporter assay demonstrated a 2-fold decrease in the 
activation of the Sox10-MCS4 enhancer compared to wild type Ets1 protein. The ability 
of Ets1 to activate the Sox10-MCS4 enhancer and the effect of the variable spotting 
mutation on Sox10-MCS4 activation suggest that Ets1 may act as a regulator of Sox10 
expression during melanocyte development in the mouse embryo. 
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4.2. Introduction 
 The transcription factor Sox10 is essential for the development of various neural 
crest (NC) cell-derived structures during vertebrate embryogenesis. During development, 
Sox10 is expressed in migrating NC cell derivatives, which include the cranial, dorsal 
root, sympathetic, and enteric ganglia, as well as the melanocyte precursors, or 
melanoblasts (Southard-Smith et al., 1998). The importance of Sox10 in the development 
of NC-derived cell lineages was first recognized in the spontaneous Dominant megacolon 
(Dom) mouse mutant. Sox10Dom mutants harbor a frameshift mutation in Sox10 that 
results in a truncated protein (Herbarth et al., 1998, Southard-Smith et al., 1998).  
Sox10Dom heterozygotes display ventral hypopigmentation and aganglionic megacolon 
(Herbarth et al., 1998, Southard-Smith et al., 1998; Kapur, 1999). Similarly, in humans, 
Sox10 mutations have been associated with Waardenburg Syndrome type IV (WS4), 
which is characterized by pigmentation defects, congenital deafness, and aganglionosis of 
the distal colon, or Hirschsprung’s disease (Tachibana et al., 2003). 
 Neural-crest derived structures can be found in Sox10Dom/Dom and in the genetically 
engineered Sox10LacZ/LacZ mouse mutants, indicating that Sox10 is not required for the 
initial specification of NC cells (Southard-Smith et al., 1998; Britsch et al., 2001). In the 
absence of Sox10, early NC-derived structures, such as the cranial ganglia, are able to 
form; however, severe morphological alterations in these structures become apparent by 
E10.5 (Herbarth et al., 1998; Southard-Smith et al., 1998). The loss of certain NC-derived 
structures in Sox10Dom/Dom and Sox10LacZ/LacZ embryos has been attributed to increased 
apoptosis, because significantly larger numbers of dying migrating NC and dorsal root 
ganglia cells are observed in Sox10Dom/Dom mice (Southard-Smith et al., 1998). The 
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absence of enteric ganglia in the guts of Sox10Dom/Dom mice has also been attributed to 
increased apoptosis because a large number of apoptotic cells can be detected in areas 
containing NC cells prior to the time when they colonize the gut (Kapur, 1999). The 
increased apoptosis observed in migratory NC cells in Dom homozygous mutants 
suggests that Sox10 is essential for NC cell survival (Mollaaghababa et al., 2003).  
 In addition to being required for NC cell survival, Sox10 is also required for the 
final specification of melanocytes and glia. Working in cooperation with the transcription 
factor Paired Box 3 (Pax3), Sox10 has been shown to bind to and activate the expression 
of the Microphthalmia- associated transcription factor (Mitf), which is required for the 
terminal differentiation of melanoblasts and for the activation of genes required for 
melanin synthesis (Bondurand et al., 2000, Potterf et al., 2000).  In in vitro studies, Sox10 
has also been shown to regulate the transcription of genes required for melanin synthesis, 
including Dopachrome tautomerase (Dct), and Tyrosinase (Tyr) (reviewed in Harris et al., 
2010). 
 Although many transcriptional targets of Sox10 have been identified, the various 
aspects of Sox10 regulation are only now beginning to be understood. The Sox10 
promoter, which has not been well characterized, does not direct the expression of Sox10 
to most of its typical expression sites (Deal et al., 2006). However, a total of 14 multiple 
conserved sequences (MCS) that can drive Sox10 expression to various cell lineages have 
been identified (Antonellis et al., 2006, Deal et al., 2007, Antonellis et al., 2008). A 
subset of these sequences was first identified by mutation analysis of the transgene-
insertion Sox10Hry mutant, a mouse model of WS4. In this mutant a 16kb area located 
47kb upstream of Sox10 is deleted (Antonellis et al., 2008). This deletion severely 
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impairs but does not completely abrogate Sox10 expression, suggesting that this 16kb 
region contains cis-regulatory elements necessary for Sox10 expression. Of these 
elements, Sox10-MCS1c, Sox10-MCS4, Sox10-MCS5, Sox10-MCS7, and Sox10-MCS9 
can drive reporter gene expression in cultured melanocytes. Furthermore, both Sox10-
MCS4 and Sox10-MCS7 are able to recapitulate Sox10 expression in vivo, in almost all 
NC-derived structures. These enhancers contain binding sites for the SoxE family of 
transcription factors, which bind as dimers and include Sox8, Sox9 and Sox10 
(Antonellis et al., 2008). Recent studies have shown that both Sox9 and Sox10 are able to 
bind to mouse Sox10 enhancers. Other transcription factors that have been shown to bind 
to Sox10 enhancers include Pax3, Activating protein 2 (AP2) and Lymphoid enhancer 
binding factor 1 (Lef1). Nevertheless, the ability of Sox9, Sox10, Pax3, AP2 and Lef1 to 
transcriptionally activate Sox10 has not been evaluated (reviewed in Harris et al., 2010). 
 In the avian system, two Sox10 enhancers have been identified approximately 1kb 
downstream of the Sox10 coding region. Together, these enhancers, termed Sox10E1 and 
Sox10E2, are able to recapitulate Sox10 expression in the chick embryo. Sox10E1 is 
active in migrating vagal and trunk NC cells, while Sox10E2 acts earlier in cranial NC 
cells. The regulatory activity of Sox10E2 is dependent on binding by the transcription 
factors Ets1, Sox9, and c-Myb; however, these factors do not appear to be required for 
Sox10E1 activity. In vivo, Ets1, Sox9, and c-Myb were also found to be required for 
endogenous Sox10 expression in delaminating and migrating NC cells in the cranial 
neural tube region. In the chick embryo, Ets1 is not normally expressed in trunk NC cells; 
however, ectopic Ets1 expression can drive reporter gene expression, via Sox10E2 
activation, in trunk NC cells (Betancur et al., 2010). Although in the chick, Ets1 is not 
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expressed in the trunk NC, studies in the mouse embryo have reported Ets1 expression 
not only in cranial NC cells (Kola et al., 1993) but also in migrating trunk NC cells 
(Vandenbunder et al., 1989). 
 Phenotypic analysis of double heterozygous mutants for the transcription factors 
Ets1 and Sox10 revealed that a synergistic genetic interaction exists between these genes. 
The presence of a synergistic genetic interaction between Ets1 and Sox10 may be the 
result of an underlying functional interaction. One possibility regarding the nature of this 
interaction, would be Ets1 acting as a regulator of Sox10 expression. Given the findings 
in the chick embryo, where Ets1 regulates Sox10 expression in the cranial NC, we sought 
to test whether a similar relationship exists between Ets1 and Sox10 in the mouse by 
studying the ability of wild type and mutated Ets1 protein to activate a Sox10 regulatory 
region. The Sox10-MCS4 enhancer was chosen as a possible target for Ets1, because this 
enhancer is critical for Sox10 expression in melanocytes.  
4.3. Materials and methods 
4.3.1. Mapping of Ets1 binding sites in the Sox10-MCS4 and Sox10-MCS7enhancers 
The coordinates of the Sox10-MCS4 and Sox10-MCS7 enhancers were obtained 
from Antonellis et al., 2008. The coordinates given in this study are from the February 
2006 University of California at Santa Cruz (UCSC) Genome Browser Mouse assembly. 
In order to obtain the appropriate Sox10-MCS4 and Sox10-MCS7 sequences, the 
coordinates were converted using BLAST analysis and the UCSC Mouse BLAT Genome 
search, which allows alignment to previous genome assemblies. The coordinates for 
Sox10-MCS4 and Sox10-MCS7 from the February 2006 UCSC Genome Browser Mouse 
assembly were chr15:79,020,080–79,020,899 and chr15:79,040,107–79,040,404, 
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respectively. These coordinates were found to correspond to chr15:79,023,255-
79,024,074 and chr15:79,043,282-79,043,579 of NCBI sequence NC_000081.5, for 
Sox10-MCS4 and Sox10-MCS7, respectively. 
 Once the correct coordinates were identified, the 820bp sequence of Sox10-MCS4 
and the 298bp sequence of Sox10-MCS7 were analyzed for potential Ets1 binding sites 
using the MatInspector program (Genomatix, Inc), which locates transcription factor 
binding sites within a sequence by using a library of matrix descriptions for these binding 
sites. 
4.3.2 Cell culture 
The B16-F10 (B16 hereafter) mouse melanoma cell line was purchased from 
ATCC (CRL-6322, ATCC). Cells were maintained in Dubelcco’s Modified Eagle’s 
Medium (DMEM) (Cellgro), supplemented with 10% Fetal Bovine Serum (FBS), 100 
U/ml penicillin, and 100 U/ml streptomycin (all from Thermo Scientific), ??????????????
CO2. 
4.3.3 Plasmid constructs 
The Ets1 overexpression vector (pCMV-HA-Ets1) and the pCMV-HA empty 
vector (Clontech) were gifts from Dr. Satrajit Sinha (State University of New York 
(SUNY) at Buffalo, Buffalo, NY). The pCMV-HA-Ets1 vector contains a Hyaluronic 
acid (HA)-tagged version of the full length mouse Ets1 coding sequence (Nagarajan et 
al., 2009). The Sox10-MCS4 luciferase vector (Sox10-MCS4 fragment in pLGF-E1b 
vector) was a gift from Dr. William J. Pavan (National Institutes of Health (NIH), 
Bethesda, MD). This vector contains the Sox10-MCS4 enhancer, which was shown to 
drive expression to melanocytes, upstream of a minimal promoter (p1EB) which directs 
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basal luciferase expression (Antonellis et al., 2008). The pRL-TK wild type Renilla 
luciferase control vector (Promega) was a gift from Dr. Erasmo Perera (Florida 
International University (FIU), Miami, FL). All plasmids were transformed into 
Escherichia coli Dh5α competent cells (Life Technologies) and glycerol stocks were 
prepared (Appendix I). Plasmids were purified from overnight culture using the QIAprep 
Spin Miniprep Kit (Qiagen). Ethanol precipitation was carried out to purify and 
concentrate plasmids to be used for transfections (Appendix V).  
4.3.4 Sequencing the variable spotting mutation 
DNA samples from 4 variable spotting mutant mice (2 homozygous and 2 
heterozygous) were purchased from The Jackson Laboratory (Bar Harbor, Maine) by our 
collaborator (Dr. William J. Pavan, NIH, Bethesda, MD) and sent to us for further 
analysis. Sequencing of DNA from all 4 variable spotting mutant mice was carried out 
using the forward primer 5’- AAGGTGTAGAGTAACTAGCATCGTCAG, or the 
reverse primer 5’- AACTCCTAAGGCAGAGAAGAAAATAAG. Sequencing was 
carried out at the Florida International University DNA Core Facility (Florida 
International University, Miami, FL). Sequences were analyzed using the Applied 
Biosystems Sequence Scanner v1.0 software (Applied Biosystems) and sequence 
alignments against the Mus musculus genomic database were carried out using the 
megablast algorithm (for highly similar sequences) via the Nucleotide BLAST server 
(NCBI, NIH). 
4.3.5 Site-directed mutagenesis 
The mutant Ets1 overexpression vector (pCMV-HA-Ets1Mut) was prepared from 
the PCMV-HA-Ets1 vector, using the Phusion Site-Directed Mutagenesis Kit (Thermo 
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Scientific), following the manufacturer’s instructions. The High Performance Liquid 
Chromatography (HPLC)-purified primers 5’-TCTGTATGAGTGAAGCAGCACTGTG 
and 5’-CACAGTGCTGCTTCACTCATACAGA, which contain the desired G647A 
mutation (corresponding to G305A in the open reading frame (ORF) of Ets1, Ref Seq 
NM_011808.2) flanked by 11 non-mutated nucleotides were used to insert the mutation 
into the Ets1 ???????? ?????????????????????????? ?????? ???? ??????? ???? ????? ???? ?????
?????????????????????????????????????????????????????????????????????????????????? ????
plasmid and were phosphorylated at the 5’ end in order to eliminate the need of a separate 
phosphorylation step prior to ligation. A total of 500pg of plasmid were used for the PCR 
reaction and the amount of PCR product was evaluated via gel electrophoresis with DNA 
standards of various concentrations. The resulting PCR product was ligated for 5 minutes 
at room temperature and transformed into Escherichia coli Dh5α competent cells (Life 
Technologies) (Appendix I). Overnight cultures were prepared from selected colonies 
and the plasmid was purified from these cultures using the QIAprep Spin Miniprep Kit 
(Qiagen). The purified plasmid was sequenced to confirm the presence of the mutation 
using the primers:  5’-CAGACACCTTGCAGACAGACTACT, 5’-
CACAGTGCTGCTTCACTCATACAGA, and 5’-GGTGAGGCGGTCACAACTAT. 
Ethanol precipitation was carried out to purify and concentrate the plasmid to be used for 
transfections (Appendix V).  
4.3.6 Plasmid DNA transfections and luciferase assay 
Approximately 1.5 x 105 B16 cells were seeded in antibiotic-free cell culture 
media, into each well of a 12 well plate (CytoOne), roughly 24 hours prior to 
transfection. Once cells had reached 70-90% confluency they were co-transfected with 
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0.5µg/well Sox10-MCS4 luciferase reporter vector, 0.5µg/well pCMV-HA-Ets1, or 
pCMV-HA-Ets1Mut or pCMV-HA empty vector, and 0.1µg/well pRL-TK Renilla 
luciferase control vector. For each well, plasmid DNA was diluted in 50µl of Opti-MEM 
I (Invitrogen). For each well, 4 µl of the lipid transfection reagent Lipofectamine 2000 
(Invitrogen) were diluted in 50µl of Opti-MEM I. The diluted DNA and diluted 
Lipofectamine reagent were incubated 5 minutes at room temperature. After 5 minutes, 
the diluted DNA was combined with the diluted Lipofectamine and incubated 30 minutes 
at room temperature. 100µl of lipid-DNA complexes were added to each well in a drop-
wise manner, evenly distributing drops throughout the well. Plates were gently rocked by 
hand for 20 seconds. Cells were ????????????????????????2 for 48 hours. After 48 hours, 
the cells were gently washed with PBS (Thermo Scientific) and lysed with 1x Passive 
Lysis Buffer (Promega), for 15 minutes at room temperature with light rocking. For each 
well, 20µl of cell lysate were used to measure firefly and Renilla luciferase activities with 
the Dual Luciferase Reporter Assay System (Promega). Firefly and Renilla luciferase 
activities were measured using a TD-20/20 Luminometer (Turner Designs). For each 
experiment the ratio of firefly to Renilla luciferase activity was calculated. Three 
independent transfections were carried out, each one in triplicates. 
4.3.7 Statistical analysis 
 The non-parametric Mann-Whitney U test was used to compare the mean 
luciferase activity in cells transfected with the Ets1 overexpression vector to that of cells 
transfected with the empty PCMV-HA vector (data from 3 independent experiments 
carried out in triplicates). This test was also used to compare the mean relative luciferase 
activity in cells transfected with the Ets1 overexpression vector to that of cells transfected 
	  121 
	  
with the Ets1 overexpression vector carrying the variable spotting mutation (data from 3 
independent experiments carried out in triplicates).  
4.4 Results 
4.4.1 The Sox10-MCS4 and Sox10-MCS7 enhancers contain putative Ets1 binding sites. 
 Analysis of the 820bp sequence of the Sox10-MCS4 enhancer using the 
MatInspector software (Genomatix, Inc.) revealed the presence of 4 potential Ets1 
binding sites (Table 4.1).  One potential Ets1 binding site was identified within the 298bp 
Sox10-MSC7 sequence (ccgggagaGGAAcaaaaggtc, from 167 to 187 in the antisense 
strand, relative to the 5’ end of the sense strand in Sox10-MCS7). The Sox10-MCS4 
enhancer was chosen for further analysis because of the higher number of potential Ets1 
binding sites present within this regulatory region. 
4.4.2 Transactivation of the Sox10-MCS4 enhancer by Ets1 
 The ability of Ets1 to activate the Sox10-MCS4 enhancer was tested via luciferase 
reporter assay. Compared to cells transfected with the empty PCMV-HA vector, cells 
transfected with the Ets1 overexpression vector (PCMV-HA-Ets1) showed significantly 
higher luciferase reporter activity (p<0.001) (Figure 4.1). The mean relative luciferase 
activity in cells transfected with the Ets1 overexpression vector was 9.51, while in cells 
transfected with the empty vector this value was 1.41. This increase in the relative 
luciferase activity of the cells transfected with the Ets1 overexpression vector 
corresponds to a 6.8 fold increase over the cells transfected with the empty vector. 
4.4.3 Ets1 is the mutated gene in the spontaneous variable spotting mouse mutant 
 Spontaneous variable spotting mutant mice exhibit a similar phenotype to that of 
the Ets1 mutant mice used in this study. Head blaze, white spotting of the tail and feet, 
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and ventral spotting, which may be large, occur sporadically in homozygous variable 
spotting (vs/vs) mice (Jackson Laboratories).  On the other hand, the Ets1 null mutant 
mice used in this study always have large belly spots and occasionally head blaze. As part 
of an exome sequencing project at the National Institutes of Health (NIH), a possible 
mutation within the ORF of Ets1 was identified. The existence of this mouse mutant was 
brought to our attention by Dr. William J. Pavan (NIH, Bethesda, MD). Via direct 
sequencing of 4 variable spotting mutants, we confirmed a nucleotide G-to-A transition 
in exon 3 of the Ets1 gene (Figure 4.2), which results in a missense Glycine to Glutamate 
mutation at amino acid 102 (G102E) of the Ets1 protein.  
4.4.4 The variable spotting mutation results in decreased Sox10-MCS4 activation 
 In order to test whether the variable spotting mutation affects the ability of Ets1 to 
activate the Sox10-MCS4 enhancer, the mutation was inserted into the Ets1 ORF via site-
directed mutagenesis. A significant decrease in relative luciferase activity was observed 
in cells transfected with the Ets1 overexpression vector carrying the variable spotting 
mutation compared to those transfected with the wild type Ets1 overexpression vector 
(p<0.001) (Figure 4.3). This decrease corresponds to approximately a 50% reduction in 
Sox10-MCS4 enhancer activation and indicates that this mutation reduces but does not 
completely abrogate the ability of Ets1 to transactivate the Sox10-MCS4 enhancer. 
4.5 Discussion 
The proximal promoter region of Sox10 dos not direct Sox10 expression to cells 
where Sox10 is typically expressed (Deal et al., 2006). A distant upstream region located 
approximately 47kb upstream of Sox10 is able to recapitulate Sox10 expression in vivo to 
most sites where Sox10 is expressed during development (Antonellis et al., 2008). 
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Analysis of Sox10-MCS4, one of the enhancers located in this region and which drives 
expression to melanocytes, revealed the presence of four potential binding sites for Ets1 
suggesting the possibility that Ets1 could regulate Sox10 expression via this enhancer. 
Through luciferase reporter assays we showed that Ets1 is able to drive reporter gene 
expression through Sox10-MCS4. Additional experiments are needed to determine 
whether Ets1 activates this enhancer by directly binding to it. Mutation or deletion of the 
putative Ets1 binding sites within Sox10-MCS4, along with Chromatin 
Immunoprecipitation (ChIP) assays may provide some insight into whether the effect of 
Ets1 is mediated by direct binding to the Sox10-MCS4 enhancer. Nevertheless, regardless 
of whether or not Ets1 binds directly to Sox10-MCS4, its ability to drive expression 
through this enhancer implies that, as in the avian system, Ets1 may regulate Sox10 
expression.   
The presence of a spontaneous mutation in Ets1 which results in a pigmentation 
phenotype provided the opportunity to validate the finding that Ets1 can drive expression 
through Sox10-MCS4. Although the G102E Ets1 mutant protein is able to activate the 
Sox10-MCS4 enhancer, reporter gene expression is reduced by approximately 50% 
compared to the wild type Ets1 protein (Figure 4.3). These results suggest that the 
variable spotting mutation is a hypomorphic mutation, which reduces but does not 
completely abrogate Ets1 protein function. The G102E mutation is present within the 
Pointed (PNT) domain of the Ets1 protein. This domain enhances the transactivation 
activity of Ets1 and contains a docking site for the mitogen-activated protein kinase 
(MAPK) ERK2 (extracellular signal regulated kinase) (Seidel and Graves, 2002). 
Docking of ERK2 at this site is critical for the phosphorylation of a threonine residue 
	  124 
	  
(T38) that is required for enhanced transcriptional activation by Ets1 via recruitment of 
the transcription factor CREB-binding protein (CBP) (reviewed in Garrett-Sinha, 2013). 
Mutating this ERK2 docking site was found to abrogate Ras/MAPK-mediated 
enhancement of Ets1 transactivation activity to the same degree as mutating the 
phosphoacceptor T38 residue (Seidel and Graves, 2002). Three residues within the PNT 
domain of Ets1, Leucine 114 (L114), L116 and Phenylalanine 120 (F120) have been 
shown to play a role in ERK2 binding (Seidel and Graves, 2002). Given the reduced Ets1 
transactivation activity of the variable spotting mutant protein, it is possible that the 
G102 residue may be important for docking of ERK2 and T38 phosphorylation; 
nonetheless, the hypomorphic nature of the G102E mutation suggests this residue 
although important, is likely not essential.  
It is also possible that the effect of this mutation on Sox10-MCS4 activation is not 
related to ERK2 docking and subsequent T38 phosphorylation. Phosphorylation of T38 is 
important for Ets1 activation of Ras-responsive genes (Seidel and Graves, 2002). To date, 
no evidence exists to support a direct role for the MAPK pathway in Sox10 activation in 
the melanocyte lineage. Additionally the G102E mutation is located outside of the (114) 
LXLXXXF(120) domain, which is crucial for ERK docking (Dittmer, 2003). Additional 
experiments are needed to dissect the specific mechanism via which the variable spotting 
mutation results in decreased Sox10-MCS4 activation.  
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Table 4.1. Putative Ets1 binding sites in the Sox10-MCS4 enhancer sequence. Using the 
MatInspector program, 4 potential Ets1 binding sites where identified within Sox10-
MCS4. The matrix similarity value refers to the conservation of the individual nucleotide 
positions within in the sequence for the transcription factor in question. A matrix 
similarity value greater than 0.80 usually indicates a good match to the matrix. The 
positions of the potential Ets1 binding sites are indicated from the 5’ end of the sense 
strand of the Sox10-MCS4 sequence. The core sequences are indicated in capital letters. 
 
 
 
 
 
 
 
 
 
 
From To Anchor Strand Matrix	  Sim Sequence
111 131 121 + 0.969 cggccccaGGATgctccagga
121 141 131 + 0.994 atgctccaGGAAgtgctgtgc
206 226 216 + 0.925 ggatgcaaGGAAggggccctt
388 408 398 -­‐ 0.908 aaacaagaGGAAccagataaa
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Figure 4.1.  Activation of the Sox10-MCS4 enhancer by Ets1. B16 mouse melanoma 
cells were co-transfected with the Sox10-MCS4 luciferase reporter vector, the pRL-TK 
Renilla luciferase control vector, and an expression vector encoding an HA-tagged 
version of the full length mouse Ets1 coding sequence (PCMV-HA-Ets1) or the PCMV-
HA empty vector. Sox10-MCS4 enhancer activation, as measured by relative luciferase 
activity, was significantly higher in cells transfected with the Ets1 overexpression vector 
(PCMV-HA-Ets1), compared to cells transfected with the empty PCMV-HA vector 
(Mann Whitney U, ***p<0.001). Firefly luciferase activity was normalized by Renilla 
luciferase activity. Data represent the mean (bar height) and standard deviation (error 
bars) of 3 independent experiments carried out in triplicates. 
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Figure 4.2. Mutation analysis of variable spotting mice. Sequencing of (A) homozygous 
and (B) heterozygous variable spotting mutant mice revealed a G-to-A transition (yellow 
boxes) in exon 3 of the Ets1 gene at nucleotide position 647 (RefSeq NM_011808.2). 
This mutation results in a Glycine to Glutamate change at amino acid 102 (G102E) of the 
Ets1 protein. 
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Figure 4.3.  The variable spotting mutation inhibits Ets1-induced Sox10-MCS4 enhancer 
activation. B16 mouse melanoma cells were co-transfected with the Sox10-MCS4 
luciferase reporter vector, the pRL-TK Renilla luciferase control vector, and either an 
expression vector encoding an HA-tagged version of the full length mouse Ets1 coding 
sequence (PCMV-HA-Ets1), an expression vector encoding an HA-tagged version of the 
full length mouse Ets1 coding sequence harboring the variable spotting mutation 
(PCMV-HA-Ets1Mut), or the PCMV-HA empty vector. Relative luciferase activity was 
significantly lower in cells transfected with the with the Ets1 overexpression vector 
carrying the variable spotting mutation compared to the wild type Ets1 overexpression 
vector (Mann Whitney U, ***p<0.001). The firefly luciferase activity was normalized by 
Renilla luciferase activity. Data represent mean (bar height) and standard deviation (error 
bars) of 3 independent experiments carried out in triplicates.  
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V. Ets1 KNOCKDOWN INDUCES THE UPREGULATION OF THE 
TRANSCRIPTION FACTOR Sox9 IN MOUSE MELANOMA CELLS 
5.1. Abstract 
The development of melanocytes from the neural crest (NC) is dependent upon 
the activation of several signaling pathways and transcription factors. These transcription 
factors, which include, Mitf, Sox10, and Pax3, work together in the modulation of 
melanocyte development. In addition to these transcription factors, signaling through the 
G-protein coupled Endothelin receptor b (Ednrb) and the tyrosine kinase receptor c-Kit is 
required for melanoblast survival, proliferation, migration, and differentiation. Much of 
what is known about the factors that regulate normal and pathological processes in 
melanocytes has been elucidated through the study of mouse pigmentation mutants. 
Mutations or deletions in the transcription factor Ets1 result in ventral hypopigmentation 
in the mouse. We previously showed that this hypopigmentation phenotype is, at least in 
part, the result of decreased survival of NC cells and melanocyte precursors 
(melanoblasts). We also characterized a synergistic genetic interaction between Ets1 and 
Sox10, and the ability of Ets1 to transactivate a Sox10 enhancer known to drive Sox10 
expression to melanocytes and melanoblasts. In order to characterize the molecular basis 
for the hypopigmentation phenotype observed in Ets1 mutant mice, we analyzed the 
effect of Ets1 overexpression and knockdown on the expression of various genes required 
for melanocyte development. Gene expression analysis in mouse melanocyte and 
melanoma cells did not reveal changes in the expression levels of Sox10, Pax3, Mitf, Kit, 
and Ednrb. Nevertheless, knockdown of Ets1 in a mouse melanoma cell line resulted in a 
6-fold increase in the expression levels of the transcription factor Sox9. Although Sox9 
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has been implicated in melanocyte development, specifically in the activation of Sox10 in 
the chick embryo and in the survival of trunk NC cells in the mouse, it is also required for 
the final specification of NC cells as chondrocytes. Our data suggest that Ets1 may act as 
a negative regulator of Sox9 and consequently a repressor of cartilage cell fate. These 
results point to an additional role for Ets1 in the specification of NC cell fate. 
5.2 Introduction 
During development melanoblasts migrate dorsolaterally below the surface 
ectoderm, eventually colonizing the epidermis and hair follicles where they proliferate 
and differentiate into pigment-producing melanocytes (Le Douarin and Kalcheim, 1999). 
Large numbers of melanocytes were also shown to derive from Schwann cell precursors 
(SCPs), which arise from ventrally migrating NC cells (Adameyko et al., 2009). The 
development of melanocytes from the NC is dependent on the activation of several 
signaling pathways and transcription factors (Figure 5.1). These transcription factors, 
which include, Mitf, Sox10 and Pax3, work together in the modulation of melanocyte 
development. Additionally, the transcription factors Lef1, acting downstream of the 
canonical Wnt/β-catenin signaling pathway, and β-catenin itself, which can translocate to 
the nucleus and act as a transcription factor, have been shown to be important modulators 
of melanocyte development (reviewed in Lin and Fisher, 2007; Hou and Pavan, 2008). In 
addition to these transcription factors, signaling through the G-protein coupled 
Endothelin receptor b (Ednrb) and the tyrosine kinase receptor c-Kit is required for 
melanoblast survival, proliferation, migration, and differentiation (reviewed in Hou and 
Pavan, 2008; Saldana-Caboverde and Kos, 2010). 
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The transcription factor Mitf has been described as the master regulator of 
melanocyte development. It has been implicated in melanocyte survival, proliferation and 
differentiation through the study of several Mitf allelic mouse pigmentation mutants (Hou 
and Pavan, 2008). Mitf is required for melanocyte survival by acting as a transcriptional 
regulator of the anti-apoptotic protein Bcl2 (McGill et al., 2002) and of cyclin-dependent 
kinase 2 (Cdk2), a cell cycle regulator essential for maintenance of melanoma cell 
viability and cell cycle (Du et al., 2004). Another transcriptional target of Mitf, is the 
hepatocyte growth factor (HGF) receptor c-Met, which has been shown to be involved in 
melanocyte survival in vitro (McGill et al., 2006). Mitf regulates melanocyte proliferation 
via transcriptional regulation of Cdk2 and the T-Box transcription factor 2 (TBX2) (Hou 
and Pavan, 2008). It also promotes early melanocyte fate specification and melanocyte 
differentiation through direct transcriptional regulation of the pigment enzymes 
Tyrosinase (TYR), Tyrosinase related protein-1 (TRP1), and Dopachrome tautomerase 
(Dct). Other genes that have been implicated in melanocyte differentiation and are 
transcriptionally regulated by Mitf include absent in melanoma-1 (AIM-1), melanoma 
antigen recognized by T-cells 1 (MART1), and silver homolog (SILV or Pmel17) 
(reviewed in Levy et al., 2006). 
The transcription factor Sox10, a member of the SoxE family of transcription 
factors, is also required for melanocyte development. The importance of Sox10 for 
melanocyte survival is evidenced by the hypopigmentation phenotype that results when it 
is mutated or deleted. Its targeted deletion in the mouse results in almost a complete 
absence of trunk melanoblasts (Hou et al., 2006). Sox10 regulates genes important for 
melanocyte development via Mitf transcriptional activation. In cooperation with Pax3, 
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Sox10 binds to and transcriptionally activates Mitf (Bondurand et al., 2000, Potterf et al., 
2000). It also activates the transcription of the melanogenic proteins Dct and TYR, which 
are essential for melanocyte differentiation (reviewed in Harris et al., 2010). Another 
SoxE-family transcription factor that has been recently implicated in melanocyte 
development is Sox9. The transcription factor Sox9 is expressed in pre- and post-
migratory NC cells and has been found to be important for the survival of trunk NC cells 
(Cheung et al., 2005).  Studies in the mouse, chick and Xenopus suggest that Sox9 acts 
upstream of Sox10 (Silver et al., 2006). In the chick Sox9 was recently shown to directly 
bind to and activate Sox10 regulatory regions, and to be required, along with Ets1, for 
Sox10 expression in cranial NC cells (Betancur et al., 2010).  
The transcription factor Pax3 is another important regulator of melanocyte 
development; however, its specific roles in melanocyte development are not fully 
understood. Pax3 has been shown to directly bind to and activate the Mitf promoter 
(Watanabe et al., 1998), and to act synergistically with Sox10 to activate Mitf 
transcription (Bondurand et al., 2000; Potterf et al., 2000). Recently, Pax3 was found to 
indirectly activate the Kit promoter in various cell lines, including melanocytes (Guo et 
al., 2010). Pax3 has also been shown to inhibit Sox10- and Mitf-dependent transcriptional 
activation of Dct. By promoting the transcription of Mitf while inhibiting that of Dct, 
Pax3 may be involved in the initial fate decision of melanoblasts as well as in preventing 
the terminal differentiation of precursors in order to allow the sufficient expansion of 
melanocyte precursors before they become terminally differentiated (Lang et al., 2005). 
Signaling via Ednrb is required for melanoblast survival, proliferation, migration, 
and differentiation. Binding of Endothelin 3 (Edn3) to Ednrb leads to the activation of the 
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G proteins Gq/G11. Hypermorphic alleles of these G proteins lead to hyperpigmentation 
in mice, however, their deletion does not result in hypopigmentation suggesting that other 
G proteins may act downstream of Ednrb during melanocyte development. The activation 
of G-proteins by Ednrb results in transcriptional and translational regulation of Mitf and 
mediates many of the Ednrb-induced effects in melanoblast development; however, other 
downstream targets of Ednrb, which may also be important for melanocyte development, 
and particularly in melanoblast migration, are not currently known. Endothelin signaling 
has been shown to interact with Kit signaling to promote melanoblast survival, 
proliferation, and differentiation, with Ednrb being required in the final steps of 
melanocyte differentiation rather than in the initial commitment to the melanocytic fate 
(reviewed in Saldana-Caboverde and Kos, 2010). In the mouse, c-Kit and Kit ligand 
(Kitl) mutations result in a phenotype characterized by a belly spot in heterozygous 
animals, and by anemia, lack of coat pigmentation, and sterility in the few homozygotes 
that survive. c-KIT and KITL mutations are responsible for human piebaldism, which is 
characterized by, among other things, hair and skin hypopigmentation (reviewed in Hou 
and Pavan, 2008). Signaling via c-Kit has been found to modulate Mitf and to be required 
for the induction of Tyr expression (Hou et al., 2000). 
The hypopigmentation phenotype of Ets1 mutant mice implies that this 
transcription factor is important in melanocyte development. We previously showed that 
this pigmentation phenotype appears to be the result, at least to some extent, of decreased 
NC cell and melanoblast survival. In an attempt to characterize the molecular mechanism 
via which Ets1 regulates melanocyte development, we examined the expression levels of 
several melanoblast-specific genes in cells with higher and lower than normal levels of 
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Ets1 protein. Understanding the molecular targets of Ets1 will provide more insight into 
the specific function of this transcription factor in melanocyte development.  
5.3. Materials and methods 
5.3.1 Cell culture 
The B16-F10 (B16 hereafter) mouse melanoma cell line was purchased from 
ATCC (CRL-6322, ATCC). Cells were maintained in Dubelcco’s Modified Eagle’s 
Medium (DMEM) (10-013-CV, Cellgro) supplemented with 10% Fetal Bovine Serum 
(FBS), 100 U/ml penicillin, and 100 U/ml streptomycin (all from Thermo Scientific), at 
?????????????2. The immortalized mouse melanocyte cell line melan-a (Sviderskaya et 
al., 2002), was a kind gift from Dr. William J. Pavan (NIH, Bethesda, MD). Melan-a cells 
were maintained in cell culture media consisting of RPMI 1640 (10-041-CV, Cellgro), 
10% FBS, 100 U/ml penicillin, 100 U/ml streptomycin, 2mM L-glutamine (all from 
Thermo Scientific), 200 nM 12-O-tetradecanoyl phorbol 13-acetate (TPA), and 200pM 
Cholera Toxin (both from Sigma-Aldrich), ????????????????2. 
5.3.2 Plasmid constructs 
The Ets1 overexpression vector (pCMV-HA-Ets1) and the pCMV-HA empty 
vector (Clontech) were gifts from Dr. Satrajit Sinha (SUNY at Buffalo, Buffalo, NY). 
The pCMV-HA-Ets1 vector contains a Hyaluronic acid (HA)-tagged version of the full 
length mouse Ets1 coding sequence (Nagarajan et al., 2009). Both plasmids were 
transformed into Escherichia coli Dh5α competent cells (Life Technologies) and glycerol 
stocks were prepared (Appendix I). Plasmids were purified from overnight cultures using 
the QIAprep Spin Miniprep Kit (Qiagen). Ethanol precipitation was carried out to purify 
and concentrate plasmids to be used for transfections (Appendix V).  
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5.3.3 Plasmid DNA transfections 
For plasmid DNA transfection, approximately, 3.5 x 105 melan-a or B16 cells 
were seeded in antibiotic-free cell culture media, into each well of a 6 well plate 
(CytoOne) roughly 24 hours before transfection. Once cells had reached 70-90% 
confluency they were transfected with 2µg/well of plasmid DNA. For each well, 2µg of 
DNA (PCMV-HA-Ets1 or PCMV_HA empty vector) were diluted in 125µl of Opti-
MEM I (Invitrogen). For each well, 10µl of the lipid transfection reagent Lipofectamine 
2000 (Invitrogen) were diluted in 125µl of Opti-MEM I. The diluted DNA and diluted 
Lipofectamine reagent were incubated 5 minutes at room temperature. After 5 minutes, 
the diluted DNA and diluted Lipofectamine were combined and incubated 30 minutes at 
room temperature. 250µl of these lipid-DNA complexes were added to each well in a 
drop-wise manner, evenly distributing drops throughout the well. Plates were gently 
???????????????????????????????????????????????????????????????????????2 (B16) or 10% 
CO2 (melan-a) for 48 hours.  After 48 hours, cells were harvested for total RNA and 
protein to assay Ets1 expression by semi-quantitative real time PCR (See 5.3.5) and Ets1 
protein by Western blot (See 5.3.6). For each cell line, three independent transfections 
were carried out, each one in triplicates. 
5.3.4 siRNA transfections 
For siRNA transfections, approximately 1.5 x 105 melan-a or 2 x 105 B16 cells 
were seeded in antibiotic-free cell culture media, into each well of a 6 well plate 
(CytoOne) roughly 24 hours prior to transfecting.  Once cells had reached 40–50% 
confluency they were transfected with mouse Ets1 siRNAs or Non-targeting siRNA 
controls. For one set of experiments, cells were transfected with 75pmol of the 
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siGENOME SMARTpool Mouse Ets1 siRNA (Thermo Scientific) or 75pmol of the 
siGENOME Non-Targeting siRNA Pool (Thermo Scientific). Each of these siRNA pools 
was composed of 4 siRNAs. For each cell line, three independent transfections were 
carried out, each one in triplicates.  
In order to validate the results of the first set of experiments and to evaluate 
possible off-target effects, cells were transfected with individual Ets1 and non-targeting 
control siRNAs. Melan-a cells were transfected with 50pmol of each of 2 ON-
TARGETplus Mouse Ets1 siRNAs (Thermo Scientific, designated as siRNAs 1 and 2) or 
100pmol of the siGENOME Non-targeting siRNA (Thermo Scientific). Three 
independent transfections were carried out, each one in triplicates. B16 cells were 
transfected with two sets of 2 Ets1 siRNAs from the ON-TARGETplus Mouse Ets1 
siRNA set of 4 (Thermo Scientific). Cells were transfected with 50pmol of each of 2 ON-
TARGETplus Mouse Ets1 siRNAs (designated siRNAs 1 and 2 and siRNAs 3 and 4, 
Thermo Scientific) or 100pmol of the siGENOME Non-targeting siRNA (Thermo 
Scientific). For each set of Ets1 siRNAs, three independent transfections were carried 
out, each one in triplicates. 
All transfections were carried out using the Lipofectamine 2000 (Invitrogen) lipid 
transfection reagent following the manufacturer’s instructions. For each well, a total of 
75-100pmol of siRNA (Ets1 or non-targeting control, as described above) were diluted in 
100µl of Opti-MEM I. For each well, 7.5µl of Lipofectamine 2000 were diluted in 100 µl 
of Opti-MEM I. The diluted siRNA and diluted Lipofectamine were incubated for 5 
minutes at room temperature. After 5 minutes, the diluted siRNA and diluted 
Lipofectamine were combined and incubated for 30 minutes at room temperature. 200µl 
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of these lipid-siRNA complexes were added to each well, in a drop-wise manner, evenly 
distributing drops throughout the well. Plates were gently rocked by hand for 
?????????????? ??? ????????? ??????????? ????? ?????????? ??? ?????? ?????2 (B16) or 10% 
CO2 (melan-a) for 48 hours.  After 48 hours, cells were harvested for total RNA and 
protein to assay Ets1 expression by semi-quantitative real time PCR (See 5.3.5) and Ets1 
protein by Western blot (See 5.3.6).  
5.3.5 RNA extraction, cDNA synthesis, and semi-quantitative real-time PCR 
Approximately 48 hours after transfection, B16 and melan-a cells were washed 
twice with ice cold filter-sterilized Phosphate Buffered Saline (PBS) (Thermo Scientific). 
Total RNA from B16 or melan-a cells was isolated using the RNeasy Mini Kit (Qiagen). 
RNA was treated with the RNase-free DNase Set (Qiagen) to remove genomic DNA 
contamination. RNA quantification was carried out with the Nanodrop 3000 System 
(Thermo Scientific). The RNA samples were then subjected to reverse transcription using 
Maxima Reverse Transcriptase (Thermo Scientific) following the manufacturer’s 
instructions. PCR using the primers 5'-CAAGCTTGCTGGTGAAAAGGA and 5'-
TGCGCTCATCTTAGGCTTTGT (Colombo et al., 2012), which flank an intronic region 
of the housekeeping gene hypoxanthine–guanine phosphoribosyltransferase (HPRT), was 
carried out to test cDNAs for the presence of genomic DNA contamination. PCR 
products were visualized in a 2% agarose gel. A single band at 186bp confirmed the 
absence of genomic DNA contamination, while the presence of an extra band at 1024bp 
indicated the presence of genomic DNA. Mouse genomic DNA was used as a positive 
control. All cDNAs synthesized were found to be free of genomic DNA contamination. 
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The levels of expression of Ets1, Sox10, Mitf, Pax3, Ednrb, Kit, Sox9, and 
Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) were examined via semi-
quantitative real-time PCR. Real-time PCR was performed using the Maxima® SYBR 
Green/ROX qPCR Master Mix (Thermo Scientific) on a 7300 Real-Time System 
(Applied Biosystems). The following primers were used to assay the levels of expression 
of each gene: Ets1: 5’-AGCGCTACGTATACCGCTTT, and 5’-
ACTAGTCAGCATCCGGCTTT, Sox10: 5’-GGACTACAAGTACCAACCTCGG and 
5’-GGACTGCAGCTCTGTCTTTGG (Seong et al., 2012), Mitf: 5’-
TGAAACCTTGCTATGCTGGA and 5’-TACCTGGTGCCTCTGAGCTT (Colombo et 
al., 2012), Pax3: 5’-TCCATCCGACCTGGTGCCAT and 5’-
TTCTCCACGTCAGGCGTTG, Ednrb: 5’-TTTGCGCATTCTTGTCTAGG and 5’- 
CTCTTGGGCATTCTTTCACA, Kit: 5’-TCCTCTGGGAGCTCTTCTCCTT and 5’-
GTTGGACAACCTGCTTGAATGTT, Sox9: 5’-CGGAGGAAGTCGGTGAAGA, and 
5’-GTCGGTTTTGGGAGTGGTG and Gapdh: 5’-GTCTCCTGCGACTTCAGC, and 5’-
TCATTGTCATACCAGGAAATGAGC. The thermal profile of the PCR reaction was 
????? ???? ??? ???????? ???? ??? ??????? ??? ????? ???? ??? ???????? ???? ????? ???? ?? ????????
Samples were analyzed in triplicates and the 2-ΔΔCT method was used to determine 
relative levels of expression of the target genes, which were normalized to Gapdh 
expression levels (Livak and Schmittgen, 2001). The reduction in Ets1 mRNA levels in 
cells transfected with Ets1 siRNA relative to those transfected with non-targeting siRNA 
was estimated from the fold change in Ets1 expression calculated via the 2-ΔΔCT method. 
 
 
	  142 
	  
5.3.6 Protein extraction and Western Blot 
Overexpression and knockdown efficiency were also assayed via Western blot. 
Approximately 48 hours after transfection, B16 and melan-a cells were washed twice 
with ice cold filter-sterilized PBS (Thermo Scientific) and lysed using ice cold RIPA 
Lysis Buffer (20mM Tris-HCl (pH7.5), 150mM NaCl, 1% Nonidet P40, 0.05% Sodium 
Deoxycholate, 0.1% SDS, 2mM EDTA (pH8.0)) containing 1mM phenylmethylsulfonyl 
fluoride (PMSF) (Sigma-Aldrich) and 1X Pierce Protease Inhibitor (Thermo Scientific) to 
prevent protein degradation. Cell lysates were centrifuged at 16,000 RPM, 20 minutes at 
????? ??? ??????? ???? ??????? ??????? ????????????? ??????????? ??? β-mercaptoethanol 
(Sigma-Aldrich) was added to the supernatants to a final concentration of 1X. Samples 
were boiled for 5 minutes and allowed to cool to room temperature prior to loading onto 
Any kD™ Mini-PROTEAN® TGX™ Precast Gels (Bio-Rad) for SDS-PAGE protein 
separation. Proteins were then transferred to 0.2µm PVDF membranes.  After protein 
transfer, the membranes were blocked with 5% Carnation non-fat instant dry milk in 
TBST (Tris Buffered Saline + 0.2% Tween 20), 1 hour at room temperature, rocking at 
75 RPM. The membranes were then incubated with a rabbit polyclonal anti-Ets1 antibody 
(C-20) (sc-350, Santa Cruz Biotechnology) (1:400 in blocking solution), overnight at 
???????????????????????????????????????, the membranes were washed with TBST and 
incubated with a goat anti-rabbit Horseradish Peroxidase (HRP)-conjugated antibody 
(611-1324, Rockland Immunochemicals) (1:3,000 in blocking solution). Membranes 
were incubated with Peroxide/Lumiglo Substrate (Cell Signaling), 15 seconds at room 
temperature. Proteins were visualized by exposure to classic blue X-ray films 
(MidScientific). 
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Normalization was carried out by re-probing the membrane used for Ets1 Western 
blot with a mouse monoclonal anti-β-actin antibody. After visualizing the results of the 
Ets1 Western blot, membranes were rinsed extensively with 1X TBS. The membranes 
were then stripped of bound antibody by incubating in stripping buffer (7M Guanidine 
Hydrochloride (MP Biomedicals), 50mM Glycine (Fisher Scientific), 100mM KCl 
(Fisher Scientific), 0.05mM EDTA (Fisher Scientific), 1.39% β-mercaptoethanol (Sigma-
Aldrich)), 10 minutes at room temperature rocking at 80 RPM. Subsequently, membranes 
were washed extensively with distilled water and blocked with 5% Carnation non-fat 
instant dry milk in TBST, for 1 hour at room temperature, rocking at 75 RPM. The 
membranes were then incubated with a mouse monoclonal anti-β-actin antibody (A5316, 
Sigma-????????? ?????????? ??? ????????? ??????????? ?????????? ??? ????? ???????? ??? ????????
The next day, the membranes were washed with TBST and incubated with a goat anti-
mouse Horseradish Peroxidase (HRP)-conjugated antibody (31430, Thermo 
Scientific/Pierce) (1:40,000 in blocking solution). Membranes were then incubated with 
Peroxide/Lumiglo Substrate, 15 seconds at room temperature. Proteins were visualized 
by exposure to classic blue X-ray films (MidScientific). 
5.4 Results 
5.4.1 Ets1 overexpression does not affect the expression of melanoblast-specific genes in 
mouse melanocytes and mouse melanoma cells. 
 In order to characterize the molecular mechanism via which Ets1 regulates 
melanocyte development, mouse melanocytes (melan-a) and melanoma cells (B16) were 
transfected with an Ets1 overexpression vector (PCMV-HA-Ets1) or an empty vector 
(PCMV-HA). Ets1 was confirmed to be overexpressed in the cells transfected with 
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PCMV-HA-Ets1 via semi-quantitative real-time PCR and Western Blot, in both melan-a 
and B16 cells (Figures 5.2 and 5.3, respectively). Transfection with PCMV-HA-Ets1 
resulted in approximately a 100 fold increase in Ets1 expression in melan-a cells, and a 
1,300 fold increase in Ets1 expression in B16 melanoma cells. For melan-a cells, the 
expression levels of Kit, Ednrb, Pax3, Mitf, Sox10 and Sox9 were analyzed and no 
substantial changes in expression were detected (Figure 5.2). Similarly, no considerable 
changes in the expression levels of Kit, Pax3, Mitf, Sox10 and Sox9 were detected in B16 
cells overexpressing Ets1. Ednrb expression was not assayed in B16 cells because 
endogenous Ednrb expression in this cell line is very low, making it impossible to 
accurately detect changes in expression levels via real-time PCR. 
5.4.2 Knockdown of Ets1 leads to Sox9 upregulation in mouse melanoma cells. 
 Given the lack of substantial changes in the expression of melanoblast-specific 
genes as a result of Ets1 overexpression, the effect of Ets1 knockdown on the expression 
of these genes was assessed. The reduction in Ets1 mRNA levels in melan-a cells 
transfected with Ets1 siRNAs relative to those transfected with non-targeting siRNAs 
ranged from approximately 68% for cells transfected with 2 individual siRNAs to 80% 
for cells transfected with the Ets1 siRNA pool (4 siRNAs).  For B16 cells, the reduction 
in Ets1 mRNA levels relative to the control ranged from approximately 65% for cells 
transfected with 2 individual siRNAs to 72% for those transfected with the Ets1 siRNA 
pool.  
For both melan-a and B16 cells, an off-target effect on Kit expression was 
detected in cells treated with the siGENOME Non-targeting siRNA pool (Thermo 
Scientific); for this reason, Kit expression was not reported for these sets of experiments 
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(Figures 5.4 B and 5.5 B). Nonetheless, no significant changes in Kit expression levels 
were detected in melan-a and B16 cells transfected with sets of 2 individual Ets1 siRNAs 
compared to those transfected with control siRNA (Figures 5.4 C and 5.5 C, D). 
Similarly, for both cell lines, no substantial changes on the expression levels of Pax3, 
Mitf, and Sox10 were detected (Figures 5.4 and 5.5). We observed a slight upregulation in 
Ednrb expression (fold change = 2.006±0.087), in melan-a cells transfected with 2 
individual Ets1 siRNAs (Figure 5.4 C). This upregulation was not observed in cells 
transfected with the Ets1 siRNA pool (Figure 5.4 B). Ednrb expression was not assayed 
for B16 cells because Ednrb expression in this cell line is very low, making it impossible 
to accurately detect changes in expression levels via real-time PCR. A 6 fold increase in 
Sox9 expression was observed in B16 cells transfected with Ets1 siRNA, regardless of the 
siRNA or non-targeting control used (Figure 5.5 B, C & D). This change was not 
observed in melan-a cells for which Sox9 expression was only evaluated in cells 
transfected with individual Ets1 and control siRNAs (Figure 5.4 C). 
5.5 Discussion 
Deletion or mutation of the transcription factor Ets1 results in ventral 
hypopigmentation in the mouse. The increased apoptosis observed in NC cells and 
melanoblasts in Ets1 null embryos suggests that Ets1 is required for the survival of these 
cells. We previously characterized a synergistic genetic interaction between Ets1 and 
Sox10, a transcription factor required for the development of several NC cell derivatives, 
including melanocytes. Additionally, we described the ability of Ets1 to activate the 
Sox10-MCS4 enhancer, which drives Sox10 expression to melanoblasts and melanocytes, 
and the impact of the spontaneous variable spotting mutation on the transactivation 
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ability of Ets1.  To further characterize the role of Ets1 in melanocyte development, we 
sought to determine the molecular targets of Ets1 regulation via gene expression analysis 
of melanocyte and melanoma cells with higher and lower than normal Ets1 expression 
levels.  
 In mouse melanocytes and melanoma cells, the expression levels of the 
transcription factors Pax3, Mitf, and Sox10 were not visibly affected by overexpression or 
knockdown of Ets1. It is possible that neither Pax3 nor Mitf are direct targets of Ets1; 
however, the lack of an effect in Sox10 expression was surprising given the ability of 
Ets1 to activate the Sox10-MCS4 enhancer and the synergistic genetic interaction 
between Ets1 and Sox10. One reasonable explanation for the absence of an effect on 
Sox10 expression as a result of Ets1 knockdown is that in the mouse melanocyte and 
melanoma cell lines used for this experiment other factors might be able to compensate 
for Ets1 deficiency. In the case of Ets1 overexpression, the absence of a significant 
change in the expression of Sox10 or other potential downstream targets could result if 
endogenous Ets1 protein is sufficient to drive the expression of said targets, so that in 
essence, the regulatory regions of these genes are already saturated by the endogenous 
protein.  
We also failed to detect substantial changes in the expression levels of Kit in 
mouse melanocytes and melanoma cells as a result of Ets1 overexpression or knockdown. 
A slight upregulation was observed in Ednrb (fold change = 2.006±0.087) in melan-a 
cells transfected with 2 individual Ets1 siRNAs (Figure 5.4 C); however, this effect was 
not observed in this cell line when transfected with an Ets1 siRNA pool (Figure 5.4 B). It 
is possible that off-target effects caused by the Ets1 or non-targeting control siRNAs 
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might be responsible for this discrepancy.  This is a plausible explanation because an off-
target effect on Kit expression was detected and found to be caused by one of the siRNAs 
in the control siRNA pool used for the first set of siRNA transfections. Additional 
experiments are needed to determine whether the slight upregulation of Ednrb expression 
observed in mouse melanocytes as a result of Ets1 knockdown is biologically relevant.  
 Knockdown of Ets1 led to a 6-fold increase in Sox9 expression in B16 melanoma 
cells (Figure 5.5). This upregulation was not observed in melan-a cells (Figure 5.4). The 
difference in Sox9 expression levels in B16 and melan-a cells emphasizes the impact that 
the use of different cell lines can have on the expression levels of downstream target 
genes in knockdown, as well as overexpression, studies. Ets1 overexpression did not 
affect Sox9 expression in melanocytes (Figure 5.2) or melanoma cells (Figure 5.3), which 
suggests that endogenous Ets1 protein might be sufficient to suppress Sox9 expression in 
these cells. 
 The transcription factor Sox9 is a member of the SoxE family of transcription 
factors, which includes Sox8, Sox9, and Sox10 (reviewed in Lee and Saint-Jeannet, 
2011). Sox9 is expressed in pre-migratory NC cells and its expression precedes that of 
migratory NC cell markers. Forced expression of Sox9 in the neural tube induces neural 
crest-like properties at the expense of neuronal progenitors; however, other factors are 
required to induce NC cell delamination (Cheung and Briscoe, 2003). In Xenopus 
embryos, morpholino-induced Sox9 depletion results in the loss of NC cell progenitors 
(Spokony et al., 2002). In the mouse embryo, Sox9 is first expressed around E8.5, in the 
hindbrain region at the dorsal tip of the closing neural tube and in the dorsal folds of the 
neural tube in the trunk. Sox9 remains expressed in migrating cranial NC cells (reviewed 
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in Lee and Saint-Jeannet, 2011) but it is downregulated in trunk NC cells soon after they 
become migratory (Cheung et al., 2005). Sox9 later becomes expressed in NC-derived 
chondrocyte precursor cells, where it drives the expression of alpha-1 type-II Collagen 
(Col2A1) (Bell et al., 1997). In the mouse, homozygous deletion of Sox9 is embryonic 
lethal. Sox9 heterozygotes, on the other hand, die shortly after birth with severe skeletal 
defects, including malformations of endochondral bones, a shortened jaw, and cleft palate 
(Hong and Saint-Jeannet, 2005). In humans SOX9 mutations are responsible for 
Campomelic Dysplasia, a disease characterized by skeletal and craniofacial 
malformations as well as sex reversal resulting from abnormal testis development 
(Wagner et al., 1994).  
The transcription factor Sox9 has been implicated in early melanocyte 
development because it is required for Sox10 expression (reviewed in Silver et al., 2006). 
In the chick embryo, Sox9, together with Ets1, and c-Myb, are required for endogenous 
Sox10 expression in the cranial NC (Betancur et al., 2010). Sox9 expression has also been 
shown to be required for the formation of trunk NC cell derivatives. In mouse embryos 
carrying a conditional Sox9 null allele, the numbers of neurons and glia in the trunk 
region were severely reduced. In these mutants, Sox10 expression was maintained in pre-
migratory NC cells, but reduced along the NC cell migration route. The large decrease in 
the number of NC cell derivatives in Sox9 mutant mice was found to be the result of 
increased apoptosis of pre-migratory and early migrating NC cells at E9.5 and E10.5. In 
pre-migratory NC cells, Sox9 was also found to be required for the expression of Snail 
(Cheung et al., 2005), a transcription factor that has been implicated in early pigment cell 
development and differentiation (Silver et al., 2006). Although Sox9 seems to be required 
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for melanocyte development early on, its prolonged expression has been shown to 
negatively affect melanocyte development. Ectopic expression of Sox9 under the 
melanocyte-specific Dopachrome tautomerase (Dct) promoter, which drives expression 
to melanoblasts beginning at E10 and thereafter (Steel et al., 1992), results in 
pigmentation defects in the mouse (Qin et al., 2004). The effect of prolonged Sox9 
expression on pigmentation implies that failure to downregulate Sox9 in melanocyte 
precursors can negatively affect melanocyte development (Qin et al., 2004).  For this 
reason, it has been suggested that the importance of Sox9 for melanocyte development is 
centered on its ability to induce Sox10 expression (Harris et al., 2013). 
Although Sox9 becomes downregulated early on during melanocyte development, 
it has been found to be expressed in melanocytes (Cook et al., 2005; Passeron et al., 
2007), nevi, primary melanoma, and melanoma metastases (Passeron et al., 2007; 
Passeron et al., 2009; Bakos et al., 2010; Rao et al., 2010). The relationship between Sox9 
expression and melanoma progression is not well understood. A small but statistically 
significant correlation between Sox9 expression, measured via immunohistochemistry, 
and melanoma progression has been reported (Bakos et al., 2010). Conversely, a 
moderate decrease in the levels of Sox9 expression with melanoma progression has also 
been reported (Passeron et al., 2009). In addition, Sox9 overexpression in various 
melanoma cell lines was found to inhibit the proliferation of these cells and their 
tumorigenic potential in mice and in a human ex vivo model of melanoma, suggesting 
that a negative relationship exists between Sox9 expression and melanoma progression 
(Passeron et al., 2009).  
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In the present study, knockdown of Ets1 led to a significant increase in Sox9 
expression in mouse melanoma cells. At first glance, this result appears to contradict a 
positive role for Ets1 in melanocyte development, since it suggests that Ets1 acts as a 
negative regulator of Sox9, which is required for the development of trunk NC cell 
derivatives. However, given the survival defect observed in NC cells and melanoblasts in 
Ets1 null mutants, it is likely that Ets1 plays a dual role in melanocyte development, 
initially, in the maintenance of NC cells and early melanocyte precursors, and later in cell 
lineage specification by modulating the expression of other NC genes, including Sox9. A 
role for Ets1 in cell lineage specification has been previously proposed. The upregulation 
of Sox9 in the hearts of Ets1 mutant mice and the presence of ectopic NC cell-derived 
cartilage nodules in these hearts suggests that Ets1 may act as a negative regulator of 
Sox9, and thus cartilage fate, in NC cells (Gao et al., 2010). Additionally, because 
prolonged Sox9 expression appears to negatively impact melanocyte development (Qin et 
al., 2004), Ets1-induced Sox9 repression may be important for melanocyte differentiation. 
It is possible that in trunk NC cells destined to become melanocytes, as in cardiac NC 
cells, Ets1 serves as a repressor of chondrocyte fate. Future experiments comparing Sox9 
expression and the numbers of chondrocyte precursors in the trunk region of Ets1 wild 
type and mutant embryos will help to address whether the effects of Ets1 deficiency on 
melanocyte development are also the result of improper NC or melanoblast 
differentiation.  
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Figure 5.1. The molecular basis for melanocyte development. The development of 
melanocytes from the NC is dependent on the activation of several signaling pathways and 
transcription factors. These transcription factors, which include, Mitf, Sox10 and Pax3, work 
together in the modulation of melanocyte development. Additionally, the transcription factors 
Lef1, acting downstream of the canonical Wnt/β-catenin signaling pathway, and β-catenin 
itself, have been shown to be important modulators of melanocyte development. In addition 
to these transcription factors, the G-protein coupled Endothelin receptor b (Ednrb) and the 
tyrosine kinase receptor c-Kit are required for melanoblast survival, proliferation, migration, 
and differentiation. 
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Figure 5.2. Ets1 overexpression in melan-a cells does not substantially affect the 
expression of melanoblast-specific genes. Melan-a cells were transfected with an Ets1 
overexpression vector (PCMV-HA-Ets1) or an empty vector (PCMV-HA). Ets1 mRNA 
and Ets1 protein overexpression were confirmed via semi-quantitative real-time PCR (B) 
and Western blot (A), respectively. The expression of the genes Kit, Ednrb, Pax3, Mitf, 
Sox10, and Sox9 did not differ substantially between cells transfected with the Ets1 
overexpression vector and those transfected with empty vector. Data represent gene 
expression levels in cells transfected with PCMV-HA-Ets1 relative to those transfected 
with PCMV-HA. The mean (bar height) and standard deviation (error bars) are shown for 
3 independent experiments carried out in triplicates. 
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Figure 5.3. Ets1 overexpression in B16 cells does not considerably affect the expression 
of melanoblast-specific genes. B16 cells were transfected with an Ets1 overexpression 
vector (PCMV-HA-Ets1) or an empty vector (PCMV-HA). Ets1 mRNA and Ets1 protein 
overexpression were confirmed via semi-quantitative real-time PCR (B) and Western blot 
(A), respectively. The expression levels of Kit, Pax3, Mitf, Sox10, and Sox9 did not differ 
substantially between cells transfected with the Ets1 overexpression vector and those 
transfected with empty vector. Data represent gene expression levels in cells transfected 
with PCMV-HA-Ets1 relative to those transfected with PCMV-HA. The mean (bar 
height) and standard deviation (error bars) are shown for 3 independent experiments 
carried out in triplicates. 
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Figure 5.4. Ets1 knockdown in melan-a cells does not substantially affect the expression 
of melanoblast-specific genes. Melan-a cells were transfected with an Ets1 siRNA pool 
or a non-targeting control siRNA pool (A & B), or with 2 individual siRNAs from the 
siRNA pool and a different individual control siRNA (C). Knockdown was confirmed via 
Western blot (A) and semi-quantitative real-time PCR (B & C). The levels of Kit, Pax3, 
Mitf, Sox10, and Sox9 did not differ considerably between cells transfected with the Ets1 
siRNAs and those transfected with the non-targeting control siRNAs. Ednrb expression 
appeared to be slightly upregulated in cells transfected with individual Ets1 siRNAs, but 
this effect on Ednrb was not observed in cells transfected with the Ets1 siRNA pool. Data 
represent gene expression levels in cells transfected with Ets1 siRNAs relative to those 
transfected with control siRNAs. The mean (bar height) and standard deviation (error 
bars) are shown for 3 independent experiments carried out in triplicates. 
	  155 
	  
 
Figure 5.5. Ets1 knockdown in B16 melanoma cells results in Sox9 upregulation. B16 
cells were transfected with an Ets1 siRNA pool or a non-targeting control siRNA pool (A 
& B), or with 2 individual siRNAs from the siRNA pool and a different individual 
control siRNA (C & D). Knockdown was confirmed via Western blot (A) and semi-
quantitative real-time PCR (B, C, D). (B, C, D) The expression levels of Kit, Pax3, Mitf, 
and Sox10 did not differ substantially between cells transfected with Ets1 siRNA and 
those transfected with control siRNA. Sox9 was notably upregulated in B16 cells 
transfected with Ets1 siRNAs compared to those transfected with control siRNAs. Data 
represent gene expression levels in cells transfected with Ets1 siRNAs relative to those 
transfected with control siRNAs. The mean (bar heights) and standard deviation (error 
bars) are shown for 3 independent experiments carried out in triplicates. 
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VI. CONCLUSIONS AND FUTURE DIRECTIONS 
6.1 Conclusions 
 Melanocytes, the pigment producing cells, are responsible for hair and skin 
pigmentation, which serves to protect organisms from damaging ultraviolet (UV) 
radiation (Lin and Fisher, 2007). The skin is the most common site of cancer in humans. 
Of all the types of skin cancers, melanoma, the cancer resulting from the malignant 
transformation of melanocytes, is the least common but is responsible for the highest 
number of skin cancer-related deaths in the United States (American Cancer Society, 
2014). Melanocytes are derived from neural crest (NC) cells, a population of pluripotent 
cells that arise from the dorsal aspect of the neural tube during vertebrate development 
(Le Douarin and Kalcheim, 1999). Melanocyte development is guided by the activation 
of transcription factors and by signaling molecules encountered by melanocyte precursors 
(melanoblasts) during their migration. Pigmentation mutants of various species have 
provided insight into the molecular pathways at work in melanocyte development and 
pigment production. These mutants have also served as models of human pigmentation 
disorders, including piebaldism, the four known types of Waardenburg Syndrome, and 
albinism (reviewed in Baxter et al., 2004). 
 The deletion of the transcription factor Ets1 was recently found to result in 
hypopigmentation in mice (Gao et al., 2010). The aim of this study was to establish the 
temporal requirement and role of Ets1 during melanocyte development and to 
characterize genetic and molecular interactions between Ets1 and other genes required for 
melanocyte development. To this end, a combination of in vivo assays, genetic crosses, 
and in vitro molecular assays were employed.  
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 In Chapter 2, the effect of Ets1 deletion on melanoblast and NC cell survival were 
described. To establish the temporal requirement and mechanism of action of Ets1 during 
melanocyte development, Dct-LacZ transgenic mice in which LacZ expression is driven 
to melanoblasts under the control of the Dopachrome tautomerase (Dct) promoter, were 
used to label melanoblasts via β-galactosidase staining in Ets1 null (Ets1-/-), heterozygous 
(Ets1+/-) , and wild type (Ets1+/+) embryos. Ets1 null embryos were found to have fewer 
melanoblasts, compared to heterozygous and wild type littermates, at all stages examined 
(Embryonic day (E) 10.75-E15.5). Melanoblast proliferation was not affected at E10.75, 
but a significant increase in melanoblast cell death was observed at this stage in Ets1 null 
embryos compared to heterozygous littermates.  At E10.25, NC cell survival was found 
to be negatively affected in Ets1 null mutant embryos; however, the numbers of NC cells, 
labeled via Sox10 immunofluorescence, did not differ significantly between Ets1 null and 
Ets1 heterozygous embryos at this stage. Similarly, the amount and pattern of Sox10 
expression was found to be unaffected in Ets1 null embryos at E9.5. These results suggest 
that Ets1 is required between E10 and E11 in melanocyte development and that it 
regulates the melanoblast and NC cell survival at this stage. 
 Given the early melanoblast and NC cell survival defect observed in Ets1 null 
mutant mice, it seemed likely that Ets1 would play a role in the regulation of one or more 
genes essential for the development of melanocytes and other NC cell derivatives. In 
Chapter 3, a genetic interactions approach was chosen to determine whether a synergistic 
genetic interaction exists between Ets1 and the transcription factor Sox10. Sox10 was 
chosen for this study because experiments in the avian system have shown that Ets1 
regulates Sox10 expression in cranial NC cells (Betancur et al., 2010). By comparing the 
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frequency and area of hypopigmentation in single (Ets1+/- and Sox10LacZ/+) and double 
heterozygous (Ets1-/-::Sox10LacZ/+) progeny from crosses between Ets1 heterozygous and 
Sox10 heterozygous mice, Ets1 and Sox10 were found to interact synergistically during 
melanocyte development.  
 In addition to its role in melanocyte development, the transcription factor Sox10 is 
also required for proper gut innervation (Southard-Smith et al., 1998; Kapur, 1999). For 
this reason, the effect of Ets1 deficiency on gut innervation was also examined. The nerve 
free area in the distal colon of Ets1 null mice was found to be significantly greater than in 
Ets1 heterozygous mice, indicating that Ets1 is also important for the development of 
enteric ganglia, which are also derived from NC cells. Furthermore, Sox10 heterozygosity 
was found to further exacerbate the decreased innervation observed in Ets1 null mice. In 
fact, severe hypoganglionosis of the distal colon, which led to megacolon, was detected 
in two Ets1-/-::Sox10LacZ/+ mice.  
 In order to further characterize the nature of the synergistic genetic interaction 
between Ets1 and Sox10, the amount and pattern of Sox10 expression was compared in 
Ets1 null, heterozygous, and wild type littermates. At E11.5 and E12.5 an apparent 
decrease in Sox10 expression was observed in at least 50% of Ets1 null embryos 
compared to Ets1 heterozygous and wild type littermates. These results suggest that Ets1 
may regulate embryonic Sox10 expression; however, they could also be indicative of a 
reduction in the number of Sox10 positive cells.  
Synergistic genetic interactions may or may not indicate the presence of a 
functional interaction between the genes in question. In order to gain a better 
understanding of the underlying functional interaction that may exist between Ets1 and 
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Sox10, the ability of Ets1 to activate the Sox10-MCS4 enhancer, an enhancer critical for 
Sox10 expression in mouse melanocytes and melanoblasts (Antonellis et al., 2008) was 
analyzed in Chapter 4 via in vitro luciferase reporter assay. In the mouse melanoma cell 
line B16, Ets1 was able to activate this enhancer, suggesting a possible role for Ets1 in 
the regulation of Sox10 expression. In this chapter, the spontaneous variable spotting 
mutation, which causes hypopigmentation in mice and was suspected to be a mutation in 
Ets1, was confirmed to be a G-to-A nucleotide transition in exon 3 of the Ets1 gene, 
which predicts in a Glycine to Glutamate amino acid change at position 102 of the Ets1 
protein (G102E missense mutation). Given that variable spotting mutants exhibit a 
hypopigmentation phenotype, this mutation likely impairs Ets1 protein function, 
particularly as it relates to potential roles in the regulation of genes critical for 
melanocyte development. Consequently, this mutation provided a means to confirm the 
effect of Ets1 in Sox10-MCS4 enhancer activity. The variable spotting mutation led to a 
2-fold decrease in the activation of the Sox10-MCS4 enhancer, which suggests that this 
mutation is hypomorphic, since it inhibits but does not completely abrogate Ets1 protein 
function. The ability of Ets1 to activate the Sox10-MCS4 enhancer and the effect of the 
variable spotting mutation on Sox10-MCS4 activation suggest that Ets1 may act as a 
regulator of Sox10 expression during melanocyte development. 
To assess the potential role of Ets1 in regulating Sox10 expression, the effect of 
Ets1 overexpression and knockdown on Sox10 expression was investigated via semi-
quantitative real-time PCR in Chapter 5. The expression of other genes critical for 
melanocyte development, including Pax3, Mitf, Kit, Sox9, and Ednrb was also examined. 
Ets1 overexpression and knockdown were carried out in mouse melanocyte and 
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melanoma cell lines because mouse melanoblast survival is severely impaired by 
traditional transfection protocols. The expression levels of Sox10, Pax3, Mitf, Kit, and 
Ednrb were not significantly affected by Ets1 overexpression or knockdown. 
Nonetheless, in mouse melanoma cells, Ets1 knockdown led to approximately a 6-fold 
increase in the expression levels of the transcription factor Sox9. The lack of a change in 
the expression level of Sox10 in cells where Ets1 was knocked down, suggests that the 
interaction between Ets1 and Sox10 may be indirect. Alternatively, it is possible that in 
the cell lines used for this experiment other factors may be able to compensate for Ets1 
deficiency. In the case of Ets1 overexpression, the absence of a significant change in the 
expression of Sox10 or other potential downstream targets could result if the endogenous 
Ets1 protein is sufficient to drive the expression of said targets.  
The expression of the transcription factor Sox9 was significantly upregulated as a 
result of Ets1 knockdown in mouse melanoma cells. Sox9 has been implicated in the 
development of melanocytes and other NC cell derivatives (reviewed in Hong and Saint-
Jeannet, 2005; Silver et al., 2006; Lee and Saint-Jeannet, 2011). Sox9, along with Ets1, is 
required for Sox10 expression in cranial NC cells in the chick embryo (Betancur et al., 
2010). In the mouse, Sox9 has been shown to be required for the survival of trunk NC 
cells (Cheung et al., 2005) and for the formation of NC-derived chondrocytes (Bell et al., 
1997). The apparent role of Ets1 as a negative regulator of Sox9 appears to be in 
contradiction with the essential functions of Sox9 in early NC development; however, 
ectopic and prolonged Sox9 expression has been shown to negatively affect melanocyte 
development (Qin et al., 2004), possibly because Sox9 is involved in chondrocyte fate 
specification. For this reason, Ets1-induced Sox9 repression may be important for 
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melanocyte differentiation by preventing the activation of genes critical for chondrocyte 
differentiation. It is possible that in trunk NC cells destined to become melanocytes, Ets1 
serves as a repressor of chondrocyte fate. 
Together, the results of this study suggest that Ets1 plays a dual role in 
melanocyte development. The transcription factor Ets1 acts early during melanocyte 
development by regulating the survival of NC cells and melanoblasts. The early role of 
Ets1 in NC and melanoblast survival may be mediated through an interaction with the 
transcription factor Sox10. The synergistic genetic interaction between Ets1 and Sox10, 
and the ability of Ets1 to activate Sox10 regulatory regions required for embryonic Sox10 
expression support this possibility. In addition to being required early for NC and 
melanoblast survival, Ets1 may also be indirectly involved in melanocyte fate 
specification by acting as a repressor of cartilage fate. 
6.2. Future Directions 
 This study provided insights into the role of the transcription factor Ets1 in 
melanocyte development and its interaction with the transcription factor Sox10 in this 
process. Future research will focus on characterizing the molecular interaction between 
Ets1 and Sox10 and Ets1 and Sox9, and on in vivo experiments aimed at understanding 
whether the regulatory role of Ets1 on Sox9 expression impacts melanocyte development.  
 Although an apparent decrease in Sox10 expression was observed in Ets1 null 
mutant embryos compared to heterozygous and wild type littermates, additional 
experiments, involving the labeling and quantification of Sox10 positive cells, are needed 
to determine whether Ets1 does in fact regulate embryonic Sox10 expression, or whether 
this apparent decrease in Sox10 expression is the result of a decrease in the number of 
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Sox10 positive cells. Sox10 expression was found to be unaffected by Ets1 knockdown 
and overexpression in mouse melanocyte and melanoma cell lines; however, these cell 
lines do not accurately represent the conditions present in melanoblasts. Given the 
difficulties involved with the transfection of melanoblasts, experiments involving viral 
infection as a means of overexpressing and knocking down Ets1 will be useful in 
addressing a potential role for Ets1 in regulating Sox10 expression during melanocyte 
development. Mouse NC cultures from Ets1 null, heterozygous and wild type embryos 
may also be able to provide some insight regarding the timing during which Ets1 is 
critical for melanocyte development and the regulation of other genes critical in this 
process. Neural crest cultures can also be used as a tool to assay the effect of Ets1 
deficiency on migration and fate specification. 
 Using in vitro luciferase reporter assay Ets1 was shown to activate the Sox10-
MCS4 enhancer. Bioinformatic analysis revealed the presence of 4 putative Ets1 binding 
sites in this enhancer, which suggests that Ets1 may act by directly binding this Sox10 
regulatory region. Mutation or deletion of the putative Ets1 binding sites within Sox10-
MCS4, along with Chromatin Immunoprecipitation (ChIP) assays may provide some 
insight into whether the effect of Ets1 is mediated by direct binding to the Sox10-MCS4 
enhancer. It will also be important to characterize the effects of the variable spotting 
mutation on Ets1 protein function in order to understand how this mutation affects the 
activation of downstream targets. 
 Gene expression analysis revealed a negative relationship between Ets1 and the 
transcription factor Sox9 in mouse melanoma cells; however, it is unclear whether this 
relationship exists in melanoblasts, and whether it is relevant in vivo. Future experiments 
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should be aimed at characterizing Sox9 expression in Ets1 mutant embryos in vivo, and in 
mouse melanoblasts and NC cells in vitro, using similar methods as aforementioned. If 
Sox9 is found to be upregulated in Ets1 mutant mice, a detailed characterization of 
chondrocyte precursor numbers and location could provide insight into a putative role for 
Ets1 in NC lineage specification. The effect of Ets1 overexpression on Sox9 promoter 
activation, in cells known to express Sox9, and direct binding of Ets1 to the Sox9 
promoter, should also be assayed to determine whether Ets1 inhibits Sox9 expression 
directly or indirectly.  
In this study we also characterized the effect of Ets1 deficiency on the 
development of enteric ganglia, which also derive from the NC. This study provided 
evidence to support a role for Ets1 in gut innervation and a potential interaction with 
Sox10 in this process. Additional cell survival and proliferation assays to compare the 
numbers of dying and proliferating enteric ganglia precursor cells in Ets1-/-::Sox10+/+ and 
Ets1-/-::Sox10LacZ/+ embryos are needed to determine whether Ets1 and Sox10 work 
together to promote the survival and/or proliferation of these cells. 
The results of this study in combination with the future work proposed will 
provide a better understanding of the gene regulatory network directing melanocyte 
development. A detailed characterization of this network is critical because alterations in 
genes required for the development of melanocytes and other NC cell derivatives have 
been recognized in human pathological conditions, including cancer. Many of the genes 
required for melanocyte survival, proliferation, migration, and/or differentiation during 
embryogenesis, have also been linked to melanoma development and progression. Some 
transcription factors, such as Mitf, Pax3, Sox10 and Lef1, which are required for 
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melanocyte development, have also been found to be either amplified or up-regulated in 
melanoma tumors compared to normal melanocytes (Larue and Delmas, 2006; Levi et al., 
2006; Kubic et al., 2008; Plummer et al., 2008; Flamminger et al., 2009; Bakos et al., 
2010). Several studies have also reported increased Ets1 expression in melanoma lesions, 
compared to benign melanocytic lesions and primary melanocytes (Keehn et al., 2003; 
Rothhammer et al., 2004; Rothhamer et al., 2005). A better understanding of the 
signaling molecules and transcription factors involved in melanocyte development will be 
instrumental for the creation of more effective therapies against melanoma and other 
pathological conditions of melanocytes. 
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APPENDIX I 
A. Transformation 
For each plasmid used, transformation into Escherichia coli Dh5αTM-T1R chemically 
competent cells (Life Technologies) was carried out as follows. A vial of E. coli Dh5α 
competent cells (Life Technologies) containing 50µl of cell suspension was removed 
from -???????????????????????? ???????????????????, 1µl of 100-200ng/µl plasmid DNA 
was added to the vial of chemically competent cells. The tube was closed tightly and the 
cells gently mixed by tapping the tube 2 times. Cells were incubated on ice for 30 
????????? ?????? ????? ????? ????? ???????? ??? ????? ???? ?? ?????? ?????? ???? ??? ???onds and 
incubated on ice for 5 minutes. After 5 minutes, working near a flame, 250µl of room 
temperature S.O.C medium (Life Technologies) was added to the vial of cells. Cells were 
??????????????????????????????????????????????????????? ??????????????????e, cells were 
spread on pre-warmed Luria Broth (LB) agar plates (1% Bacto-Tryptone (BD 
Biosciences), 0.5% yeast extract (Fisher Scientific), 1% NaCl (Fisher Scientific), 1.5% 
agarose (Fisher Scientific)), containing 100µg/ml Ampicillin (Fisher Scientific). The 
following dilutions were plated: 20µl of cell suspension + 80µl of LB, 50µl of cell 
suspension + 50µl of LB, or 100µl of undiluted cell suspension. Sterile, flamed Pasteur 
pipets were used to spread cell suspensions on the LB agar plates. Plates were allowed to 
dry at room temperature, near a flame for 15 minutes and then incubated overnight, 
????????????????????? 
B. Pre-culture and Overnight Culture Preparation 
Plates containing transformed ?????? ????? ???????? ????? ???? ????? ?????????? ??????
overnight incubation following transformation. Working near a flame, individual colonies 
from each plate were carefully selected, using a different sterile pipet tip for each colony, 
and placed in sterile 15ml conical tubes (Fisher Scientific) containing 3ml of LB media 
with 100µg/ml Ampicillin (Fisher Scientific). ???????????????????????????????????????????
For colonies that produced growth, 100µl of pre-culture were added to a sterile 50ml 
centrifuge tube containing 10ml of LB media with 100µg/ml Ampicillin. Cultures were 
incubated overnight (no more than 16 hours). 
C. Glycerol Stock Preparation 
Plasmid purification was carried out using the Promega Wizard Plus SV Minipreps DNA 
Purification System (Promega) or the QIAprep Spin Miniprep Kit (Qiagen), following the 
manufacturer’s instructions. Approximately 8ml of overnight culture were used for 
plasmid purification (2 minipreps of 4ml each). The remaining 2ml of culture were used 
to prepare glycerol stocks (between 3 and 4 stocks per construct).  
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Glycerol stocks were prepared from overnight cultures for cryopreservation. Working 
near a flame 600µl of filtered, sterile 50% Glycerol (Fisher Scientific) were added to a 
2ml cryovial (Corning). Subsequently 400µl of overnight culture were added to the vial, 
which was then sealed tightly. Cells were mixed very gently by tapping the tube 3 times. 
Cryovials were then placed on ice and transferred to -??????????????????????????? 
Note: The cultures used for glycerol stocks were confirmed to contain the desired 
plasmid prior to preparing the glycerol stock. For plasmids used for in situ hybridization 
riboprobe synthesis, purified plasmids were visualized via gel electrophoresis (1% 
agarose). Plasmids used for transfections into mammalian cells (luciferase and 
overexpression assays) were analyzed via Polymerase Chain Reaction (PCR) or DNA 
sequencing. 
 
APPENDIX II 
Embryo Powder 
E15.5 embryos were dissected in cold PBS (pH7.4). Embryos were homogenized in PBS 
by passing the embryos first through a 1ml pipette and then through a syringe with 
18gauge 1 ½ inch needle. The homogenized embryos were transferred to a sterile 50ml 
centrifuge tube (Corning). Four volumes of cold acetone were added to the homogenized 
embryos. The embryos were incubated in ice for 30 minutes and centrifuged at 10,000g, 
???? ??????????? ??? ????????? ???????????????? ?????????? ???? ???? ???????????????????????
????? ????????? ???? ???????????? ????? ?????? ??? ????????? ???? ??? ???????? ??? ????? ????
supernatant was discarded and the pellet was placed in a mortar and macerated into a fine 
powder using a pestle. The embryo powder was placed on a sheet of filter paper and air-
dried overnight at room temperature. The embryo powder was transferred to sterile 2ml 
centrifuge tubes and sto??????????? 
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APPENDIX III 
A. Normal Q-Q plots of original and transformed hypopigmentation area data for 
generation 1 (F1) 
Figure A.1 Normal Q-Q plots of raw and transformed hypopigmentation area data for 
generation 1. Normal Q-Q plots before (A) and after (B) applying the Box-Cox 
transformation using a lambda value of 0.35. The transformed data have a distribution 
that more closely resembles the normal distribution. 
 
B. PAWS Output for One-Way ANOVA and contrasts of hypopigmentation areas of 
Generation 1 (F1) 
Table A.1. Descriptive statistics for Box-Cox-transformed hypopigmentation area data 
for generation 1. 
 
	  
Descriptives 
Area_mm2_Lambda0.35 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Ets1+/- 46 1.1719 1.49371 .22024 .7283 1.6155 .00 4.93 
Sox10+/- 42 1.2282 1.49597 .23083 .7620 1.6943 .00 4.21 
Ets1+/-::Sox10+/- 33 4.0468 1.34398 .23396 3.5702 4.5233 .00 6.50 
Total 121 1.9755 1.92505 .17500 1.6290 2.3220 .00 6.50 
	  176 
	  
 
Table A.2. Levene’s test of Homogeneity of Variances for the areas of hypopigmentation 
of Ets1+/-, Sox10LacZ/+, and Ets1+/-::Sox10LacZ/+ mice in generation 1. The population 
variances are significantly different (p=0.044, α=0.05). 
 
 
Table A.3. One-Way ANOVA for the areas of hypopigmentation of Ets1+/-, Sox10LacZ/+, 
and Ets1+/-::Sox10LacZ/+ mice in generation 1. The population means are significantly 
different (p<0.001, α=0.05). 
 
 
Table A.4. Contrast Coefficients assigned to Ets1+/-, Sox10LacZ/+, and Ets1+/-::Sox10LacZ/+ 
mice in generation 1. These contrast coefficients were assigned to test whether the mean 
area of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice was significantly greater than the 
sum of the mean areas of hypopigmentation of Ets1+/- and Sox10LacZ/+ mice. 
 
 
 
 
 
Test of Homogeneity of Variances 
Area_mm2_Lambda0.35 
Levene Statistic df1 df2 Sig. 
3.200 2 118 .044 
	  
ANOVA 
Area_mm2_Lambda0.35 
 Sum of Squares df Mean Square F Sig. 
Between Groups 194.741 2 97.370 45.967 .000 
Within Groups 249.958 118 2.118   
Total 444.699 120    
	  
Contrast Coefficients 
Contrast Genotype 
Ets1+/- Sox10+/- Ets1+/-::Sox10+/- 
1  1 1 -2 
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Table A.5. Contrast test comparing the sum of the mean areas of hypopigmentation in 
Ets1+/- and Sox10LacZ/+ mice to the mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+ 
mice in generation 1. The mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice is 
significantly greater than the sum of the mean areas of hypopigmentation of Ets1+/- and 
Sox10LacZ/+ mice (equal variances not assumed (Table A.2), p<0.001, α=0.05). 
 
C. Normal Q-Q plots of original and transformed hypopigmentation area data for 
generation 2 (F2) 
 
Figure A.2 Normal Q-Q plots of raw and transformed hypopigmentation area data for 
generation 2. Normal Q-Q plots before (A) and after (B) applying the Box-Cox 
transformation using a lambda value of 0.3. The transformed data have a distribution that 
more closely resembles the normal distribution. 
 
 
 
 
 
 
Contrast Tests 
  
Contrast Value of 
Contrast 
Std. 
Error t df Sig. (2-tailed) 
Area_mm2_
Lambda0.35 
Assume equal variances  1 -5.6935 .59435 -9.579 118 .000 
Does not assume equal 
variances 
 
1 -5.6935 .56633 -10.053 63.517 .000 
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D. PAWS Output for One-Way ANOVA and contrasts of hypopigmentation areas of 
Generation 2 (F2) 
 
 
Table A.6. Descriptive statistics for Box-Cox-transformed hypopigmentation area data 
for generation 2. 
 
 
Table A.7. Levene’s test of Homogeneity of Variances for the areas of hypopigmentation 
of Ets1+/-, Sox10LacZ/+, and Ets1+/-::Sox10LacZ/+ mice in generation 2. The population 
variances are not significantly different (p=0.332, α=0.05). 
 
 
Table A.8. One-Way ANOVA for the areas of hypopigmentation of Ets1+/-, Sox10LacZ/+, 
and Ets1+/-::Sox10LacZ/+ mice in generation 2. The population means are significantly 
different (p<0.001, α=0.05). 
	  
Descriptives 
Area_mm2_Lambda0.3 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Ets1+/- 29 .8388 1.14211 .21208 .4044 1.2732 .00 3.62 
Sox10+/- 19 1.2997 1.36898 .31407 .6399 1.9595 .00 3.45 
Ets1+/-::Sox10+/- 28 3.5491 1.30402 .24644 3.0435 4.0548 .00 6.11 
Total 76 1.9526 1.75732 .20158 1.5510 2.3541 .00 6.11 
 
 
Test of Homogeneity of Variances 
Area_mm2_Lambda0.3 
Levene Statistic df1 df2 Sig. 
1.121 2 73 .332 
 
 
 
 
ANOVA 
Area_mm2_Lambda0.3 
 Sum of Squares df Mean Square F Sig. 
Between Groups 115.443 2 57.722 36.272 .000 
Within Groups 116.170 73 1.591   
Total 231.613 75    
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Table A.9. Contrast Coefficients assigned to Ets1+/-, Sox10LacZ/+, and Ets1+/-::Sox10LacZ/+ 
mice in generation 2. These contrast coefficients were assigned to test whether the mean 
area of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice was significantly greater than the 
sum of the mean areas of hypopigmentation of Ets1+/- and Sox10LacZ/+ mice. 
 
 
Table A.10. Contrast test comparing the sum of the mean areas of hypopigmentation in 
Ets1+/- and Sox10LacZ/+ mice to the mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+ 
mice in generation 2. The mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice is 
significantly greater than the sum of the mean areas of hypopigmentation of Ets1+/- and 
Sox10LacZ/+ mice (equal variances assumed (Table A.7), p<0.001, α=0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
Contrast Coefficients 
Contrast Genotype 
Ets1+/- Sox10+/- Ets1+/-::Sox10+/- 
 1 1 1 -2 
 
 
 
 
 
 
 
 
 
Contrast Tests 
  
Contrast Value of 
Contrast 
Std. 
Error t df Sig. (2-tailed) 
Area_mm2_
Lambda0.3 
Assume equal variances  1 -4.9597 .60495 -8.199 73 .000 
Does not assume equal 
variances 
 
1 -4.9597 .62172 -7.977 53.392 .000 
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E. Normal Q-Q plots of original and transformed hypopigmentation area data for 
generation 3 (F3) 
 
Figure A.3 Normal Q-Q plots of raw and transformed hypopigmentation area data for 
generation 3. Normal Q-Q plots before (A) and after (B) applying the Box-Cox 
transformation using a lambda value of 0.35. The transformed data have a distribution 
that more closely resembles the normal distribution. 
 
F. PAWS Output for One-Way ANOVA and contrasts of hypopigmentation areas of 
Generation 3 (F3) 
Table A.11. Descriptive statistics for Box-Cox-transformed hypopigmentation area data 
for generation 3. 
Descriptives 
Area_mm2_Lambda0.35 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Ets1+/- 26 1.1366 1.45646 .28564 .5484 1.7249 .00 4.32 
Sox10+/- 17 1.4384 1.78357 .43258 .5213 2.3554 .00 5.77 
Ets1+/-::Sox1o+/- 34 4.8214 1.63322 .28009 4.2516 5.3913 1.34 8.19 
Total 77 2.8303 2.39041 .27241 2.2877 3.3729 .00 8.19 
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Table A.12. Levene’s test of Homogeneity of Variances for the areas of 
hypopigmentation of Ets1+/-, Sox10LacZ/+, and Ets1+/-::Sox10LacZ/+ mice in generation 3. 
The population variances are not significantly different (p=0.613, α=0.05). 
 
 
Table A.13. One-Way ANOVA for the areas of hypopigmentation of Ets1+/-, Sox10LacZ/+, 
and Ets1+/-::Sox10LacZ/+ mice in generation 3. The population means are significantly 
different (p<0.001, α=0.05). 
 
 
Table A.14. Contrast Coefficients assigned to Ets1+/-, Sox10LacZ/+, and Ets1+/-
::Sox10LacZ/+ mice in generation 3. These contrast coefficients were assigned to test 
whether the mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice was significantly 
greater than the sum of the mean areas of hypopigmentation of Ets1+/- and Sox10LacZ/+ 
mice. 
 
 
 
Test of Homogeneity of Variances 
Area_mm2_Lambda0.35 
Levene Statistic df1 df2 Sig. 
.492 2 74 .613 
 
	  
 
ANOVA 
Area_mm2_Lambda0.35 
 Sum of Squares df Mean Square F Sig. 
Between Groups 242.313 2 121.156 46.707 .000 
Within Groups 191.954 74 2.594   
Total 434.267 76    
 
 
Contrast Coefficients 
Contrast Genotype 
Ets1+/- Sox10+/- Ets1+/-::Sox1o+/- 
 1 1 1 -2 
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Table A.15. Contrast test comparing the sum of the mean areas of hypopigmentation in 
Ets1+/- and Sox10LacZ/+ mice to the mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+ 
mice in generation 3. The mean area of hypopigmentation of Ets1+/-::Sox10LacZ/+ mice is 
significantly greater than the sum of the mean areas of hypopigmentation of Ets1+/- and 
Sox10LacZ/+ mice (equal variances not assumed (Table A.12), p<0.001, α=0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contrast Tests 
  
Contrast Value of 
Contrast 
Std. 
Error t df Sig. (2-tailed) 
Area_mm2_
Lambda0.35 
Assume equal variances  1 -7.0678 .74668 -9.466 74 .000 
Does not assume equal 
variances 
 
1 -7.0678 .76323 -9.260 62.390 .000 
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APPENDIX IV 
 
Figure A.4. Acetylcholinesterase staining on the distal portion of colons from Ets1+/-
::Sox10+/+ mice. For each colon shown, the nerve free area in 8 randomly selected 
0.25mm2 squares was measured using the ImageJ Program (NIH) (Magnifications A-E = 
16x, F=12.5x). 
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Figure A.5. Acetylcholinesterase staining on the distal portion of colons from Ets1+/-
::Sox10LacZ/+ mice. For each colon shown, the nerve free area in 8 randomly selected 
0.25mm2 squares was measured using the ImageJ Program (NIH) (Magnifications A-E = 
16x). 
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Figure A.6. Acetylcholinesterase staining on the distal portion of colons from Ets1-/-
::Sox10+/+ mice. For each colon shown, the nerve free area in 8 randomly selected 
0.25mm2 squares was measured using the ImageJ Program (NIH) (Magnifications A-H = 
16x). 
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Figure A.7. Acetylcholinesterase staining on the distal portion of colons from Ets1-/-
::Sox10LacZ/+ mice. For each colon shown, the nerve free area in 8 randomly selected 
0.25mm2 squares was measured using the ImageJ Program (NIH) (Magnifications A-E = 
16x). 
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APPENDIX V 
Ethanol Precipitation  
Ethanol precipitation was carried out to purify and concentrate plasmids to be used for 
transfections into mammalian cells. The process was carried out in a biosafety hood to 
avoid contamination. To each plasmid, 2.5 volumes of 100% ethanol (Fisher Scientific) 
and one tenth volume of 3M Na+ Acetate (Fisher Scientific) were added and the samples 
mixed gently by inverting. Plasmids were incubated overnight at -???????????????????????
????????????????????????????????????????????????????????? ??????????? ???? ????????????
discarded. Plasmids were washed with 70% Ethanol (diluted in Nuclease-free water 
(Thermo Scientific)????????????????????????????????????? ????????????????????????????????
the supernatant plasmid pellets were allowed to dry for 10 minutes at room temperature. 
Plasmids were then re-suspended in nuclease-free water and the concentration of each 
plasmid was measured using a spectrophotometer. All plasmids were diluted to the 
desired final concentrations using nuclease-free water. 
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